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When a chemist determines the structure of a different natural product or 
synthesises a new compound, the effect of a small chemical change — a 
double bond moved here, an oxygen atom substituted there, an alteration to a 
side group — often seems of little consequence. It is only with hindsight that 
we recognise the momentous effect that very small chemical changes can 
have. 
– Penny Le Couteur, Napoleon’s Buttons 
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Abstract 
 
The shikimate pathway is a biosynthetic pathway that is responsible for producing a variety 
of organic compounds that are necessary for life in plants and microorganisms. The pathway 
consists of seven enzyme catalysed reactions beginning with the condensation reaction 
between D-erythrose 4-phosphate (E4P) and phosphoenolpyruvate (PEP) to give the seven-
carbon sugar DAH7P. 
 
 
 
This thesis describes the design, synthesis and evaluation of a range of alternative non-natural 
four-carbon analogues of E4P to help to probe the substrate specificity of the different types 
of DAH7P synthases. 
 
Chapter 2 describes the synthesis of 2- and 3-deoxyE4P and their evaluation on the type II 
DAH7P synthase from M. tuberculosis. These E4P analogues were found to be substrates for 
this type II enzyme, indicating that removal of either the C2 or C3 hydroxyl groups on E4P 
does not completely disrupt catalysis. 
 
 
 
iii 
In Chapter 3, the synthesis of 3-methylE4P and the attempts to synthesise 2-methylE4P are 
described. 3-MethylE4P was prepared in nine steps from DL-malic acid and was found not to 
be a substrate for the type Iα DAH7P synthase (phe) from E. coli. 
 
 
 
Chapter 4 describes the synthesis of 2,3-dideoxy erythrose 4-phosphonate 4.38 and the 
attempts at synthesising the phosphonate analogue of E4P, D-erythrose 4-phosphonate. 
Compound 4.38 was prepared in overall eight steps from butan-1,4-diol. Evaluation of 
compound 4.38 on the type Iα DAH7P synthase (phe) from E. coli found that it was not a 
substrate for this enzyme. 
 
 
 
In Chapter 5, the substrate specificity of DAH7P synthases are discussed and interpreted. 
Predicted outcomes for 2-methylE4P and D-erythrose 4-phosphonate are also included. 
Several approaches are described for the completion and advancement of the studies 
presented here in this thesis. 
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Chapter 1:  Introduction 
 
1.1 The shikimate pathway 
 
The shikimate pathway (Figure 1.1) is a biosynthetic pathway that is responsible for 
producing a variety of organic compounds that are necessary for life in plants and 
microorganisms. The pathway consists of seven enzyme catalysed reactions beginning with 
the condensation reaction between D-erythrose 4-phosphate (E4P) and phosphoenolpyruvate 
(PEP), and ultimately ending with the synthesis of chorismate.1-3 
 
 
Figure 1.1: The shikimate pathway. 
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The shikimate pathway is named after its central metabolic intermediate, shikimic acid, 
which was first isolated from Illicium religiosum (in Japanese, shik-imi-no-ki) in 1885.4 
However, the structure and stereochemistry of shikimic acid was not determined until the 
1930s and it was not till the 1950s that the structure of shikimic acid was noted to be similar 
to that of aromatic compounds. Subsequently, shikimic acid was found to be an important 
intermediate in the biosynthesis of aromatic compounds.5,6 
 
Chorismate, the end product of the shikimate pathway, is a highly important precursor for the 
synthesis of the essential aromatic amino acids phenylalanine, tyrosine and tryptophan, as 
well as other important aromatic compounds such as ubiquinones (an electron transfer agent 
used in cellular respiration) and para-aminobenzoic acid (PABA) which is converted into 
folates (Figure 1.2).7,8 
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O
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NH3+
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CO2-
HN NH3+
CO2-
PEPE4P +
O
O
H
10
ubiquinone
para-aminobenzoic acid
O
O-
+H3N
folates
H3CO
H3CO
 
Figure 1.2: Chorismate is a key precursor for the biosynthesis of aromatic amino acids, ubiquinones and folates. 
 
The shikimate pathway is essential for the production of the aromatic amino acids in plants, 
bacteria and fungi, but the pathway is absent in animals. The absence of this pathway in 
animals makes this pathway an important target for the action of herbicides and  
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antibiotics.9-11 One such example is the herbicide glyphosate (Roundup®, Sigma)1,9,12, a 
compound of enormous commercial and agricultural importance as it inhibits the sixth 
enzyme of the pathway (Figure 1.3), 5-enolpyruvyl-shikimate 3-phosphate (EPSP) synthase. 
In addition to being a potent broad spectrum herbicide it has been successfully tested on mice 
as a therapeutic agent against diseases such as toxoplasmosis and malaria.1,13,14 
 
 
Figure 1.3: The structure of N-(phosphonomethyl) glycine (Glyphosate), a broad spectrum herbicide used to kill 
weeds. Also know as Roundup®. 
 
1.2 DAH7P synthase 
 
The first step of the shikimate pathway is catalysed by the enzyme 3-deoxy-D-arabino-
heptulosonate 7-phosphate (DAH7P) synthase. The enzyme catalyses the condensation 
reaction between E4P, an intermediate of the pentose-phosphate cycle, and PEP, an 
intermediate of the glycolytic pathway, to give the seven carbon sugar DAH7P (Figure 
1.4).12,15 It constitutes the first committed step in the biosynthesis of aromatic amino acids, 
various aromatic cofactors and secondary metabolites that are formed in microorganisms, 
plants and fungi. The reaction catalysed by DAH7P synthase was first demonstrated 
experimentally in 1959 in Escherichia coli cellular extracts.16,17 
 
 
Figure 1.4: The reaction catalysed by the first enzyme, DAH7P synthase, in the shikimate pathway. 
 
There is also a very closely related enzyme to DAH7P synthase, 3-deoxy-D-manno-
octulosaonate 8-phosphate (KDO8P) synthase. KDO8P synthase catalyses a similar reaction 
to that of DAH7P synthase, except that D-arabinose 5-phosphate (A5P) is used in place of 
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E4P to form 3-deoxy-D-manno-octulosonate 8-phosphate (KDO8P), an eight carbon analogue 
of DAH7P. This enzyme is described in a later section (page 21). 
 
1.2.1 Classification 
 
The family of DAH7P synthases can be broadly divided into two groups based on amino acid 
sequence and molecular mass, and are classified as type I or type II DAH7P synthases 
according to Walker et al. (Figure 1.5).18 The type I and type II DAH7P synthases have also 
been referred to as the AroAI and AroAII families, respectively, by Gosset et al.19 
 
 
Figure 1.5: The families of DAH7P synthases, based on sequence relationships. 
 
Type I DAH7P synthases are defined as having an E. coli-like sequence with molecular 
masses of less than 40 kDa; and represent the most well characterised family of DAH7P 
synthases. The type I DAH7P synthases can be further divided into two subfamilies, denoted 
Iα and Iβ, based on sequence similarity.20 Subfamily Iα consist entirely of DAH7P synthases 
and include the structurally characterised enzymes from E. coli21-24 and Saccharomyces 
cerevisiae.25-27 Subfamily Iβ on the other hand contain both DAH7P synthases (subfamily 
IβD) and KDO8P synthases (subfamily IβK), based on sequence similarities.28 The Iβ 
subfamily is also considered to be ancestral to all DAH7P and KDO8P synthases with ancient 
lineages such as Pyrococcus furiosus and Thermotoga maritima.29 The IβD are functionally 
related to the Iα enzymes (catalysing the same reaction between E4P and PEP) but bear more 
structural similarities with the IβK enzymes.20 The IβK enzymes can also be further divided 
into metallo30 and non-metallo enzymes.31 All DAH7P synthase are metallo enzymes. 
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Type II DAH7P synthases are defined as “plant-like” homologues with a molecular mass 
around 54 kDa. Additionally, type II DAH7P synthases were originally identified in plant 
proteins, they are now known to encompass a diverse set of microbial protein and include the 
bacterial DAH7P synthases from Mycobacterium tuberculosis and Streptomyces.12,19 
 
A phylogenetic tree based on sequence similarity between type I enzymes has been 
constructed by Jensen et al. (Figure 1.6).29 The subfamily Iα contains only DAH7P synthases. 
All of which have feedback regulation. Subfamily Iβ consists of the subfamilies IβD and IβK, 
representing the DAH7P and KDO8P synthases, respectively. Among the structurally 
characterised members of subfamily Iβ, only the T. maritima DAH7P synthase has feedback 
regulation. Birck et al.28 have suggested that DAH7P and KDO8P synthases are evolutionally 
related by divergent evolution from a common ancestor and are based on the two enzymes 
having similar proposed mechanisms and very similar monomer structures. Gosset et al.19 
proposed that due to the widely distributed Iβ enzymes found in nature, the ancestral form of 
DAH7P synthase must be a Iβ-like protein. Subramaniam et al.20 proposed that substrate 
specificity could explain the differences between the Iα and Iβ subfamilies, and that ancient 
proteins had broad substrate specificities which narrowed over time. For example, the 
enzyme from P. furiosus, a IβD DAH7P synthase, is considered one of the most closely 
related enzymes to the ancestral enzyme, and displays a broad substrate specificity and no 
feedback regulation.32 
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Figure 1.6: Phylogentic tree of homology type I proteins consisting of subfamilies Iα and Iβ modified from Jensen et 
al.29 Subfamily I contain only DAH7P synthase proteins that have feedback regulation. Subfamily I consists of 
subfamily ID (DAH7P synthases) and subfamily IK (KDO8P synthases). The white circle indicates the hypothetical 
root. 
 
1.2.2 Feedback regulation 
 
The first step of the shikimate pathway, catalysed by DAH7P synthase, regulates carbon flow 
though the entire pathway by feedback regulation. In addition, the shikimate pathway is 
responsible for up to 30% of the total carbon flux within the cell, so this makes DAH7P 
synthase a vital part of the overall control of cellular carbon flux.15 E. coli DAH7P synthase 
has three isozymes, each sensitive to feedback regulation by one of the three aromatic amino 
acid products of the pathway; phenylalanine, tyrosine or tryptophan. DAH7P synthase (phe), 
the phenylalanine inhibited isozyme of DAH7P synthase, is responsible for about 80% of the 
total activity in E. coli.15 The rest of the activity is made up from the tyrosine-sensitive 
isozyme, DAH7P synthase (tyr), and the tryptophan-sensitive isozyme, DAH7P synthase 
(trp), which accounts for ~20% and <1% activity, respectively.33 The structural genes, aroG, 
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aroF and aroH are scattered over the E. coli chromosome and encode the phenylalanine-, 
tyrosine-, and tryptophan-sensitive DAH7P synthases, respectively.34 
 
Not all DAH7P synthases are inhibited by the three aromatic amino acids in the same way as 
the enzymes from E. coli. Different microorganisms express between one and three isozymes 
of DAH7P synthase which are inhibited by end products or intermediates of the pathway, or a 
combination of the two, while some enzymes are entirely unregulated.18 For example, 
DAH7P synthase from the hyperthermophile T. maritima is inhibited by phenylalanine or 
tyrosine, but not by tryptophan, and the enzyme from the extremophile P. furiosus is not 
inhibited by phenylalanine, tyrosine or tryptophan.7,35 
 
Structural and kinetic studies have provided some insight into the mechanism by which this 
feedback regulation works. All DAH7P synthases characterised to date, except P. furiosus, 
have some kind of decoration on the basic (β/α)8 barrel (Figure 1.7).25 The Iα proteins from 
E. coli and S. cerevisiae have an N-terminal extension and a β-sheet inserted between the α5 
and β6 strands of the barrel. The type II enzyme from M. tuberculosis has a major extension 
at the N-terminus and a pair of α-helices inserted into the α2-β3 connecting loop. Evidence 
based on studies with S. cerevisiae, P. furiosus and M. tuberculosis suggests that these 
decorations contain the binding sites for allosteric inhibitors (Figure 1.7).36-39 Studies on the 
tyrosine-sensitive S. cerevisiae DAH7P synthase showed that by deleting the N-terminal 
extensions the enzyme becomes unregulated.25 The lack of feedback regulation of the P. 
furiosus enzyme can be explained by the absence of the regulatory extensions on the 
enzyme.35 Like P. furiosus DAH7P synthase, KDO8P synthases have only a basic barrel 
structure and are unregulated.31 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
 
Figure 1.7: The monomer structures of (a) E. coli DAH7P synthase (phe) (PDB code 1KFL), (b) S. cerevisiae DAH7P 
synthase (tyr) (PDB code 1OF6), (c) T. maritima DAH7P synthase (PDB code 1RZM), (d) P. furiosus DAH7P synthase 
(PDB code 1ZCO), (e) E. coli KDO8P synthase (PDB code 1D9E), and (f) Aquifex aeolicus KDO8P synthase (PDB 
code 1FWW). Structures from Meekyung Ahn.40 The views of the structures are looking down their (/)8-barrel. 
The overall structures of T. maritima and P. furiosus DAH7P synthases appear to be more similar to those of E. coli 
and A. aeolicus KDO8P synthases than those of E. coli and S. cerevisiae DAH7P synthases. The helices and loops are 
highlighted in blue and N-terminal extension, along with extended loops, is highlighted in red. The extra extension 
and loops are implicated in feedback regulation. P. furiosus DAH7P synthase, and E. coli and A. aeolicus KDO8P 
synthases do not have feedback regulation and lack N-terminal extensions. 
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1.2.3 Metal activation 
 
Studies testing the sensitivity of DAH7P synthases to the presence of metal ions and to the 
metal chelator ethylenediaminetetraacetic acid (EDTA), have found that all DAH7P 
synthases characterised to date require a divalent metal ion for activity.22,42-46 Although the 
role of the divalent metal ion for the reaction catalysed by DAH7P synthase is still unclear. 
These studies showed that DAH7P synthases completely lost activity in the presence of 
EDTA and were reactivated by the addition of metal ions. Additionally, sequence alignments 
have shown that all identified DAH7P synthases possess the metal-binding residues Cys, His, 
Glu and Asp.46 
 
Although DAH7P synthases appear to have an absolute requirement for the presence of a 
divalent metal ion, there is considerable variation in the ability of different metal ions to 
activate the enzyme after treatment with a metal chelator. The extent to which a given metal 
ion can do this in vitro differs from species to species and also in the different isozymes of 
the same organism.35,38,47 For example, the tyrosine regulated isozyme of S. cerevisiae is most 
activated by Co2+, whilst the phenylalanine regulated isozyme is most activated by Mn2+.26 
 
The three isozymes of DAH7P synthase from E. coli and their specific reactions by various 
metal ions has been reported by Stephens et al.48; with the order of activation as follows: 
Mn2+ > Cd2+, Fe2+ > Co2+ > Ni2+, Cu2+, Zn2+ >> Ca2+. Interestingly, although Mn2+ showed 
the highest activity with all three isozymes of DAH7P synthase from E. coli, the Mn2+ bound 
to the enzymes is highly labile and can be displaced by other metals. In contrast, the Fe2+, 
Co2+ and Zn2+ enzyme complexes are considerably less labile. These workers suggested that 
Fe2+ and perhaps Zn2+ may be the preferred metal cofactors in vivo. 
 
There has been an ongoing debate in literature regarding the nature of the metal ion at the 
active site of DAH7P synthase in vivo. A variety of metal ions have been proposed to reside 
at the active site under physiological conditions.7,49 The metal present in E. coli DAH7P 
synthase (phe) from in vivo studies was thought to be Co2+ or Fe2+ or even Cu2+ as these 
metals were found in the enzyme solution after purification.42,43,50,51 Analysis of purified 
samples of E. coli DAH7P synthase (phe) using atomic absorption spectroscopy by Stephens 
et al.48, indicated Fe2+, Zn2+, Cu2+, Mn2+ and Co2+ metal ions to be present in the enzyme. As 
mentioned before, it was suggested that Fe2+ and perhaps Zn2+, may be the preferred metal 
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cofactors in vivo and was based on the presence of these two metals before removal by 
chelation, their high bioavailability, and the high affinity of the enzymes for these metal ions 
in vitro.48 
 
It is clear from these studies that DAH7P synthases are activated by a wide range of divalent 
metal ions and that all DAH7P synthases, to date, require a metal for enzyme activity. 
However, after more than 30 years of research, the nature of the physiological metal ion at 
the active site is still an open question and the metal ion is likely to depend on various factors 
such as bioavailability and growth conditions.7 
 
The presence of high concentrations of metal ions in enzymes can also cause the inactivation 
of the enzyme, in particular it has been shown that in the absence of the substrate PEP, redox-
active metal ions (e.g. Cu2+ and Fe2+) catalyse the inactivation of E. coli DAH7P synthase 
(phe).52 The inactivation of this enzyme is caused by the metal-catalysed oxidation of two 
cysteine residues, Cys61 and Cys328, which is not seen when the enzyme is treated with 
EDTA. The presence of high metal concentrations allows a conformational change in the 
active site of the enzyme, causing the thiol groups of Cys61 and Cys328 to be orientated in a 
position to enable disulfide bond formation. The binding of PEP in the active site presumably 
hinders this conformational change.20,52,53 Studies on M. tuberculosis DAH7P synthase have 
identified the formation of disulfide bonds between the metal-binding Cys61 and other Cys 
residues.37 Reducing agents such as tris(2-carboxyethyl)phosphine (TCEP) have to be added 
to reactions in order to maintain full enzyme activity.38,47 
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1.2.4 Mechanism 
 
The mechanism of DAH7P synthase has been investigated widely in literature and several 
studies have provided valuable information on the mechanism. Analysis of the product of the 
reaction utilising stereospecifically labelled PEP has shown that the addition of PEP to E4P 
proceeds stereospecifically with the si face of PEP attacking the re face of E4P (Figure 1.9) 
to produce the seven carbon sugar DAH7P.54,55 
 
 
Figure 1.9: The stereospecific reaction between PEP onto E4P catalysed by DAH7P synthase. 
 
Labelling studies using 18O have shown that DAH7P synthase catalyses the unusual cleavage 
of the C-O bond rather the P-O bond of PEP.56 Typical enzymes utilising PEP make use of 
the high energy contained in the phosphate ester bond (Gº = −62 kJ mol-1) by cleavage of 
the P-O bond of PEP; only a few enzymes such as EPSP synthase and UDP-N-acetyl-
glucosamine enolpyruvyltransferase (MurA), cleave via the C-O bond in PEP.57,58 
 
It was originally thought the reaction between E4P and PEP catalysed by DAH7P synthase 
followed a ping-pong mechanism59, but this was eventually disproven through detailed 
kinetic studies.45 In fact, the reaction proceeds though an ordered sequential mechanism, with 
PEP binding first before E4P, followed by the release of phosphate and then DAH7P.45 
 
The exact mechanism of DAH7P synthase has been the subject of ongoing controversy. Two 
possible mechanisms have been proposed (Figure 1.10). These differ by the order in which 
water adds to PEP and PEP adds to E4P. 
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In path A (Figure 1.10), the C3 of PEP attacks the metal-activated carbonyl group of E4P to 
form the oxocarbenium ion intermediate 1.1. The mechanism then diverges into two possible 
pathways for the synthesis of DAH7P, the acyclic path (a) and the cyclic path (b). In the 
acyclic pathway, the intermediate 1.1 is attacked by water to give the labile phosphate 
hemiketal intermediate 1.4. This intermediate then undergoes loss of phosphate forming the 
acyclic DAH7P 1.5, and giving the observed C-O phosphate bond cleavage. The DAH7P 
sugar is then released, followed by spontaneous cyclisation in solution to give the more stable 
hemiacetal form of DAH7P. In the cyclic pathway (Path A, Figure 1.10) the oxocarbenium 
ion intermediate 1.1 cyclises to give the cyclic hemiketal biphosphate compound 1.2. 
Cyclisation is achieved by the hydroxyl group on C3 of E4P attacking the carbocation formed 
at C2 of PEP. The biphosphate compound 1.2 then undergoes a C-O bond cleavage to give 
the cyclic oxonium ion 1.3, with the release of inorganic phosphate. Water then attacks the 
C2 position of the oxonium ion 1.3 to give the cyclic form of DAH7P.56,58,60,61 
 
The proposed mechanism shown in path B (Figure 1.10) begins with the formation of a 
carbanion intermediate 1.6 that is formed by the attack of a hydroxide ion onto the C2 
position of PEP (the hydroxide ion is produced by the deprotonation of a metal-water 
complex). The carbanion 1.6 then attacks the carbonyl group of E4P to give the labile 
phosphate hemiketal intermediate 1.4. Intermediate 1.4 then follows the same route as the 
acyclic path (a) mentioned before, eventually giving the cyclic DAH7P.45,61-64 
 
Both path B and the cyclic pathway of path A have been discredited due to a number of 
factors and the most plausible mechanistic route is seen in the acyclic pathway of path A. 
Path B requires the existence of an unstabilised carbanion, with a likely pKa of > 30, inside 
the enzyme active site that contains carbon-hydrogen bonds of greater acidity in addition to 
water molecules, carboxylic acids and ammonium ions. Any of these species in the active site 
could potentially and immediately quench the carbanion long before it has a chance to attack 
E4P making path B an implausible mechanism.65 The cyclic pathway in path A, has been 
discredited by a number of observations. Firstly, the compound 3-deoxyE4P has been shown, 
by Dr Amy Pietersma66 and in this thesis (Chapter 2), to be a substrate for DAH7P synthase. 
If only the cyclic mechanism operated, then 3-deoxyE4P should not be a substrate as the C3-
hydroxy group in E4P is required for cyclisation in this pathway. Therefore, this cyclic 
pathway is not the exclusive mechanism for the formation of DAH7P. Secondly, studies of 
the structure of DAH7P synthase active site has shown the active site to be a long linear 
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There is a channel leading to PEP from the top of the (β/α)8 barrel in the active site of E. coli 
DAH7P synthase. C3 of PEP, which forms a covalent bond with C1 of E4P in the 
condensation reaction (Figure 1.10, page 13), is pointed towards this opening. Additionally, 
the structure shows a sulphate ion in this channel and it has been suggested that this sulphate 
ion occupies the binding site of the phosphate of E4P.21,63 When the phosphate group of E4P 
is docked to the sulphate ion binding site, E4P in the extended conformation fits into the 
channel leading to the bound PEP molecule. The C1 of E4P can approach to within 3.0 Å of 
C3 of PEP.21 
 
While to date there is no structure that shows E4P bound in the active site of DAH7P 
synthase in a manner competent for reaction, the structure of S. cerevisiae DAH7P synthase 
(tyr) has been determined containing bound Co2+, PEP and D-glycerol 3-phosphate (G3P) 
(Figure 1.14) and provides some insight into the probable binding site of E4P.61 
 
 
Figure 1.14: Structures of G3P and E4P. 
 
In the active site of S. cerevisiae DAH7P synthase (tyr)-Co2+-PEP complex (Figure 1.15), the 
C3 hydroxyl group in G3P, corresponding to C2 hydroxyl group of E4P, is hydrogen bonded 
to Asp342 and the C2 hydroxyl group of G3P, corresponding to C3 hydroxyl group of E4P, is 
hydrogen bonded to the main chain carbonyl group of Pro113. The position of G3P in this 
structure has been used to infer information about the binding of E4P in the active site. 
Pro113 has been found to be a conserved residue in all DAH7P synthases and is part of a 
conserved LysProArgThr(Ser) motif found in all DAH7P synthases. The phosphate moiety of 
G3P forms salt bridges to the guanidino group of Arg114 and hydrogen bonds to both the N 
and O atom of Thr115. This phosphate binding site coincides with the sulphate binding site in 
the structure of E. coli DAH7P synthase (phe). 
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Figure 1.16: Active site in the DAH7P synthase Co2+-PEP-G3P complex from S. cerevisiae (tyr) after replacement of 
G3P by E4P and modelling of the carbonyl group of E4P. Diagram from Konig et al.61 
 
The structure of the type II DAH7P synthase from M. tuberculosis was recently solved by 
Webby et al.38 as a PEP-Mn2+ complex. The quaternary structure is a homotetramer 
consisting of two tight dimers (Figure 1.17). Each dimer consists of a (β/α)8 TIM barrel, as is 
found in type I DAH7P synthases and the closely related KDO8P synthases. As is typical for 
TIM-barrel enzymes like E. coli DAH7P synthase (phe), the active site of M. tuberculosis 
DAH7P synthase is located at the C-terminal end of the barrel at the bottom of a deep cavity 
with Mn2+ and PEP bound. 
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various glycolipids coating the surface of the outer membrane of Gram-negative organisms, 
including the lipopolysaccharide (LPS) region.24,68,69 As the formation of the LPS is essential 
for the growth and virulence of Gram-negative organisms, KDO8P synthase has been a target 
for the development of novel anti-infective agents.70-72 
 
 
Figure 1.20: Biosynthesis of Lipid A from ribose 5-phosphate. 
 
The two substrates, A5P and E4P, are similar with only a difference in carbon chain length 
and stereochemistry; A5P is longer by one carbon length and the stereochemistry at C2 is 
inverted compared to E4P (Figure 1.21). Both enzymes catalyse an aldol-like condensation 
reaction of which the si face of PEP attacks the re face of their respective phosphorylated 
monosaccharide and are part of a unique class of PEP-utilising enzymes in which loss of the 
phosphate moiety of PEP occurs through cleavage of the C-O bond rather than through the 
more common mode in which the O-P bond is broken.24 
 
 
Figure 1.21: Structures of A5P and E4P. 
 
DAH7P and KDO8P synthases catalyse different reactions and there is very little primary 
sequence similarity between the two enzymes e.g. only 13% of the residues are identical 
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between the E. coli KDO8P synthase and the E. coli DAH7P synthase. Despite these 
differences, the two enzymes have strong similarities in regards to their mechanism and 
structures.20 Due to these similarities these enzymes are often compared.24,31 
 
1.2.7 Inhibitors 
 
The design of inhibitors for DAH7P synthase has been of great interest in our laboratory and 
in literature.73-75 As previously mentioned, DAH7P synthase is the first enzyme in the 
shikimate pathway, which leads to the synthesis of aromatic amino acids and other aromatic 
metabolites in microorganisms and plants. The disruption of this pathway leads to death of 
microorganisms and plants and makes it an attractive target for the development of new anti-
infectious agents without side effects. Unfortunately, little has been published on inhibitors of 
DAH7P synthase.75-77 
 
Designing inhibitors that mimic the transition state or intermediates can lead to very high 
potencies and the best ligand for an enzyme is likely to be the transition state or a high energy 
intermediate for the reaction, rather than the substrate or products.65,78 
 
KDO8P synthase and DAH7P synthase share strong mechanistic similarities between their 
respective reactions and it has been proposed that it should be possible to inhibit DAH7P 
synthase by mimicking the oxocarbenium ion intermediate 1.1 involved in the DAH7P 
synthase reaction (Figure 1.10, page 13). This was the basis of several of the inhibitors 
synthesised by Scott Walker in our laboratory.65 One such inhibitor that was synthesised and 
tested is the bisubstrate inhibitor 1.7 which mimics the oxocarbenium ion 1.1 (Figure 1.22). 
The inhibitor 1.7 was based on another inhibitor, the aminophosphonate inhibitor 1.9, which 
inhibits E. coli KDO8P synthase strongly (Ki = 50±8 µM, Figure 1.22).76,77 Inhibitor 1.7 was 
shown to be a very slow binding inhibitor of E. coli DAH7P synthase (phe) with an IC50 
value of 6.6 μM.79 
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Figure 1.22: Inhibitors of KDO8P synthase and DAH7P synthase and their putative oxocarbenium ion intermediates. 
 
Several PEP mimicking inhibitors of DAH7P synthase were synthesised as part of Scott 
Walker65 and Hemi Cumming’s80 thesis work, beginning with the (R)- and (S)-
phospholactates 1.10 and 1.11 (Figure 1.23) which were designed based on their similarity to 
the oxocarbenium ion intermediate 1.1 (Figure 1.10 and Figure 1.22).81 Both phospholactates 
had previously been synthesised in a study of PEP utilising enzymes and were found to be 
moderately effective inhibitors of PEP carboxykinase, pyruvate kinase and enolase.82 Other 
inhibitors included the PEP mimics 1.12–1.15. All the compounds were found to be 
competitive inhibitors of E. coli DAH7P synthase (phe) (with respect to PEP), with the 
exception of compound 1.14 which did not inhibit the enzyme (Figure 1.23). 
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Figure 1.23: PEP-mimicking inhibitors. All compounds inhibited E. coli DAH7P synthase (phe) except 1.14. 
 
Grison et al.75 have synthesised a mechanism based inhibitor mimicking the open chain 
hemiketal intermediate 1.4. This inhibitor, compound 1.16, differs from the intermediate 1.4 
in that the labile C-O phosphate bond is replaced by a more stable C-C linkage i.e. a 
phosphonate moiety (Figure 1.24). 
 
 
Figure 1.24: The hemiketal intermediate 1.4 and the inhibitor 1.16 synthesised by Grison et al.75 
 
Although no kinetic data was reported for the above mechanistic inhibitor by Grison et al., 
the authors did report that this compound had antibacterial activity inhibiting the growth of E. 
coli, Yersinia enterocolitica and Pseudomonas aeruginosa Gram-negative bacteria on 
Mueller-Hinton agar plates.75  
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1.3 Substrate specificity of DAH7P synthase 
 
Substrate analogues are a tool that has been used widely in literature and in our research 
laboratory for studying enzyme-substrate interactions, and for the investigation into 
enzymatic reaction mechanisms. PEP and E4P are the natural substrates for DAH7P synthase 
but this enzyme has been shown to accept a wide range of alternative non-natural substrates 
(to varying degrees) and the substrate specificity is described in the next sections. 
 
1.3.1 PEP analogues 
 
Substrate specificity studies have been performed using substrate analogues of PEP on 
DAH7P synthase. These include the C3-substituted PEP analogues (Z)-3-chloroPEP 1.17, 
(Z)-3-bromoPEP 1.18, (Z)-3-methylPEP 1.19, (Z)-3-fluoroPEP 1.20 and (E)-3-fluoroPEP 
1.21 (Figure 1.25).83 These four PEP analogues were tested as substrates for E. coli DAH7P 
synthase (phe) and was found that both isomers of (Z)- and (E)-3-fluoroPEP were substrates 
for DAH7P synthase (phe) with KM values of 4.0 and 18 µM, respectively (Table 1.1). These 
higher KM values, coupled with the extremely low kcat values, suggests that (Z)- and (E)-3-
fluoroPEP are poorer substrates for E. coli DAH7P synthase (phe) when compared to the 
natural substrate PEP. 
 
 
Figure 1.25: PEP analogues 1.17–1.21. 
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The (Z)-3-chloroPEP 1.17, (Z)-3-bromoPEP 1.18 and (Z)-3-methylPEP 1.19 analogues of 
PEP were not substrates for E. coli DAH7P synthase (phe), and were found to be only weak 
reversible competitive inhibitors (Table 1.1). This indicates that the size of the substituent on 
C3 of PEP is a factor, as fluorine is the only substituent that is comparable in size with the 
hydrogen that it is replacing. 
 
Substrate KM (M) Ki (M) kcat (s-1) kcat/KM (s-1µM-1) 
PEP 2.00.2  713 36 
(E)-3-fluoroPEP 1.21 4.00.4  1.00.2 0.3 
(Z)-3-fluoroPEP 1.20 181  4.10.2 0.2 
(Z)-3-chloroPEP 1.17  316   
(Z)-3-methylPEP 1.19  16030   
(Z)-3-bromoPEP 1.18  25050   
Table 1.1: Analogues of PEP as substrates and inhibitors of E. coli DAH7P synthase (phe).83  
 
Along with the C3-substituted PEP analogues, the difluoromethylenephosphonate 1.22, and 
phosphoamidate 1.23 analogues of PEP have been tested as substrates on E. coli DAH7P 
synthase (phe) (Figure 1.26). None of these analogues were substrates for DAH7P synthase 
indicating the intolerance to changes in the phosphate moiety of PEP.83 
 
 
Figure 1.26: PEP analogues 1.22 and 1.23. 
 
1.3.2 E4P analogues 
 
Three, five and six carbon sugar analogues of E4P have been used to probe the substrate 
specificity of three different families of DAH7P synthase and include E. coli DAH7P 
synthase (phe) (type Iα), P. furiosus DAH7P synthase (type Iβ) and Helicobacter pylori 
DAH7P synthase (type II).24,32,47 A summary of the kinetic data for these enzymes is shown 
in Table 1.2. 
 
C
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Substrate 
DAH7P Source 
E. coli (phe) (type Iα) P. furiosus (type Iβ) H. pylori (type II) 
KM (µM) kcat (s-1) kcat/KM (s-1µM-1) KM (µM) kcat (s-1) kcat/KM (s-1µM-1) KM (µM) kcat (s-1) kcat/KM (s-1µM-
1) 
 E4P  
141 10 0.07 9±1 1.4±0.1 0.2 6±1 3.3±0.3 0.6 
1.24  
NS   NS   NS   
A5P  
30 0.054 0.002 2700±200 1.1±0.1 0.0004 4800±360 0.3±0.01 0.00006 
1.25  
6000 0.72 0.0001 1580±110 2.5±0.1 0.002 1700±400 3.5±0.2 0.002 
1.26  
6800 0.46 0.00007 2500±150 1.7±0.1 0.0007 2300±500 0.95±0.06 0.0004 
  
NS   NS   NS   
Table 1.2: Kinetic constants of E. coli, P. furiosus and H. pylori DAH7P synthases with alternative substrates of E4P. E. coli DAH7P synthase (phe) kinetic data from Sheflyan et al.24 
P. furiosus DAH7P synthase kinetic data from Schofield et al.32 H. pylori DAH7P synthase kinetic data from Webby et al.47 NS = not a substrate. 
G6P 
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Sheflyan et al.24 have determined that the type Iα E. coli DAH7P synthase can accept the five 
carbon sugars ribose 5-phosphate 1.25 (R5P, with the same C2 configuration as the natural 
substrate E4P), 2-deoxyribose 5-phosphate 1.26 (with no C2-hydroxyl) and A5P (with the 
opposite C2 stereochemistry to E4P) as substrates for this enzyme and produce KDO8P-like 
products. Although, the five carbon analogues were accepted as substrates by this type Iα 
enzyme, the KM values were significantly higher and the kcat values were extremely low 
compared to those obtained with E4P, indicating that these five carbon analogues were 
significantly poorer substrates for E. coli DAH7P synthase (phe) than the natural substrate. 
 
Schofield et al.32 have determined that the type Iβ P. furiosus DAH7P synthase was able to 
utilised the five carbon sugars 1.25, 1.26 and A5P as substrates. It was found that these five 
carbon sugars had similar kcat values as the natural substrate E4P. This is in contrast to the 
studies carried out on the Iα enzyme from E. coli by Sheflyan et al., which is only able to 
utilise these five carbon sugars with kcat values comparable to E4P. This indicates that this 
type Iβ P. furiosus DAH7P synthase is a more promiscuous enzyme compared to the type Iα 
E. coli DAH7P synthase. 
 
The substrate specificity of the type II H. pylori DAH7P synthase was examined by Webby et 
al.47 H. pylori DAH7P synthase was found to be able to utilise all three five carbon sugar 
analogues 1.25, 1.26 and A5P with greatly elevated KM values compared to E4P. 
Additionally, the kcat values for A5P and compound 1.26 were significantly lower than E4P, 
with the exception of compound 1.25 whose kcat value is comparable to E4P. The higher KM 
values and lower kcat values seen for the five carbon sugars on H. pylori DAH7P synthase 
were similar to the trends seen for the type Iα and Iβ enzymes (Table 1.2) i.e. all three 
families of DAH7P synthase had significantly higher KM values for these substrates when 
compared to E4P. This indicates that the five carbon sugar analogues examined were poorer 
substrate for all three families of DAH7P synthases, with the type Iβ enzyme being the most 
promiscuous, followed by the type II enzyme, while the type Iα enzyme showing the least 
tolerance to changes in substrate. 
 
Although all five carbon sugars were found to be substrates for type Iα, Iβ and II DAH7P 
synthases, none of these enzymes were able to utilise the three and six carbon sugars (D-
glyceraldehyde 3-phosphate 1.24 and D-glucose 6-phosphate (G6P) respectively). These 
findings are consistent with crystal structure studies of the active site of E. coli DAH7P 
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synthase (phe) with G3P bound by Shumilin et al.21 i.e. if a shorter carbon chain is bound in 
the active site, then the aldehyde is not close enough to react with C3 of PEP as the phosphate 
moiety of the aldose phosphate binds in the same position. A carbon chain longer than five 
carbons would be unlikely to fit in the active site.24 
 
Sheflyan et al.24 also discovered that the phosphate group on the sugars appeared to be 
absolutely essential for enzyme activity as the non-phosphorylated forms of the substrates 
E4P, A5P, 1.25 and 1.26 were not substrates for E. coli DAH7P synthase (phe) (Figure 1.27). 
Crystal structures have shown that the phosphate group has many binding interactions, so the 
phosphate group may be important for positioning the substrate into the proper location in the 
active site, thus orientating the carbonyl group for attack by PEP.24 
 
 
Figure 1.27: The non-phosphorylated versions of E4P, A5P, R5P (1.25) and 2-deoxyR5P (1.26). Erythrose, arabinose, 
ribose and 2-deoxyribose were all tested on E. coli DAH7P synthase (phe) and found not to be substrates for this 
enzyme. 
 
The tolerance of DAH7P synthase to configurational changes at C2 or C3 of natural substrate 
E4P has been previously studied in our laboratory by Meekyung Ahn.40 D-Threose 4-
phosphate (T4P) and L-threose 4-phosphate have been prepared synthetically from D-diethyl 
tartaric acid and L-diethyl tartaric acid respectively. These two substrate analogues of E4P 
have the opposite stereochemistry at C2 (D-T4P) or C3 (L-T4P) with respect to E4P (Figure 
1.28). 
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Figure 1.28: Substrate analogues of E4P with the opposite stereochemistry at C2 (D-T4P) or C3 (L-T4P). 
 
Substrate specificity tests on E. coli (type Iα) and P. furiosus (type Iβ) DAH7P synthases 
showed that both D- and L-T4P were alternative substrates for the two enzymes. The seven-
carbon phosphorylated sugar products of the enzymatic reactions for both D- and L-T4P were 
isolated and characterised by both NMR spectroscopy and mass spectrometry and were 
identified as the expected 3-deoxy D-lyxo heptulosonate 7-phosphate and 3-deoxy L-xylo 
heptulosonate 7-phosphate respectively. For E. coli DAH7P synthase (phe), a significant 
increase in the KM value was recorded with both substrates, whereas D- and L-T4P were 
utilised with a comparable catalytic efficiency to the natural substrate E4P for P. furiosus 
DAH7P synthase (Table 1.3). 
 
 
Substrate 
E. coli DAH7P synthase (phe) (type Iα) P. furiosus DAH7P synthase (type Iβ) 
KM (M) kcat (s-1) kcat/KM (s-
1µM-1) 
KM (M) kcat (s-1) kcat/KM (s-
1µM-1) 
E4P 39±4 26±2 0.7 9±1 1.4±0.1 0.2 
D-T4P 390±13 2.5±0.1 0.006 21±1 2.4±0.1 0.1 
L-T4P 750±10 1.5±0.1 0.002 47±3 4.0±0.1 0.09 
Table 1.3: Kinetic parameters of E. coli DAH7P synthase (phe) and P. furiosus DAH7P synthase with D- and L-T4P. 
 
The results with D- and L-T4P suggest that both enzymes can tolerate configurational changes 
to either the C2 or C3 hydroxyl groups from the natural substrate E4P. These observations 
suggest that the configurations of the C2 and C3 hydroxyl groups on E4P do not play a 
critical role in the DAH7P synthase enzymatic reaction.  
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1.4 Properties and preparation of E4P 
 
E4P is an extremely unstable and difficult to handle compound in solution.84 In aqueous 
solutions of ~1.0 M, E4P consists of a mixture of monomeric aldehyde, hydrated aldehyde 
and three major contributing dimeric forms (Figure 1.29). In dilute solutions of ~0.04 M only 
the hydrate monomer is predominant and the dimeric forms are not detectable at this 
concentration by NMR.85 The two major dimers of E4P, I and II, are asymmetrically 
substituted 1,3-dioxane and 1,3-dioxolane structures, respectively, and dimer III is the α-
anomer of dimer I. Although these dimers are not normally significant at biological 
concentrations, as the concentrations used are very low, they could interfere in some of the in 
vitro enzymatic studies using E4P as a substrate.86 Frozen preparations of the compound 
should be allowed sufficient time to reach equilibrium before use and freeze-dried samples or 
samples that have been evaporated to dryness to give solid E4P have a tendency to 
dephosphorylate on concentration. Overall, this instability of E4P poses particular difficulties 
with the isolation and purification of this compound and with the synthesis of analogues of 
this molecule. 
 
 
Figure 1.29: The monomeric and dimeric forms of E4P in solution determined by Duke et al.85 
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E4P can be brought commercially but the cost of purchasing this compound is extremely 
high; approximately $1700 NZD for 100 mg of E4P (Sigma-Aldrich). Therefore, to able to 
synthesis E4P by other means would be highly advantageous. 
 
Two methods can be used to synthesis E4P, enzymatically from the enzyme transketolase or 
synthetically from the precursor D-glucose 6-phosphate.87-90 In the enzymatic route, the 
enzyme transketolase catalyses the reaction between D-fructose and 1.25 to produce E4P, 
sedoheptulonase 7-phosphate and other sugar phosphates at equilibrium (Figure 1.30). 
However, it has been reported to be highly difficult to purify E4P from this mixture.87 
 
 
Figure 1.30: Synthesis of E4P using the enzyme transketolase. 
 
E4P can also be prepared by oxidative cleavage of D-glucose 6-phosphate with lead 
tetraacetate (Figure 1.31).89 This is a convenient one step procedure and it is the commonly 
used method for the synthesis of E4P. By using this method E4P can be obtained in a good 
yield (63%). Substrate analogues such as D- and L-T4P were prepared by this lead 
tetraacetate method. 
 
Figure 1.31: Synthesis of E4P from oxidative cleavage of D-glucose 6-phoshate. 
 
Although this method can be high yielding, there are a couple of drawbacks. These include a 
long and tedious experimental procedure and non-selective cleavage of carbon atoms as the 
oxidative cleavage is not 100% selective for cleaving only two carbons to give E4P. The 
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reaction also produces D-glyceraldehyde 3-phosphate from over oxidation, and D-arabinose 
5-phosphate from under oxidation (Figure 1.32).91 Optimisation studies in our laboratory 
conducted by Meekyung Ahn40 showed that only 1.7 equivalents of lead tetraacetate had to 
be used in the reaction to achieved a high 73% yield for E4P, compared to the stoichiometric 
two equivalents that is usually required to cleave two carbons. The use of fewer or more 
equivalents of lead tetraacetate resulted in lower yields of E4P and more side-products. 
 
 
Figure 1.32: Oxidative cleavage of D-glucose 6-phosphate to give E4P and unwanted side-products. Cleavage of one 
carbon gives D-arabinose 5-phosphate, two carbons gives E4P and three carbons gives D-glyceraldehyde 3-phosphate 
1.24. 
 
1.5 The project 
 
DAH7P synthase is the first enzyme of the shikimate pathway, catalysing the reaction 
between three carbon PEP and the four carbon sugar E4P. This pathway exists in plants and 
microorganisms, but not mammals, making it a potential target for novel fungicides, 
herbicides and antibiotics. Although there has been a lot of work done on the substrate 
specificity of PEP analogues on this enzyme, little work has been done on the substrate 
specificity of alternative four carbon sugars of E4P. 
 
Therefore, the aim of this project was to synthesise a range of alternative non-natural four 
carbon analogues of E4P for DAH7P synthase to help to probe the substrate specificity of the 
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different types of DAH7P synthase. This would allow us to further understand how variations 
in sequence relate to variations in substrate selection and reaction chemistry in this group of 
enzymes. In particular, we wished to investigate the importance of the C2 and C3 hydroxyl 
groups in E4P and the effect of changing the phosphate groups in E4P to their phosphonate 
analogues. Specific goals of the project were to (Figure 1.33): 
 
 Chemically synthesise both 2- and 3-deoxy analogues of E4P. 
 Chemically synthesise both 2- and 3-methyl analogues of E4P. 
 Chemically synthesise the phosphonate analogue of E4P. 
 Chemically synthesise the dideoxyphosphonate analogue of E4P. 
 To examine the tolerance of DAH7P synthase to changes in the C2 or C3 hydroxyl 
group of E4P. 
 To examine the tolerance of DAH7P synthase to changes in the phosphate moiety of 
E4P. 
 To characterise the products of the DAH7P synthase reactions where these 
compounds do act as alternative substrates to E4P. 
 
 
Figure 1.33: Target compounds for DAH7P synthase (analogues of E4P). 
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Chapter 2:  Deoxy analogues of E4P 
 
2.1 Introduction 
 
As introduced in Chapter 1, we are interested in how sensitive DAH7P synthase is to 
structural changes in the E4P moiety. In particular, the importance of the hydroxyl groups on 
C2 and C3 of E4P for binding and catalysis in the active site. 
 
Substrate specificity studies on D- and L-threose 4-phosphate (T4P), in which the 
stereochemistry is reversed at the C2 and C3 positions with respect to E4P (Figure 2.1), were 
part of Meekyung Ahn’s PhD studies.40 These studies demonstrated that both analogues were 
alternative substrates for the type I E. coli (phe) and P. furiosus DAH7P synthases, indicating 
the correct configuration of the hydroxyl groups at C2 and C3 of E4P is not critical to allow 
the enzymatic reaction to proceed. 
 
Following Meekyung Ahn’s studies, investigations were carried out to determine whether the 
deoxy analogues of E4P were possible substrates for DAH7P synthase. The deoxy analogues 
corresponding to the removal of the hydroxyl groups of the C2 or C3 position of E4P to give 
2- and 3-deoxyE4P respectively, were investigated as part of Amy Pietersma’s PhD studies 
(Figure 2.1).66 
 
 
Figure 2.1: Substrate analogues of E4P investigated on type I DAH7P synthases. D- and L-T4P were investigated by 
Dr Ahn.40 The enantiopure and racemic deoxy substrates of E4P were investigated by Dr Pietersma.66 
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Dr Pietersma demonstrated that the enantiopure analogues (3S)-2-deoxyE4P and (2R)-3-
deoxyE4P were all found to be substrates for the type I E. coli (phe), N. meningitidis and P. 
furiosus DAH7P synthases. Studies on the racemic substrates with E. coli DAH7P synthase 
(phe) found that both rac-2-deoxyE4P and rac-3-deoxyE4P were substrates for this enzyme. 
Interestingly, rac-3-deoxyE4P was found not to be a substrate for P. furiosus DAH7P 
synthases (Table 2.1). 
 
Substrate DAH7P synthase source 
E. coli (phe) P. furiosus N. meningitidis 
(3S)-2-deoxyE4P    
(2R)-3-deoxyE4P    
rac-2-deoxyE4P  ND ND 
rac-3-deoxyE4P   ND 
Table 2.1: Substrate specificity tests on (3S)-2-deoxyE4P, (2R)-3-deoxyE4P, rac-2-deoxyE4P and rac-3-deoxyE4P on 
type I DAH7P synthases.66 ND = not determined. 
 
Although the majority of substrate specificity investigations have been done on type I 
DAH7P synthases, little work has been done on the type II DAH7P synthases. The M. 
tuberculosis enzyme is a type II enzyme, and therefore is significantly different in sequence 
compared to the type I DAH7P synthases. The investigation of how sensitive this particular 
enzyme is to structural changes and the importance of the hydroxyl groups on C2 and C3 of 
E4P for binding and catalysis in the active site of this enzyme could be valuable information 
for the design of inhibitors for DAH7P synthase. Additionally, investigations into the 
substrate specificity of 2- and 3-deoxyE4P on this type II enzyme would also give a platform 
for which we can compare the substrate specificities of type I DAH7P synthases with the type 
II enzyme. 
 
Preliminary studies on the role of the hydroxyl groups of E4P on M. tuberculosis DAH7P 
synthase were investigated by Dr Pietersma66, but these investigations was not completed. 
For example, the determination of the kinetic data for racemic 2- and 3-deoxyE4P analogues 
was not accomplished. In addition, the investigations into whether M. tuberculosis DAH7P 
synthase could accept both enantiomers from racemic 2- and 3-deoxyE4P as substrates were 
not performed. Therefore, as part of the studies described in this thesis it was decided to 
synthesise the racemic and enantiopure forms of 2- and 3-deoxyE4P, and to further examine 
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the substrate specificity of the type II DAH7P synthase from M. tuberculosis. Additionally, 
synthesis of these deoxy analogues would allow the development of the chemistry that is 
required for the synthesis of more complex analogues such as the methyl-substituted 
analogues. This work is described in Chapter 3. 
 
2.1.1 Outline of chapter 
 
This chapter is divided into four main sections. The first section describes the synthesis of the 
enantiopure and racemic substrates, 2- and 3-deoxyE4P, using a modification of a synthetic 
route previously reported by Dr Pietersma.66 Rac-3-deoxyE4P was synthesised using DL-
malic acid whereas (2R)-3-deoxyE4P was synthesised from (2R)-malic acid. Rac-2-
deoxyE4P was synthesised from a readily available precursor 2.18 (Figure 2.15, page 47) that 
was previously synthesised by Dr Rachel Williamson.92 Synthesis of enantiopure (3S)-2-
deoxyE4P and (2R)-3-deoxyE4P allow for direct comparison with the natural substrate E4P, 
as these two analogues have the same C2 and C3 hydroxyl configurations as E4P, 
respectively. 
 
The second section provides evidence for the formation of the 6-deoxyDAH7P sugar that is 
formed from the reaction between 3-deoxyE4P with PEP catalysed by DAH7P synthase. 
Prior work by Dr Pietersma66 had demonstrated the formation of 5-deoxyDAH7P from the 
reaction between 2-deoxyE4P and PEP catalysed by DAH7P synthase. 
 
The third section describes the investigations into the enantiomer utilisation of racemic 2- and 
3-deoxyE4P by M. tuberculosis DAH7P synthase. Standard enzyme assays, Lanzetta assays93 
and 31P NMR spectroscopy were used to determine the concentrations of the racemic 
mixtures. Once an accurate concentration of each substrate was known, the investigation of 
whether M. tuberculosis DAH7P synthase was utilising one or both enantiomers of the 
racemic mixtures were determined. 
 
The fourth section describes the kinetic studies that were undertaken for the reaction of 
enantiopure and racemic 2- and 3-deoxyE4P with PEP catalysed by M. tuberculosis DAH7P 
synthase. A comparison of the substrate specificities of these deoxy analogues on the type II 
DAH7P synthase from M. tuberculosis, with type I DAH7P synthases is also described. 
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2.2 Synthesis of the deoxy analogues of E4P 
 
2.2.1 Synthesis of 3-deoxyE4P 
 
Rac-3-deoxyE4P was previously synthesised by Dr Pietersma using the synthetic route 
shown in Scheme 2.1.66 DL-Malic acid was esterified by MeOH and concentrated H2SO4 to 
give diester 2.1. The secondary alcohol group was then protected as the benzyl ether, and the 
ester functionalities were reduced using LiAlH4 to give diol 2.3. Phosphorylation of this diol 
produced monophosphorylated compound 2.4. Oxidation of phosphate 2.4 using Dess-Martin 
periodinane (DMP) gave aldehyde 2.7. The aldehyde functionality was protected as its 
dimethyl acetal prior to hydrogenolysis. Deprotection of compound 2.8 gave rac-3-
deoxyE4P. 
 
 
Scheme 2.1: Synthetic route used by Dr Pietersma to synthesise rac-3-deoxyE4P. Modifications were made to steps 1 
and 2 for the synthesis of diester 2.1 and compound 2.2 respectively. All other steps were identical to Dr Pietersma’s66 
synthetic route for the synthesis of rac-3-deoxyE4P. 
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Although the synthetic route in Scheme 2.1 was used by Dr Pietersma to synthesise rac-3-
deoxyE4P in the work described in this thesis, complications arose for the synthesis of diester 
2.1 and compound 2.2. Due to these complications, modifications were made for the 
synthesis of these two compounds, and the reasons for these modifications are described in 
the next section. 
 
2.2.1.1 Synthesis of rac-3-deoxyE4P from DL-malic acid 
 
DL-Malic acid was first esterified by treatment with MeOH and concentrated H2SO4 under 
reflux conditions to give diester 2.1 (Scheme 2.1). The resulting yields from this method 
ranged from 50–96% following purification of the product by flash chromatography. Due to 
this inconsistency, the procedure was carried out via the initial formation of the acyl chloride 
using SOCl2, and subsequent esterification using MeOH to give diester 2.1. The yields 
obtained were consistent and higher using the SOCl2 method: diester 2.1 was obtained in 90–
99% yield following purification by flash chromatography (Figure 2.2). 1H NMR 
spectroscopy confirmed the synthesis of diester 2.1, with the appearance of the methyl 
resonances at 3.82 and 3.72 ppm in the spectrum. 
 
 
Figure 2.2: Synthesis of diester 2.1 using SOCl2 and MeOH. 
 
Benzylation of diester 2.1 was first carried out using BnBr and freshly prepared Ag2O, and 
gave multiple unidentifiable side-products (as detected by TLC analysis). These unknown 
impurities were separated from the desired compound 2.2 (26% yield) by flash 
chromatography (Figure 2.3). Base-catalysed hydrolysis of the ester functionality could 
possibly be a cause for the low yield of compound 2.2. It is possible that cleavage may be 
occurring due to contamination of the Ag2O with NaOH (Ag2O was prepared from NaOH 
and AgNO3).94 The 1H NMR spectrum of the crude unidentifiable products showed that one 
or both of the ester group methyl resonances at 3.82 and 3.72 ppm were no longer present, 
indicating the loss of the methyl group(s). 
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Figure 2.3: Benzylation of diester 2.1 using BnBr and Ag2O. 
 
To improve the yield of the benzylation reaction and to avoid the possibility of side-products, 
an acid-catalysed benzylation reaction was used instead. Diester 2.1 was benzylated using 
benzyl 2,2,2-trichloroacetimidate (BTCA) and trifluoromethanesulfonic acid (TfOH) to 
give compound 2.2 in 75% yield following purification by flash chromatography (Figure 
2.4). Benzylation using this method was found to be considerably more reliable and higher 
yielding than the BnBr/Ag2O method. 
 
 
Figure 2.4: Benzylation of diester 2.1 using BTCA and triflic acid. 
 
Reduction of compound 2.2 using LiAlH4 provided the diol 2.3 in 63% yield (Figure 2.5). 
NMR spectroscopy confirmed that the reduction had occurred with the disappearance of the 
ester group methyl resonances at 3.77 and 3.69 ppm in the 1H NMR spectrum, and the 
disappearance of the carbonyl resonances at 172.1 and 170.7 ppm in the 13C NMR spectrum. 
 
 
Figure 2.5: Synthesis of diol 2.3. 
 
Diol 2.3 was phosphorylated using diphenyl chlorophosphate and imidazole to give 
phosphate 2.4. The yield of the desired phosphate 2.4 was 18%, compared to 6% for the other 
monophosphorylated product 2.5 (Figure 2.6). A large amount of starting material, diol 2.3 
(24%), was also recovered along with diphosphorylated compound 2.6 (6%). The 1H, 13C and 
31P NMR spectra of phosphate 2.4 matched those previously described by Dr Pietersma.66 It 
was found, as expected, the benzyl group of diol 2.3 offered some directing effect for 
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monophosphorylation due to the steric hindrance that it would provide at C1 of diol 2.3.66 
The bulkiness of the phosphorylating reagent may also aid in this directing effect by 
encouraging reaction at the less hindered primary alcohol. 
 
 
Figure 2.6: Phosphorylation of diol 2.3 to give a mixture of compounds 2.4–2.6. 
 
The remaining primary hydroxyl group of phosphate 2.4 was oxidised using freshly prepared 
DMP to give aldehyde 2.7 (85% yield, Figure 2.7). The 1H and 13C NMR spectra confirmed 
the presence of the aldehyde resonance with signals at 9.62 and 202.5 ppm respectively. 
 
 
Figure 2.7: Oxidation of phosphate 2.4 to give aldehyde 2.7. 
 
Aldehyde 2.7 was protected as the dimethyl acetal, using trimethyl orthoformate and 
concentrated H2SO4 to afford the fully protected analogue 2.8 in 94% yield (Figure 2.8). 1H 
NMR spectroscopy confirmed the synthesis of compound 2.8, with the appearance of the 
diastereotopic methoxy group proton resonances at 3.43 and 3.39 ppm in the spectrum. 
 
 
Figure 2.8: Synthesis of protected analogue 2.8. 
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The protected analogue 2.8 was hydrogenated at room temperature and monitored using TLC 
analysis until no UV active compound was present, indicating the phenyl groups had been 
cleaved. A small sample was then taken and concentrated under vacuum for 1H NMR 
analysis. The 1H NMR spectrum of this sample showed that all aromatic proton resonances 
between 7.41–7.09 ppm in the spectrum had gone, confirming the deprotection of the phenyl 
groups in compound 2.8. Acetal 2.9 was then immediately hydrolysed to remove the acetal 
protecting group to give rac-3-deoxyE4P (Figure 2.9), where the phosphate group of acetal 
2.9 provided the acidity required to cleave the acetal groups in water. 1H NMR spectroscopy 
showed the disappearance of the methoxy proton resonances at 3.43 and 3.39 ppm in the 
spectrum. Additionally, mass spectrometry detected rac-3-deoxyE4P as a compound with a 
molecular mass of 207.0038 (calc. C4H9NaO6P [M+Na]+: 207.0029). Rac-3-deoxyE4P was 
then used in enzyme assays without further purification. 
 
 
Figure 2.9: Synthesis of rac-3-deoxyE4P. 
 
The enantiopure (2R)-3-deoxyE4P was also synthesised using the same route described in 
this section, but starting with (2R)-malic acid instead of DL-malic acid. Similar yields and 
identical spectroscopic data were obtained for the synthesis of (2R)-3-deoxyE4P as for rac-3-
deoxyE4P. Once (2RS)-3-deoxyE4P and (2R)-3-deoxyE4P were synthesised, both were 
tested as substrates for DAH7P synthase from M. tuberculosis. 
 
2.2.2 Synthesis of 2-deoxyE4P 
 
(3S)-2-DeoxyE4P was previously synthesised by Dr Pietersma using the synthetic route 
shown in Scheme 2.2.66 β-hydroxy-γ-butyrolactone was protected as its benzyl ether to give 
compound 2.11. Compound 2.11 was then reduced to give lactol 2.12. Subsequent protection 
of lactol 2.12 to give compound 2.14, followed by phosphorylation of the exposed hydroxyl 
group gives compound 2.16. Deprotection of compound 2.16 gives (3S)-2-deoxyE4P. 
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Scheme 2.2: Synthetic route used by Dr Pietersma66 to synthesise (3S)-2-deoxyE4P. Only step 1 was modified. All 
other steps were identical to Dr Pietersma’s synthetic route for the synthesis of (3S)-2-deoxyE4P. 
 
Although the synthetic route in Scheme 2.2 was used by Dr Pietersma to synthesise (3S)-2-
deoxyE4P, complications arose for the synthesis of compound 2.11 and modifications were 
made for the synthesis of this compound (described in the next section). 
 
2.2.2.1 Synthesis of (3S)-2-deoxyE4P from β-hydroxy--butyrolactone 
 
Benzylation of β-hydroxy-γ-butyrolactone was carried out using BnBr and freshly prepared 
Ag2O (Scheme 2.2). When the reaction was carried out in this way, lactone 2.11 was obtained 
in 7% yield, in addition with several unidentifiable products were formed (as detected by 
TLC analysis). Similar yields and results were also found during the synthesis of compound 
2.2 for the synthesis of 3-deoxyE4P, and a marked improvement was observed by switching 
to the reagents BTCA and TfOH. When BTCA and TfOH was used for the benzylation of β-
hydroxy-γ-butyrolactone (Figure 2.10), the lactone 2.11 was obtained in a much higher yield 
of 71%. This was a marked improvement in the reaction outcome compared to the 
BnBr/Ag2O method. Lactone 2.11 was confirmed by a 1H NMR spectrum showing the 
aromatic proton resonances between 7.41–7.24 ppm. 
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Figure 2.10: Synthesis of compound 2.11. 
 
The next step in the synthetic scheme involved the reduction of lactone 2.11 to the 
corresponding lactol 2.12. Lactol 2.12 is in equilibrium with its open-chain form, and this 
allows access to both the aldehyde functionality and the primary alcohol (Figure 2.11). The 
reduction was carried out at −78°C in order to prevent over reduction of the lactone to the 
alcohol, and DIBALH was added dropwise till no starting material was detectable by TLC 
analysis. Analysis of the reaction by 1H NMR spectroscopy determined that reduction had 
occurred to give a mixture of diastereoisomers of lactol 2.12 (62% yield). The two acetal 
proton resonances were observed as either a multiplet between 5.84–5.61 ppm or a doublet of 
doublets at 5.44 ppm (J = 5.1, 10.6 Hz) in the spectrum. The two diastereoisomers were 
present in a 3:2 ratio. Evidence for the existence of the open-chain aldehyde was also present 
in the 1H and 13C spectra with small peaks (1:4 ratio, open-chain:major lactol) observable at 
9.80 ppm and 208.8 ppm respectively. 
 
 
Figure 2.11: Reduction of lactone 2.11 with DIBAL to give lactol 2.12. 
 
Ring opening of lactol 2.12 using neopentyl glycol and chlorotrimethylsilane (TMSCl) gave a 
mixture of products. The desired six membered ring product 2.14 was produced in 79% yield, 
along with a mixture of diastereoisomers of the five membered ring product 2.15 in 2% yield 
(Figure 2.12). The TMSCl acts as both a dehydrating agent and the acid catalyst in the 
reaction, eliminating the need to add molecular sieves or other drying agents and the products 
were separated by flash chromatography.95 
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Figure 2.12: The synthesis of the six and five membered ring products from lactone 2.12. Products were separated by 
flash chromatography. 
 
With the aldehyde protected as its cyclic acetal, the exposed primary alcohol could now be 
phosphorylated. The phosphorylation was carried out using diphenyl chlorophosphate and 
imidazole to afford phosphate 2.16 in 95% yield following purification (Figure 2.13). The 1H, 
13C and 31P NMR spectra of phosphate 2.16 matched those previously reported by Dr 
Pietersma.66 
 
 
Figure 2.13: Synthesis of phosphate 2.16. 
 
The benzyl and phenyl protecting groups of phosphate 2.16 were removed by hydrogenolysis 
using a platinum catalyst. The reaction mixture was stirred at room temperature until TLC 
analysis showed no UV active compound was present. A small sample was then taken and 
concentrated under vacuum for 1H NMR analysis. The 1H NMR spectrum of this sample 
showed that all aromatic signals between 7.37–7.14 ppm had been removed to give acetal 
2.17. Acetal 2.17 was then deprotected by the treatment with Dowex-H+ cation exchange 
resin and heating to 40°C in water overnight to give (3S)-2-deoxyE4P (Figure 2.14). Mass 
spectrometry detected the mass for (3S)-2-deoxyE4P with a molecular mass of 183.0060 
(C4H8O6P [M−H]−: 183.0064). (3S)-2-DeoxyE4P was then used in enzyme assays without 
further purification. 
 
Chapter 2: Deoxy analogues of E4P  47 
 
Figure 2.14: Synthesis of (3S)-2-deoxyE4P. 
 
The synthesis of rac-2-deoxyE4P was previously carried out by Dr Rachel Williamson.92 
Only the final deprotection step using Dowex-H+ resin was carried out in these studies as the 
precursor 2.18 was already available for use (Figure 2.15). Rac-2-deoxyE4P was then used in 
enzyme assays without further purification. 
 
 
Figure 2.15: The synthesis of rac-2-deoxyE4P from precursor 2.18. 
 
The 2-deoxy analogues of E4P, (3RS)-2-deoxyE4P and (3S)-2-deoxyE4P, were synthesised 
and both these analogues of E4P were then assayed as substrates on DAH7P synthase from 
M. tuberculosis. 
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2.3 Evidence for product identity in the M. tuberculosis DAH7P 
synthase catalysed reaction between 3-deoxyE4P and PEP 
 
A standard enzyme assay carried out on 3-deoxyE4P shows that DAH7P synthase is utilising 
3-deoxyE4P as a substrate. The standard enzyme assay used to monitor the reaction catalysed 
by DAH7P synthase monitors only the loss of PEP (at 232 nm) and does not confirm the 
formation of the seven carbon product. When 3-deoxyE4P is used in place of E4P, instead of 
DAH7P, the expected product is 6-deoxyDAH7P (Figure 2.16). To confirm formation of 6-
deoxyDAH7P, an alternate thiobarbituric acid assay method was employed.96 
 
 
Figure 2.16: Synthesis of 6-deoxyDAH7P from 3-deoxyE4P and PEP catalysed by DAH7P synthase. 
 
2.3.1 Thiobarbituric acid assay 
 
The thiobarbituric acid assay is a colourimetric method for the detection of molecules that 
contain a specific 1,2-diol moiety (Figure 2.17).96 
 
 
Figure 2.17: General structure of a molecule with the 1,2-diol moiety (blue) required to form β-formyl pyruvate from 
oxidative cleavage of this moiety. 
 
In the assay, a molecule containing the 1,2-diol moiety is first oxidatively cleaved using 
NaIO4 to generate β-formyl pyruvate. Thiobarbituric acid is then added, which reacts with β-
formyl pyruvate to give a product with a characteristic pink chromophore (λmax = 549 nm). 
The pink chromophore is due to the reaction of β-formyl pyruvate with thiobarbituric acid 
(Figure 2.18), and is a positive test for the presence of the 1,2-diol moiety.97 If the 1,2-diol 
moiety is absent in the structure of the molecule, β-formyl pyruvate will not be formed and 
the assay will give a negative result. 
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Figure 2.18: Structures of β-formyl pyruvate, thiobarbituric acid and chromophore I.97 A pink complex is formed 
between β-formyl pyruvate and two molecules of thiobarbituric acid. 
 
The seven carbon product of DAH7P synthase, DAH7P, which contains the requisite 1,2-diol 
moiety, has previously been detected using the thiobarbituric acid assay.17,98 Oxidative 
cleavage of the diol between C4 and C5 of DAH7P using NaIO4 gives β-formyl pyruvate, 
which after reaction with thiobarbituric acid results in formation of the pink chromophore 
(Figure 2.19). 
 
 
Figure 2.19: Enzyme catalysed reaction of E4P with PEP by DAH7P synthase to give DAH7P. Oxidative cleavage 
with NaIO4 between C4 and C5 would give β-formyl pyruvate. The 1,2-diol moiety in DAH7P is shown in blue. 
 
2.3.2 Detection of 6-deoxyDAH7P by thiobarbituric acid assay 
 
Formation of 6-deoxyDAH7P, predicted to be formed in the reaction between 3-deoxyE4P 
and PEP catalysed by DAH7P synthase, can also be measured by the thiobarbituric acid assay 
as it contains the required 1,2-diol moiety (Figure 2.20). 
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Figure 2.20: Thiobarbituric acid assay test on 6-deoxyDAH7P. The 1,2-diol moiety in 6-deoxyDAH7P is shown in 
blue. 
 
A positive control using the thiobarbituric acid assay was carried out to detect the formation 
of DAH7P. The experiment involved the reaction between E4P and PEP, catalysed by M. 
tuberculosis DAH7P synthase, to form DAH7P, followed by analysis of the sample by the 
thiobarbituric acid assay. A pink coloured solution was observed that had an absorption 
maximum at 549 nm, corresponding to the pink chromophore. This indicated the formation of 
DAH7P from the reaction between E4P and PEP catalysed by M. tuberculosis DAH7P 
synthase. 
 
An analogous reaction was carried out, but with 3-deoxyE4P instead of E4P. The 
characteristic absorption maximum at 549 nm from the pink chromophore was also detected. 
This was consistent with the formation of 6-deoxyDAH7P from the reaction between 3-
deoxyE4P and PEP catalysed by M. tuberculosis DAH7P synthase. 
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2.4 Enantiomer utilisation 
 
Enantiomer utilisation studies were carried out in order to confirm whether the enzyme M. 
tuberculosis DAH7P synthase is utilising either one or both of the 3-deoxyE4P enantiomers 
present in the assay when racemic 3-deoxyE4P was employed. By comparing the total 
concentration of racemic 3-deoxyE4P in solution with the amount of 3-deoxyE4P consumed 
in the enzyme assay, the enantioselectivity of the enzyme can be determined. This was also 
investigated for racemic 2-deoxyE4P with the M. tuberculosis enzyme. 
 
2.4.1 Determination of the utilisation of racemic 3-deoxyE4P by M. 
tuberculosis DAH7P synthase 
 
Two experimental methods were employed to investigate enantiomer utilisation of rac-3-
deoxyE4P by M. tuberculosis DAH7P synthase. The first was a standard enzyme assay and 
the second used 31P NMR spectroscopy. The amount of rac-3-deoxyE4P being utilised by M. 
tuberculosis DAH7P synthase was determined using a standard enzyme assay. The assay was 
carried out using the substrate rac-3-deoxyE4P, metal (MnSO4), PEP (in excess), and was 
initiated by the addition of M. tuberculosis DAH7P synthase. The loss of absorbance due to 
the consumption of PEP at 232 nm was monitored using a UV-Visible spectrophotometer. As 
PEP was present in excess in the assay, the loss of absorbance is proportional to the amount 
of rac-3-deoxyE4P being consumed by the catalysed reaction. To convert absorbance into 
concentration, Beer’s Law was applied (A = εcl, εPEP = 2.8 x 103 M-1cm-1 at 25°C). The stock 
solution concentration of utilised 3-deoxyE4P from rac-3-deoxyE4P was determined by this 
method to be 22.9 mM. 
 
The concentration of rac-3-deoxyE4P in solution was determined by integrating the 
phosphorus resonances of a standard solution of glucose 6-phosphate (G6P) with rac-3-
deoxyE4P in the 31P NMR spectrum. The exact rac-3-deoxyE4P concentration could then be 
determined, as the relative concentrations of G6P and rac-3-deoxyE4P were known from the 
31P NMR spectrum. An accurate concentration of G6P was determined using a Lanzetta 
assay.93 Although 31P NMR spectra are not routinely integrated, there are examples in the 
literature where this has been carried out successfully.99-101 A 31P-1H-decoupled NMR 
spectrum was collected and the phosphorus resonance of G6P at 1.7 ppm was integrated with 
Chapter 2: Deoxy analogues of E4P  52 
the phosphorus resonance of rac-3-deoxyE4P at 3.4 ppm to give a relative concentration of 
G6P:rac-3-deoxyE4P. The concentration determined for rac-3-deoxyE4P by this method was 
40.2 mM, and represents the total concentration of rac-3-deoxyE4P in solution. 
 
2.4.1.1 Conclusions 
 
The results from these experiments showed that the concentration determined from the use of 
3-deoxyE4P by M. tuberculosis DAH7P synthase, is approximately half (0.57) that of the 
total concentration. This was consistent with M. tuberculosis DAH7P synthase only using one 
enantiomer. It was expected that the (2R)-enantiomer of rac-3-deoxyE4P i.e. the one with the 
same C2 hydroxyl configuration as E4P, was the enantiomer being used based on the kinetic 
results for (2R)-3-deoxyE4P (Table 2.2, page 54). 
 
2.4.2 Determination of the utilisation of racemic 2-deoxyE4P by M. 
tuberculosis DAH7P synthase 
 
Two experimental methods were employed to investigate enantiomer utilisation of rac-2-
deoxyE4P by M. tuberculosis DAH7P synthase. The first was a standard enzyme assay and 
the second was the Lanzetta assay. The amount of rac-2-deoxyE4P being utilised by M. 
tuberculosis DAH7P synthase was determined using a standard enzyme assay. The assay was 
analogous to that described for rac-3-deoxyE4P, except rac-2-deoxyE4P was used instead of 
rac-3-deoxyE4P. The stock solution concentration of utilised 2-deoxyE4P from rac-2-
deoxyE4P was determined by this method to be 13.2 mM. 
 
The Lanzetta assay is a colourimetric method for the detection of phosphate.93 A positive test 
for phosphate results in a green complex being formed between phosphate and the 
ammonium molybdate–malachite green–Triton X-100 reagent (Lanzetta reagent). Although 
the structure of this complex was not reported by Lanzetta et al.93, the absorbance of this 
green complex is measured at 630 nm and compared to a calibration curve to determine 
phosphate concentration. A modified form of this assay was used to quantify phosphate 
containing molecules. The samples were digested using calf alkaline phosphatase to free the 
phosphate, which was then detected using the Lanzetta assay. 
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The Lanzetta assay was employed to determine the concentration of rac-2-deoxyE4P in 
solution. The concentration determined for rac-2-deoxyE4P by this method was 23.6 mM, 
and represents the total concentration of rac-2-deoxyE4P in solution. 
 
2.4.2.1 Conclusions 
 
The results from these experiments showed that the concentration determined from the use of 
2-deoxyE4P by M. tuberculosis DAH7P synthase, is approximately half (0.56) that of the 
total concentration. This was consistent with M. tuberculosis DAH7P synthase only using one 
enantiomer. It was expected that the (3S)-enantiomer of rac-2-deoxyE4P i.e. the one with the 
same C3 hydroxyl configuration as E4P, was the enantiomer being used based on the kinetic 
results for (3S)-2-deoxyE4P in the next section. 
 
2.5 Kinetic studies on the deoxy analogues of E4P 
 
The kinetic data for both the enantiopure and racemic 2- and 3-deoxyE4P with M. 
tuberculosis DAH7P synthase were determined by monitoring the loss of PEP at 232 nm 
using a UV-Visible spectrophotometer. The kinetic data were calculated by fitting the initial 
data to the Michaelis–Menten equation using GraFit (Erithacus Software). The Michaelis–
Menten and Lineweaver–Burk plots for racemic and enantiopure 2- and 3-deoxyE4P can be 
found in Figure 2.21 and Figure 2.22, respectively. A summary of these results can be found 
in Table 2.2, along with the kinetic data for E. coli (phe) (type Iα) and P. furiosus (type Iβ) 
DAH7P synthase for comparison. 
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Substrate DAH7P synthase source 
E. coli (phe) (type Iα) P. furiosus (type Iβ) M. tuberculosis (type II) 
KM (µM) kcat (s-1) kcat/KM (s-1µM-1) KM (µM) kcat (s-1) kcat/KM (s-1µM-1) KM (µM) kcat (s-1) kcat/KM (s-1µM-1) 
E4P 
 
39±4 26±2 0.67 9±1 1.4±0.1 0.16 37±2 5.4±0.1 0.15 
(3S)-2-deoxyE4P 
 
410±40 19±1 0.05 6±1 3.0±0.1 0.49 46±5 4.9±0.2 0.11 
rac-2-deoxyE4P(a) 650±30 1.4±0.1 0.02 ND   85±7 6.8±0.2 0.14 
(2R)-3-deoxyE4P 
 
2700±140 4.5±0.1 0.002 200±30 2.1±0.1 0.01 77±9 2.4±0.1 0.031 
rac-3-deoxyE4P(a) 
 
2600±330 4.5±0.1 0.002 NS   663±51 1.7±0.04 0.044 
Table 2.2: Comparison of type I DAH7P synthases with the type II M. tuberculosis DAH7P synthase. (a) Kinetic data for racemic substrates were determined from the total 
concentration of the racemic mixture. E. coli DAH7P synthase (phe) kinetic data were determined by Dr Pietersma.66 P. furiosus DAH7P synthase kinetic data determined by Dr 
Schofield.32 ND = not determined. NS = not a substrate.
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2.5.1 M. tuberculosis DAH7P synthase 
 
The concentration studies of rac-3-deoxyE4P carried out on M. tuberculosis (type II) DAH7P 
synthase showed the enzyme was only utilising one enantiomer in the racemic mixture. 
Comparison of the kinetic data obtained for (2R)-3-deoxyE4P and rac-3-deoxyE4P indicated 
that only the (2R)-enantiomer of the racemic mixture was being utilised by the enzyme. The 
KM value of rac-3-deoxyE4P with M. tuberculosis DAH7P synthase was found to be 
approximately nine (8.6) times higher than (2R)-3-deoxyE4P, and the kcat values were found 
to be similar to each other. These results suggest that the (2S)-enantiomer in the racemic 
mixture may be acting as a competitive inhibitor towards the enzyme. To confirm whether 
the (2S)-enantiomer was a competitive inhibitor, the (2S)-3-deoxyE4P substrate could be 
synthesised in the future and investigated with M. tuberculosis DAH7P synthase. 
Additionally, the higher KM and lower kcat values for 3-deoxyE4P indicates that it is a poorer 
substrate compared to E4P and 2-deoxyE4P, with M. tuberculosis DAH7P synthase. 
 
Concentration studies conducted on M. tuberculosis DAH7P synthase with rac-2-deoxyE4P 
found that the enzyme only utilised one enantiomer of the racemic mixture. Comparison of 
the KM values of rac-2-deoxyE4P with M. tuberculosis DAH7P synthase found that only the 
(3S)-enantiomer of the racemic mixture was being utilised by the enzyme. Although the kcat 
values were different, the discrepancy was thought to be due to a more active batch of M. 
tuberculosis DAH7P synthase being used on rac-2-deoxyE4P. The KM value for rac-2-
deoxyE4P was found to be about twice (1.8) that of (3S)-2-deoxyE4P and suggests that only 
the (3S)-enantiomer is being utilised, with the (3R)-enantiomer having no affect on the kinetic 
parameters of the enzyme. Interestingly, the kinetic data for (3S)-2-deoxyE4P were 
comparable to that of E4P, indicating that the C2 hydroxyl group plays no significant role in 
the catalysis reaction by M. tuberculosis DAH7P synthase. 
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2.5.2 Type I and type II DAH7P synthases 
 
The kinetic data in Table 2.2 shows that the 2- and 3-deoxyE4P analogues of E4P are 
substrates for enzymes of each of the three families of DAH7P synthase. 
 
The type Iα DAH7P synthase from E. coli was found to be able to utilise both the enantiopure 
and racemic 2- and 3-deoxyE4P as substrates, but with significantly higher KM and lower kcat 
values compared to E4P.66 In contrast, the KM value for (3S)-2-deoxyE4P was found to be 
lower than E4P, and the kcat was more than twice that of E4P for the type Iβ (P. furiosus) 
enzyme. This indicates that (3S)-2-deoxyE4P was a better substrate for P. furiosus DAH7P 
synthase than E4P. Furthermore, the type II DAH7P synthase from M. tuberculosis was 
found to be able to utilise (3S)-2-deoxyE4P with a similar catalytic efficiency as E4P, as 
indicated by the KM and kcat values. Both the type Iβ (P. furiosus) and II (M. tuberculosis) 
enzymes were overall more promiscuous than the type Iα (E. coli) enzyme in utilising the 
deoxy substrates. 
 
Studies on rac-3-deoxyE4P on the type Iα DAH7P synthases from E. coli found that the type 
Iα enzyme utilises both enantiomers of the racemic mixture with no detectable change in the 
rate of reaction between rac-3-deoxyE4P and (2R)-3-deoxyE4P.66 In contrast, the type II 
enzyme from M. tuberculosis utilised only the (2R)-enantiomer. Interestingly, rac-3-
deoxyE4P was not a substrate for the type Iβ enzyme from P. furiosus, consistent with 
significant inhibition of this enzyme and non-productive binding with (2S)-3-deoxyE4P 
preventing productive binding by (2R)-3-deoxyE4P (Table 2.3).32,66 This result was 
unexpected given the tolerance of this enzyme to the loss of the C2 hydroxyl group. 
 
Studies on rac-2-deoxyE4P with the type Iα66 and II DAH7P synthase from E. coli and M. 
tuberculosis respectively, showed that both enzymes only took the (3S)-enantiomer of the 
racemic mixture. Interestingly, the results for the type Iα (E. coli) enzyme indicated that the 
(3R)-enantiomer of the racemic mixture was inhibiting the enzyme, whereas the type II (M. 
tuberculosis) enzyme indicated the (3R)-enantiomer had no affect on the kinetic parameters 
of the enzyme (Table 2.3).  
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Substrate DAH7P synthase source 
E. coli (phe) (type Iα)  P. furiosus (type Iβ)  M. tuberculosis (type II) 
(2R)-3-deoxyE4P    
rac-3-deoxyE4P (R) & (S)  (R) only 
(3S)-2-deoxyE4P    
rac-2-deoxyE4P (S) only ND (S) only 
Table 2.3: Summary of enantiomer utilisation and substrate studies on type Iα66, Iβ32 and II DAH7P synthases. ND = 
not determined. 
 
Comparisons of all three families of DAH7P synthase have shown that the C2 and the C3 
hydroxyl group on E4P are not essential for catalysis and binding in the enzymes. The results 
in Table 2.2 also show that 3-deoxyE4P is a poorer substrate for the DAH7P synthases from 
E. coli, P. furiosus and M. tuberculosis compared to 2-deoxyE4P. This indicates that the C2 
hydroxyl group on E4P is less significant for binding and catalysis in the active site than the 
C3 hydroxyl group. Additionally, the type Iβ and II DAH7P synthase from P. furiosus and M. 
tuberculosis (respectively) were found to be the most promiscuous enzymes, with the type Iα 
DAH7P synthase from E. coli showing the least tolerance to the loss of the hydroxyl groups 
of E4P. 
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2.6 Summary 
 
The synthesis of the enantiopure and racemic forms of 3-deoxyE4P was completed in eight 
steps from (2R)-malic acid and DL-malic acid respectively. The overall synthetic scheme that 
was used for the synthesis of rac-3-deoxyE4P is summarised below (Figure 2.23). 
 
 
Figure 2.23: Overall synthetic scheme used to synthesise rac-3-deoxyE4P. 
 
The yields of each step in the synthesis of rac-3-deoxyE4P were generally high, with the 
exception of the reaction for the formation of phosphate 2.4. Similar yields were obtained for 
both the synthesis of enantiopure and racemic 3-deoxyE4P. 
 
The low yield attributed to phosphate 2.4 is due to the formation of the side-products 2.5 
(6%) and 2.6 (6%), and the recovery of a large amount of unreacted starting material 2.3 
(24%). The monophosphorylated product 2.5 could also be useful in the potential synthesis of 
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2-deoxyE4P (Figure 2.24). Additionally, future work could involve investigations into 
bulkier protecting groups for the secondary alcohol of compound 2.3, such as the sterically 
demanding TIPS group.102,103 This group could potentially increase the yield of the desired 
phosphate 2.4, and decrease the amount of side-products by adding to the steric hindrance for 
the phosphate group reacting at the other end of the molecule. 
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Figure 2.24: Potential route for the synthesis of 2-deoxyE4P starting with DL-malic acid. 
 
The synthesis of (3S)-2-deoxyE4P was completed in six steps using the synthetic route in 
Scheme 2.2, and is summarised below (Figure 2.25). The yields of each step in the synthesis 
of (3S)-2-deoxyE4P were generally high. 
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Figure 2.25: Overall synthetic scheme used to synthesise (3S)-2-deoxyE4P. 
 
The successful synthesis of 2- and 3-deoxyE4P analogues (enantiopure and racemic 
substrates) has allowed for evaluation of their behaviour with M. tuberculosis DAH7P 
synthase, a type II enzyme. It has found that both 2- and 3-deoxyE4P are substrates for M. 
tuberculosis DAH7P synthase with the 3-deoxyE4P substrate being a worse substrate for the 
enzyme as indicated by its higher KM value. The implication of these results for the kinetic 
mechanisms of DAH7P synthase is discussed in Chapter 5. 
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Chapter 3:  Methyl analogues of E4P 
 
3.1 Introduction 
 
Carbon-carbon bond formation lies at the heart of organic synthesis. For complex, 
multifunctional target structures that are difficult to prepare by conventional means, 
asymmetric framework construction by enzymatic catalysis could be an attractive alternative 
to standard chemical methods.104 The use of enzymes in organic synthesis has the advantage 
of being able to carry out reactions under mild conditions, allows a high degree of 
stereochemical control, and does not require the use of protecting group chemistry.105 The 
DAH7P synthases could have potential use in this field, as the reaction between E4P and PEP 
results in the stereospecific formation of a new stereogenic centre and carbon-carbon bond 
(Figure 3.1). In addition, this enzyme has already been shown to have a broad tolerance for 
non-natural substrates taking the place of E4P24,32,40,47 and could provide organic chemists 
with a useful synthetic tool for carrying out stereospecific aldol reactions with other 
aldehydic substrates. 
 
 
Figure 3.1: Catalysed reaction between E4P and PEP by DAH7P synthase to give the seven carbon sugar DAH7P. A 
new carbon-carbon bond (red) and a new stereocentre (*) is formed in DAH7P. 
 
DAH7P synthase is able to utilise E4P analogues where the: 
 configuration of the hydroxyl groups on the C2 and C3 positions of E4P are inverted 
(e.g. D/L-T4P)40 
 hydroxyl group at either C2 or C3 has been removed (e.g. 2/3-deoxyE4P)66 
 sugar is up to one carbon longer than E4P (compounds 1.25, 1.26 and A5P)24,32,47 
However, the presence of the phosphate and aldehyde groups in a potential substrate is 
essential for enzyme activity (Figure 3.2).24,61 
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These results suggest that the C2 and C3 hydroxyl groups of E4P are not necessary for 
substrate placement. Therefore the C2 and C3 hydroxyl groups of E4P and the active site 
residues they interact with have a limited role to play in substrate selection by the enzyme. 
 
 
Figure 3.2: Structural requirements of E4P for binding and catalysis in the active site of DAH7P synthase. Red boxes 
indicate essential groups for binding and catalysis. Black boxes indicate non-essential groups for binding and 
catalysis. 
 
Although the E4P analogues mentioned above (where the C2 or C3 hydroxyls are inverted or 
removed) were all substrates for DAH7P synthase, studies where these hydroxyl groups are 
replaced by different substituents (e.g. alkyl or halide groups) have not been investigated. 
Therefore, target analogues where the hydroxyl groups on C2 or C3 of E4P are replaced with 
methyl groups to give 2-methylE4P and 3-methylE4P respectively, were chosen as substrate 
analogues to synthesise for testing as substrates (Figure 3.3). 
 
 
Figure 3.3: 2- and 3-methylE4P analogues of E4P. 
 
The synthesis and evaluation of the 3-methylE4P analogue as a substrate for DAH7P 
synthase, and the attempts to synthesise the 2-methylE4P analogue are described in this 
chapter. 
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3.2 Synthesis of 3-methylE4P 
 
DL-Malic acid was chosen as the starting material for the synthesis of 3-methylE4P. By 
examining the structure of DL-malic acid we can see that it has the potential to be readily 
chemically manipulated into 3-methylE4P (Figure 3.4). DL-Malic acid contains four carbons, 
has a hydroxyl group at the C2 position, an acidic α-proton on C3 which can be removed to 
form an enolate, so that the carbon can be readily alkylated, and the two carboxylic acid 
groups can be reduced to either aldehyde or primary alcohol functionalities. The primary 
alcohol group can be phosphorylated to give the phosphate functionality. Additionally, DL-
malic acid had already been used for the synthesis of rac-3-deoxyE4P (Chapter 2), and the 
chemistry used for the synthesis of rac-3-deoxyE4P could also be applied here for the 
synthesis of 3-methylE4P. 
 
Another advantage of DL-malic acid is that it is available commercially as both the racemic 
mixture and the enantiopure (2R) and (2S) forms, providing the option to use this as a starting 
material for the synthesis of enantiopure versions of 3-methylE4P. DL-Malic acid is also 
relatively inexpensive (500g for ~$70 NZD, Aldrich) which means the synthesis can be 
carried out on a multigram scale. 
 
 
Figure 3.4: Structural analysis of DL-malic acid. 
 
Shown in Scheme 3.1 is the synthetic route that was initially developed for the synthesis of 3-
methylE4P. It was proposed that DL-malic acid would be converted into diester 2.1, this 
would then be alkylated to give the α-alkylated diester 3.1. The free hydroxyl group on 
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diester 3.1 would then be protected to give benzyl ether 3.2, which would be reduced using 
LiAlH4 to give diol 3.3. Diol 3.3 would need to be phosphorylated at the C1 hydroxyl end 
and oxidised at the other to give compounds 3.4 and 3.7 respectively. The aldehyde group on 
compound 3.7 would then be protected as an acetal, to prevent reduction from the 
hydrogenation step, followed by two deprotection steps to give 3-methylE4P. 
 
 
Scheme 3.1: The proposed synthetic route for the synthesis of 3-methylE4P from DL-malic acid. 
 
3.2.1 Synthesis of 3-methylE4P from DL-malic acid 
 
Following the successful synthesis of diester 2.1 (Chapter 2), diester 2.1 was alkylated using 
the method described by Seebach et al.106,107 to give two diastereoisomers of diester 3.1 (66% 
yield) with diastereoselectivity of 6:1 (Figure 3.5). The formation of both diastereoisomers of 
diester 3.1 was confirmed by two sets of doublets in the 1H NMR spectrum at 1.26 and 1.14 
ppm corresponding to the new methyl resonances on the two products (Figure 3.6). However, 
the diastereomers could not be separated by flash chromatography and the mixture was used 
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in the next step. The stereo-selection in the reaction to form diester 3.1 is discussed in the 
next section. 
 
 
Figure 3.5: Alkylation of diester 2.1 to give a mixture of diastereoisomers of diester 3.1. 
 
 
Figure 3.6: 1H NMR spectrum of compound 3.1. Two sets of doublets corresponding to each methyl group on the 
diastereoisomers of diester 3.1. 
 
Hydroxyl groups can participate in numerous transformations under mild conditions such as 
oxidation, halogenations and elimination reactions.108-112 For this reason it was decided to 
protect the hydroxyl group of diester 3.1. The benzyl ether protecting group was chosen due 
to its successful use for the synthesis of 2- and 3-deoxyE4P. Diester 3.1 was protected under 
mild conditions using freshly prepared Ag2O and BnBr to give compound 3.2 in 79% yield 
(Figure 3.7).113-115 Compound 3.2 was confirmed by an 1H NMR spectrum showing the 
aromatic proton resonances between 7.35–7.26 ppm. 
 
CH3 
CH3’ 
3’ 
3
2’ 
2
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Figure 3.7: Benzylation of the α-alkylated diester 3.1 to give compound 3.2. 
 
Reduction of compound 3.2 with LiAlH4 gave diol 3.3 in 81% yield (Figure 3.8).116,117 The 
1H NMR spectrum confirmed the synthesis of diol 3.3 had been achieved, by the 
disappearance of the ester group methyl resonances between 3.77–3.63 ppm. 
 
 
Figure 3.8: Reduction of benzyl ester 3.2 to give diol 3.3. 
 
The phosphorylation of diol 3.3 can potentially give three compounds, the two 
monophosphorylated regioisomers 3.4, 3.5 and the diphosphorylated compound 3.6 (Figure 
3.9). The ratio of the phosphorylating reagent to the starting material was expected to be 
important in this reaction as too much could result in increased amounts of the 
diphosphorylated compound 3.6, and too little may result in low yields of desired compound 
3.4. 
 
 
Figure 3.9: Possible compounds from phosphorylation of diol 3.3. 
 
It was expected that the bulky benzyl group of diol 3.3 would have some sort of steric effect 
on the phosphorylation reaction, and the desired compound 3.4 was expected to be the major 
Chapter 3: Methyl analogues of E4P  68 
isomer. This is due to the results seen with phosphorylating diol 2.3 in Chapter 2 to give 
desired phosphate 2.4, the other monophosphorylated compound 2.5 and diphosphorylated 
compound 2.6 in a 3:1:1 ratio. In the hope of further increasing the yield of compound 3.4 
over those of compounds 3.5 and 3.6, the sterically bulky diphenyl chlorophosphate was 
chosen as the phosphorylating reagent. 
 
Diol 3.3 was phosphorylated using diphenyl chlorophosphate and imidazole giving a mixture 
of compounds. TLC analysis of the crude mixture before separation by flash chromatography, 
showed four compounds with Rf values of 0.81, 0.57, 0.27 and 0.15 (1:1 EtOAc:Pet ether), 
corresponding to phosphorylating reagent, unknown compound 1, unknown compound 2, and 
starting material 3.3 respectively. The mixture was separated by flash chromatography and 
mass spectrometry was used to ascertain that unknown compound 1 (Rf = 0.57) was the 
diphosphorylated compound 3.6 (mass spectrometry determined a mass of 675.1913 (calc. for 
C36H36O9 [M+H]+: 675.1913)). Whereas, compound 3.4 and 3.5 would have a lower mass 
(calc. C24H28O6P [M+H]+: 443.1624). Mass spectrometry also determined unknown 
compound 2 (Rf = 0.27) was monophosphorylated compound 3.4 or 3.5 (calc. C24H28O6P 
[M+H]+: 443.1624; found: 443.1626). 
 
To determine which monophosphorylated compound had been isolated, phosphates 3.4 or 
3.5, 13C NMR spectroscopy was used. If compound 3.4 was isolated we would expect the 
resonance arising from C4 to have altered chemical shifts due to the attachment of a 
phosphorous group. We would also expect the resonance arising from C4 to spilt due to 31P-
13C coupling (2JPOC). The same would be true for the formation of compound 3.5 except the 
changes would be expected to be observed at C1 not C4. By comparing the two 13C spectra of 
starting material diol 3.3 and unknown compound 2 (Figure 3.10), it was determined that 
unknown compound 2 was the desired monophosphorylated compound 3.4. The resonance 
for C4 was observed further downfield relative to its position in the starting material (65.8 
ppm to 71.5 ppm). This signal also was present as a doublet due to 31P-13C coupling (2JPOC = 
6.6 Hz). 2D NMR spectroscopy, COSY and HSQC were used to fully assign the 1H and 13C 
NMR spectra of this compound. 
 
Surprisingly, the 13C NMR spectrum of diol 3.3 showed no minor peaks due to the minor 
diastereoisomer, with the exception of a very small peak at 36.9 ppm corresponding to the 
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resonance for C3 of the minor diastereoisomer (Figure 3.10). Phosphorylation of diol 3.3 
results in the resolution of the two diastereoisomers.  
 
 
Figure 3.10: (Top) Partial 13C NMR spectrum of diol 3.3. (Bottom) Partial 13C NMR spectrum of compound 3.4 
showing minor peaks due to diastereoisomers. 
 
Overall, analysis of the separated components of the reaction mixture by mass spectrometry 
and NMR (particularly using 13C NMR spectroscopy and 31P-13C coupling) showed only the 
desired monophosphorylated compound 3.4 and the diphosphorylated compound 3.6 had 
been formed in 22% and 21% yields, respectively. Unreacted starting material 3.3 was also 
recovered (30% recovered). Phosphate 3.4 was isolated as a pair of inseparable 
diastereoisomers (ratio 3:1). The best yields of the desired monophosphorylated compound 
3.4 were obtained using 0.9 equivalents of the phosphorylating reagent. No 
monophosphorylated compound 3.5 was isolated or detected in the reaction. This compound 
could have been useful for the synthesis of the 2-methylE4P analogue. 
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DMP was chosen as the oxidising agent for the oxidation of compound 3.4 due to its milder 
reaction conditions (room temperature, neutral pH), shorter reaction times and higher yields 
compared to more traditional chromium- and DMSO-based oxidants.118-122 This reagent is 
even preferred over the Swern oxidation123,124 and is mainly due to the side-product dimethyl 
sulphide, one of the most foul odours known in organic chemistry, that is produced during the 
oxidation reaction. 
 
The monophosphorylated compound 3.4 was oxidised using freshly prepared DMP to give 
aldehyde 3.7 in 81% yield (Figure 3.11).125 The ratio of diastereoisomers also changed when 
phosphate 3.4 (ratio 3:1) was oxidised to give aldehyde 3.7 (ratio 2:1). This change is thought 
to be due to partial resolution of the diastereoisomers of aldehyde 3.7 during purification by 
flash chromatography. Aldehyde 3.7 was confirmed by a 1H NMR spectrum showing the 
aldehyde resonances at 9.69 and 9.60 ppm, corresponding to the diastereoisomers of aldehyde 
3.7. 
 
 
Figure 3.11: Oxidation of monophosphorylated compound 3.4 with DMP to give aldehyde 3.7. 
 
Aldehyde 3.7 needed to be protected as its dimethyl acetal to prevent reduction from 
hydrogenation in the following deprotection step. Aldehyde 3.7 was protected as the dimethyl 
acetal giving the fully protected analogue 3.8 in 87% yield (Figure 3.12).95 1H NMR 
spectroscopy confirmed the disappearance of the aldehyde resonances at 9.69 and 9.60 ppm 
in the spectrum. Additionally, formation of the diastereotopic methoxy group proton 
resonances at 3.44 and 3.40 ppm for the major diastereoisomer, and at 3.34 and 3.32 ppm for 
the minor diastereoisomer was also observed in the 1H NMR spectrum (ratio 2:1). 
 
 
Figure 3.12: Acetal protection of aldehyde 3.7 to give the protected analogue 3.8. 
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The protected analogue 3.8 was treated by hydrogenolysis over PtO2 in MeOH to give crude 
sugar 3.9 in 100% yield (Figure 3.13). The reaction mixture was checked by 1H NMR 
spectroscopy to ensure complete loss of the aromatic proton resonances between 7.34–7.16 
ppm was observed in the spectrum. The acetal protecting groups were then hydrolysed in 
water at 40°C, where the phosphoric acid group provided the acid catalyst, to give 3-
methylE4P. 1H NMR spectroscopy was used to confirm that the methoxy group proton 
resonances between 3.46–3.32 ppm had been cleaved. Additionally, 3-methylE4P was 
detected by mass spectrometry with a molecular mass of 197.0223 (calc. C5H10O6P [M−H]−: 
197.0215). 3-MethylE4P was used directly in enzyme assays without further purification. 
 
 
Figure 3.13: Synthesis of 3-methylE4P. 
 
3.2.1.1 Stereochemistry of diester 3.1 
 
Seebach et al.107 have reported that methylation of compound (2S)-2.1 gave diester 3.1 in 
65% yield as a mixture of diastereoisomers (Figure 3.14). The diastereoisomer ratio of the 
major product ((2S, 3R)-3.1) to the minor product ((2S, 3S)-3.1) was 10:1 and was determined 
by capillary gas chromatography. 
 
 
Figure 3.14: Synthesis of the diastereoisomers of diester 3.1 from (2S)-2.1 by Seebach et al.107 
 
From these results by Seebach et al., methylation of the racemic mixture of compound 2.1 
(c.f. Figure 3.5, page 66) would be expected to result in a mixture of isomers with the major 
products of diester 3.1 having the (2S, 3R)- and (2R, 3S)-configurations and the minor 
products having the (2S, 3S)- and (2R, 3R)-configurations (ratio of 6:1 as determined by 1H 
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NMR spectroscopy, Figure 3.15). Diester (2R, 3S)-3.1 would have the correct 
stereochemistry with respect to E4P. 
 
 
Figure 3.15: Stereoisomers of diester 3.1 from methylation of racemic diester 2.1. E4P is shown for comparison. 
 
Although the ratio of diastereoisomers was not the same as that reported by Seebach et al., 
this was probably due to different experimental conditions for the synthesis of the mixture of 
diastereoisomers of diester 3.1, and that used for the synthesis of (2S, 3R)-3.1 by Seebach et 
al. Only a general experimental procedure was reported by Seebach et al. Purification of the 
mixture of diastereoisomers of diester 3.1 could also account for the lower ratio seen, as the 
diastereoisomers of diester 3.1 may have been partially resolved during flash 
chromatography. 
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3.2.2 Initial enzyme assays with E. coli DAH7P synthase 
 
Standard assay conditions were used to first determine whether 3-methylE4P was a substrate 
for the type Iα E. coli DAH7P synthase (phe) or not. 
 
To determine whether 3-methylE4P was a substrate or not, reaction mixtures were setup that 
contained 3-methylE4P (5–50 µL, unknown concentration), MnSO4 (100 µM) and PEP (150 
µM) in 50 mM BTP buffer at pH 6.8. In each case, the reaction was initiated by the addition 
of purified E. coli DAH7P synthase (2–30 µL, 5.86 mg/mL). All assays were carried out at 
25°C in a total volume of 1.0 mL and the loss of PEP was monitored at 232 nm. Initial 
readings showed that 3-methylE4P was not a substrate for E. coli DAH7P synthase, as no 
PEP loss was observed at 232 nm, even though high concentrations of enzyme were 
employed. 
 
To confirm the enzyme was active under the assay conditions, selected reactions were spiked 
with the natural substrate E4P. Absorption loss of PEP was observed immediately indicating 
the enzyme was catalysing the reaction between E4P and PEP and not between 3-methylE4P 
and PEP. An analysis of why 3-methylE4P was not a substrate for E. coli DAH7P synthase 
can be found in Chapter 5. 
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3.3 Attempts to synthesise 2-methylE4P 
 
3.3.1 Early approaches: Method 1 
 
The first attempted synthesis of 2-methylE4P followed a similar route to that which was 
employed for the successful synthesis of 3-methylE4P and used the same starting material, 
DL-malic acid. Figure 3.16 shows the three general key chemical manipulations that are 
required to convert the acid into 2-methylE4P. These steps are alkylation at the α-position, 
phosphorylation at one end of the molecule and reduction at the other end to give the 
aldehyde functionality. 
 
 
Figure 3.16: Analysis of DL-malic acid for the synthesis of 2-methylE4P. 
 
Shown in Scheme 3.2 is the first synthetic scheme that was used to attempt to synthesise 2-
methylE4P from DL-malic acid. The first two steps of the proposed scheme would require the 
orthogonal protection of each of the carboxylate ends of malic acid to give acid 3.11 and ester 
3.12. Ester 3.12 would then be alkylated to afford compound 3.13 followed by deprotection 
of the cyclohexylidene acetal protecting group to give acid 3.14. Acid 3.14 would then be 
selectively reduced at the carboxylate end, followed by monophosphorylated at the primary 
alcohol position to give compounds 3.15 and 3.16 respectively. Selective reduction of the 
ester to an aldehyde would afford aldehyde 3.17, followed by protection of the aldehyde 
group with dimethyl acetal to give the protected analogue 3.18. Subsequent deprotection 
steps would give 2-methylE4P. 
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Scheme 3.2: Proposed synthetic scheme for the synthesis of 2-methylE4P. Method 1. 
 
3.3.1.1 Implementation of Scheme 3.2 
 
The first attempts to synthesise acid 3.11 followed the procedure of Monma et al.126 and 
yielded acid 3.11 in a disappointingly low yield of 7–8%. The low yields were attributed to 
the reaction producing an equivalent of water which would be detrimental to the reaction. 
However, Monma et al. did not report the use of any dehydrating reagents in their procedure. 
The reaction was retried but this time with an added dehydrating reagent, 4Å sieves, to 
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remove water and drive the reaction to completion. The yield obtained for acid 3.11 was 66% 
(lit.126 67%) following purification by flash chromatography (Figure 3.17). The 1H and 13C 
NMR spectra of acid 3.11 matched those reported in literature.126,127 
 
 
Figure 3.17: Synthesis of acid 3.11. 
 
Esterification of acid 3.11 using a modified method by Karanewsky et al.128 gave the ester 
3.12 with a 95% yield after flash chromatography (Figure 3.18). Ester 3.12 was confirmed by 
a 1H NMR spectrum showing the ester group methyl resonance at 3.71 ppm. 
 
 
Figure 3.18: Synthesis of ester 3.12. 
 
With the successful synthesis of ester 3.12, attempts were made to alkylate the ester at the C3 
position to give compound 3.13. The first attempts involved using the base LDA and the 
electrophile MeI, but these were unsuccessful in alkylating the ester 3.12 (Figure 3.19). 
Several attempts were trialled using either 1.2 or 2.2 equivalents of LDA but with no success. 
TLC analysis of the reactions mixtures showed multiple unidentifiable side-products (most 
likely due to degradation of ester 3.12), and only some starting material 3.12 could be 
recovered (16% recovered). Due to these problems, this reaction was not investigated further. 
 
Chapter 3: Methyl analogues of E4P  77 
 
Figure 3.19: Attempts to alkylate ester 3.12 using LDA and MeI. 
 
Following the unsuccessful synthesis of compound 3.13 using the LDA/MeI method, the 
procedure by Casper et al.129 was also trialled. Casper et al. synthesised compound 3.21 using 
TiCl4, Et3N via the enolate 3.20 (Figure 3.20). This reaction is similar to the reaction 
described in Figure 3.19 using LDA. The procedure was trialled on ester 3.12, but 
unfortunately only starting material could be detected by TLC during the reaction (Figure 
3.21). 
 
 
Figure 3.20: Synthesis of compound 3.21 by Casper et al.129 
 
 
Figure 3.21: Attempts to alkylate ester 3.12 using TiCl4, Et3N and MeI. 
 
The lack of success with this alkylation reaction may well be due to steric factors. The bulky 
cyclohexylidene protecting group could hinder access to the carbonyl group of ester 3.12 
from coordinating with the large TiCl4 Lewis acid, as seen in enolate 3.20. Therefore, 
stabilisation of the enolate would not be possible and the reaction would not proceed. This 
was supported by a large amount of starting material being recovered following purification 
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by flash chromatography (75–100% recovered). In contrast, the reaction carried out by 
Casper et al.129 worked because the large TiCl4 Lewis acid was able to stabilise the enolate 
3.20, by coordinating to the two carbonyl groups. 
 
Due to the failed attempts in alkylating ester 3.12 to give compound 3.13, this 
cyclohexylidene protecting group method shown in Scheme 3.2 was abandoned and 
alternative schemes were investigated. 
 
3.3.2 Selective reduction of dimethyl malate ester 2.1: Method 2 
 
With the failed attempts in alkylating ester 3.12, as described in the previous section, it was 
thought that the use of a protecting group at the start of the synthesis (i.e. the cyclohexylidene 
protecting group, Scheme 3.2) may not be necessary. A search of literature110,130-133 revealed 
that diester 2.1 (a readily available starting material used for the synthesis of 3-methylE4P 
and 3-deoxyE4P) can be selectively reduced at the C1 ester end over the C4 end. By 
selectively reducing the C1 ester end of diester 2.1 over the C4 end, one could then alkylate 
the C3 position to give compound 3.23. Phosphorylation at the primary hydroxyl, followed 
by selective reduction at the ester end of compound 3.23 would give the phosphate and 
aldehyde groups of 2-methylE4P, respectively (Figure 3.22). The proposed synthetic scheme 
for this route is shown in Scheme 3.3 and requires eight steps to reach the target compound. 
 
 
Figure 3.22: Analysis of DL-malic acid for selective reduction at only one of the carboxylate ends. 
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Scheme 3.3: Proposed synthetic scheme for the synthesis of 2-methylE4P. Method 2. 
 
3.3.2.1 Implementation of Scheme 3.3 
 
Initial attempts to selectively reduce diester 2.1 using borane-dimethyl sulphide complex and 
a catalytic amount of NaBH4 (10 mol%), gave the diol 3.22 in 52% yield. By dropping the 
molar percentage of NaBH4 to 3% and carefully monitoring the reaction by TLC, diol 3.22 
was obtained in 94% yield (Figure 3.23). The NMR spectral data for diol 3.22 were in 
accordance with the literature report.131 
 
 
Figure 3.23: Selective reduction of diester 2.1 using BH3.SMe2 and NaBH4 to give diol 3.22. 
 
Unfortunately, attempts to alkylate 3.22 were unsuccessful (Figure 3.24). TLC analysis 
observed that starting material was being consumed to give a new compound but on closer 
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analysis with 1H NMR spectroscopy it was determined this new compound was not 
compound 3.23. Instead, the 1H NMR spectrum of this compound showed that the peak at 
3.70 ppm, corresponding to the ester group methyl resonance, had gone. One possible reason 
for the disappearance of the methyl resonance is that the reaction produced lactone 3.28 
instead of the desired compound 3.23 (Figure 3.25). Analysis of this compound by mass 
spectrometry would confirm whether lactone 3.28 was being formed, but was not investigated 
as this method was subsequently abandoned. Although lactone 3.28 could still be alkylated 
itself, no alkylated product was detected in the 1H NMR spectrum. 
 
 
Figure 3.24: Attempts to alkylated diol 3.22. 
 
 
Figure 3.25: Possible cyclisation of diol 3.22 to lactone 3.28 mechanism. 
 
In an attempt to prevent cyclisation of diol 3.22 to lactone 3.28, the primary alcohol group on 
diol 3.22 was protected using a silyl ether protecting group, TBDPS, to give ester 3.29 with a 
90% yield (Figure 3.26). Unfortunately, attempts to alkylate ester 3.29 using LDA and MeI 
resulted in multiple unidentifiable side-products (TLC analysis). These side-products were 
not isolated or investigated further. 
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Figure 3.26: Synthesis of ester 3.29 and attempts to synthesise compound 3.30. 
 
With the unsuccessful synthesis of compounds 3.23 and 3.30 by alkylation using LDA/MeI, 
the method proposed in Scheme 3.3 was subsequently abandoned and another method to 
synthesise 2-methylE4P was investigated. 
 
3.3.3 A modified method of the synthesis of 3-methylE4P: Method 3 
 
Due to the difficulties encountered in alkylating derivatives of DL-malic acid in Scheme 3.2 
and Scheme 3.3 (previous sections) it was decided to look back at the synthetic scheme for 
the synthesis of 3-methylE4P (Scheme 3.1), in particular the successful synthesis of diester 
3.1 and diol 3.3 (Figure 3.27). 
 
 
Figure 3.27: Compounds 3.1 and 3.3 from the synthesis of 3-methylE4P. 
 
Diester 3.1 can be readily prepared from DL-malic acid as seen previously for the synthesis of 
3-methylE4P. Furthermore, following two more steps, diester 3.1 can be converted to the diol 
3.3. The idea was to monoprotect diol 3.3 using a large protecting group at the less hindered 
primary alcohol, and follow this with phosphorylation on the other end. The large 
triisopropylsilane (TIPS) protecting group was chosen (Figure 3.28), due to its availability 
and use in our laboratory, steric bulk, and stability under a wide range of reaction 
conditions.103,134 
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Figure 3.28: Analysis of diol 3.3 for the synthesis of 2-methylE4P. The less hindered alcohol end of diol 3.3 would be 
protected using a large TIPS group followed by phosphorylation at the other end. 
 
The synthetic scheme proposed to synthesise 2-methylE4P from diol 3.3 is shown in  
Scheme 3.4. Diol 3.3 would be monoprotected using TIPSCl giving three possible products 
3.31–3.33. The major regioisomer 3.31 would then be isolated from the other compounds and 
phosphorylated, followed by deprotection of the TIPS group to give alcohol 3.35. The 
exposed primary alcohol group on alcohol 3.35 would then be oxidised to give aldehyde 3.36. 
Subsequent reactions of protection of the aldehyde group on aldehyde 3.36, followed by 
deprotection steps would give 2-methylE4P.  
 
In addition, it was thought that the diphenyl chlorophosphate reagent used for the synthesis of 
3-methylE4P may be too bulky to give the phosphorylated compound 3.31. This is because 
no regioisomer 3.5 (Figure 3.9, page 67) was detected or isolated during the 
monophosphorylation reaction of diol 3.3. Therefore, the less bulky phosphorylating reagent, 
diethyl chlorophosphate, was chosen instead (Scheme 3.4). 
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Scheme 3.4: The proposed synthetic scheme for the synthesis of 2-methylE4P. Method 3. 
 
3.3.3.1 Implementation of Scheme 3.4 
 
Following the successful synthesis of diol 3.3 using the method shown in Scheme 3.1, diol 
3.3 was monoprotected using TIPSCl (1.1 equiv.) and imidazole to give a mixture of three 
compounds, as indicated by TLC analysis. These compounds could potentially be the three 
products 3.31–3.33 (Figure 3.29). 
 
Chapter 3: Methyl analogues of E4P  84 
 
Figure 3.29: Monoprotection of diol 3.3 using TIPS giving potentially three regioisomers 3.31–3.33. 
 
The three unknown compounds with Rf (1:9 EtOAc:Pet ether) values of 0.58, 0.13 and 0.04 
were separated by flash chromatography and TLC analysis indicated the most polar 
compound, Rf = 0.04, was starting material 3.3 (28% recovered). 1H NMR analysis 
confirmed that this lowest Rf spot was indeed starting material 3.3. It was assumed that the 
less polar compound, Rf = 0.58, was the disilylated compound 3.33 as this compound would 
be the less polar compared to compounds 3.3, 3.31 and 3.32. Analysis of this compound by 
mass spectrometry determined a mass of 523.3945 (calc. C30H59O3Si2 [M+H]+: 523.3940), 
which corresponds to the disilylated compound 3.33 (20% yield). The mass determined for 
the compound with Rf = 0.13, was 367.2655 (calc. C21H39O3Si [M+H]+: 367.2668). This 
mass corresponds to either monosilylated compound 3.31 or 3.32. Interpretation of the 1H and 
13C NMR spectrums, with the aid of 2D NMR spectroscopy (HSQC, HMBC and COSY), 
confirmed that this compound was the desired regioisomer 3.31 (51% yield). 
 
The overall yield for the monoprotection reaction of diol 3.3 using TIPS to give 
monosilylated compound 3.31 (51% yield, Figure 3.30), was better than expected in 
comparison to the synthesis of compound 3.4 (22% yield) from the monophosphorylation of 
diol 3.3. The ratio of the reagent TIPSCl used in this reaction, compared to the starting 
material diol 3.3, also seemed to matter in the synthesis of alcohol 3.31. When 0.9 
equivalents of TIPSCl was used instead of 1.1 equivalent, compound 3.31 was synthesised in 
32% yield i.e. fewer equivalents decreased the yield. This was the opposite observation to 
that which was made with the monophosphorylation of diol 3.3, as more equivalents of the 
phosphorylating reagent resulted in a decrease in yield of compound 3.4. Optimisation 
studies, where the amount of silyating reagent is varied, could be done in the future to obtain 
the maximum yield for alcohol 3.31. 
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Figure 3.30: Monoprotection of diol 3.3 using the TIPS protecting group. 
 
No minor regioisomer 3.32 could be isolated or detected in the reaction (Figure 3.30), and 
this observation was similar to that made in the monophosphorylation reaction for the 
synthesis of 3-methylE4P where no minor regioisomer 3.5 could be detected in the reaction 
as well (Figure 3.9, page 67). The minor regioisomer 3.32 could have also been useful for the 
synthesis of 3-methylE4P analogue. 
 
Alcohol 3.31 was then phosphorylated using diethyl chlorophosphate and imidazole to give 
phosphate 3.34 in 72% yield (Figure 3.31 and Figure 3.32). 31P NMR spectroscopy confirmed 
the presence of the phosphate ester resonance at −0.33 ppm in the spectrum. Additionally, 
phosphate 3.34 was detected by mass spectrometry as the protonated compound, with a 
molecular mass of 503.2937 (calc. C25H48O6SiP [M+H]+: 503.2958). 
 
 
Figure 3.31: Synthesis of phosphate 3.34. 
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Figure 3.32: Comparison of the partial 13C NMR spectra of compounds 3.31 and 3.34. Peaks were assigned using 
HSQC and COSY spectra. 
 
Deprotection of phosphate 3.34 using TBAF at room temperature gave alcohol 3.35 in 90% 
yield (Figure 3.33). 1H NMR spectroscopy confirmed that the deprotection had occurred, 
with the disappearance of the peaks arising from the isopropyl group resonances between 
1.09–0.98 ppm in the spectrum. 
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Figure 3.33: Synthesis of alcohol 3.35. 
 
Alcohol 3.35 was initially oxidised using DMP that had been prepared a month earlier to give 
aldehyde 3.36 in 56%. By using freshly prepared DMP, which had been prepared the day 
before, the yield for aldehyde 3.36 was increased to 72% (Figure 3.34). The presence of the 
product was confirmed by a 1H NMR spectrum showing the aldehyde resonances at 9.74 and 
9.70 ppm, corresponding to the diastereoisomers of aldehyde 3.36 (ratio 2:1). 
 
 
Figure 3.34: Oxidation of alcohol 3.35 using DMP to give aldehyde 3.36. 
 
The aldehyde group on aldehyde 3.36 needed to be protected as its dimethyl acetal to prevent 
reduction from hydrogenation in the following deprotection steps. Protection of aldehyde 
3.36 was accomplished using MeOH and concentrated H2SO4 to give acetal 3.37 in 77% 
yield (Figure 3.35). The presence of the product was confirmed by a 1H NMR spectrum 
showing the aldehyde resonances at 9.74 and 9.70 ppm had disappeared. Additionally, the 
formation of the diastereotopic methoxy group proton resonances at 3.36 and 3.33 ppm for 
the major diastereoisomer, and at 3.47 and 3.43 ppm for the minor diastereoisomer were also 
observed in the spectrum (ratio 2:1). 
 
 
Figure 3.35: Synthesis of acetal 3.37. 
 
Hydrogenation of acetal 3.37 using a platinum catalyst on carbon gave compound 3.38 in 
95% yield (Figure 3.36). 1H NMR spectroscopy confirmed that all aromatic proton 
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resonances had been lost with the disappearance of the peaks between 7.37–7.26 ppm in the 
spectrum. 
 
 
Figure 3.36: Synthesis of compound 3.38. 
 
Unfortunately, treatment of compound 3.38 with TMSBr (2.2 equiv.) did not result in the 
synthesis of 2-methylE4P (Figure 3.37). During the reaction, TLC analysis indicated the loss 
of the starting material 3.38 and the development of a new compound producing a spot on the 
baseline. It was thought that the phosphate ester ethyl groups had been hydrolysed off 
forming the polar phosphate acid that would appear on the baseline. The 1H NMR spectrum 
of the crude sample after work up (concentrated in vacuo to remove volatiles) showed that 
the phosphate ester group ethyl resonances at 4.11 and 1.73 ppm had not been cleaved by 
TMSBr. The dimethyl acetal protection group had however been removed to give the 
aldehyde functionality. This was indicated by the disappearance of the methoxy group proton 
resonances at around 3.40 ppm and the appearance of the aldehyde group at 9.20 ppm in the 
1H NMR spectrum. It appears the acidity of the reaction mixture (pH 1–2, by pH paper) 
resulted in the hydrolysis of the dimethyl acetal protection group rather than the ester groups. 
Unfortunately, at this point of the synthesis all of compound 3.38 had been used up. 
 
 
Figure 3.37: Attempts to synthesise 2-methylE4P. 
 
Chouinard et al.135 also observed that the cleavage of alkyl phosphate esters was extremely 
difficult using TMSBr. The authors reported deprotection of compound 3.41 using TMSBr 
resulted in dephosphorylation and the cleavage of the allylic C-O bond of compound 3.41 
(Figure 3.38). Although some product 3.43 was formed, the reaction was not reproducible. 
The authors eventually directed their efforts to phosphate esters that were more readily 
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cleaved, and used compound 3.42 for the synthesis of compound 3.43. It was also noted that 
Chouinard et al. added pyridine in their reaction to reduce the acidity of the reaction mixture. 
Although no basic reagents were added during the attempted deprotection of compound 3.38 
with TMSBr, this could be trialled in the future to prevent cleavage of the acetal protection 
group. Investigations into using the benzyl phosphate for phosphorylating compound 3.31 
could also be trialled, as Chouinard et al. found that cleavage of phosphate 3.42 was easier 
than when alkyl phosphates were used. Additionally, research into the use of a more robust 
aldehyde protecting group (e.g. cyclic acetals)103 for compound 3.36 may aid in the 
survivability of the compound during the TMSBr deprotection step. 
 
 
Figure 3.38: Deprotection of compound 3.41 and 3.42 to give compound 3.43 by Chouinard et al.135 
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3.4 Summary 
 
3-MethylE4P was successfully synthesised in nine steps via DL-malic acid as seen in Scheme 
3.1, and summarised in Figure 3.39 below. The yields for each step were generally moderate 
to high yielding, with only the monophosphorylation of diol 3.3 step being low yielding 
(22%). 
 
 
Figure 3.39: Overall synthetic scheme used to synthesis 3-methylE4P from DL-malic acid. 
 
Standard enzyme assays showed that 3-methylE4P was not a substrate for E. coli DAH7P 
synthase (phe), although substrate specificity tests with D/L-T4P and 2/3-deoxyE4P indicated 
that the C2 and C3 hydroxyls of E4P and the active site residues they interact with have a 
limited role to play in substrate selection by the enzyme. This suggests that the active site of 
E. coli DAH7P synthase (phe) cannot accommodate the bulk of a methyl group in the C3 
position of E4P. 
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The summary for the attempted synthesis of 2-methylE4P starting from DL-malic acid is 
shown below (Figure 3.40). Although the synthesis of this compound was not completed due 
to the difficulties in the deprotection of compound 3.38 the characterisation and methodology 
for the synthesis of compounds 3.3, 3.31, 3.32 and 3.34–3.38 have been well documented in 
this thesis. Future synthesis of 2-methylE4P could re-use this synthetic route but use a 
different phosphorylating method or a more robust aldehyde protecting group to facilitate the 
deprotection method. 
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Figure 3.40: Overall synthetic scheme used for the attempted synthesis of 2-methylE4P. 
 
A discussion on why 3-methylE4P was not a substrate for DAH7P synthase, and the 
predicted outcome for 2-methylE4P can be found in Chapter 5. 
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Chapter 4:  Phosphonate analogues of E4P 
 
4.1 Introduction 
 
Phosphonic acids often exhibit important biological properties because of their similarity to 
phosphates, and the preparation and investigation of phosphonic acid analogues of natural 
substrates has been of particular interest in the literature.136-139 For example, the phosphonate 
analogue of adenosine triphosphate (ATP), adenosine 5’-[-methylene] triphosphate 
(Figure 4.1), has been found to be an inhibitor of polynucleotide phosphorylase (involved in 
mRNA processing) and is capable of replacing ATP as a substrate in RNA polymerase.136,140 
Phosphonate analogues of natural substrates also have the advantage of being more stable to 
hydrolysis as the C-P bond in phosphonates, unlike the O-P bonds of phosphates or 
phosphate esters, is resistant towards chemical and enzymatic hydrolysis. This resistance to 
hydrolysis by enzymes is advantageous in drug design as most biological fluids contain 
phosphatases that cleave phosphate containing drugs before they are able to reach their 
intracellular targets.138,139 
 
 
Figure 4.1: The isosteric phosphonate analogue of ATP. 
 
Analogues of E4P in which the phosphate group C-O-P is replaced by a C-P group (non-
isosteric phosphonate analogue) or by a C-CH2-P group (isosteric or homophosphonate 
analogue) have been synthesised in the past by Le Marechal et al.141, and substrate specificity 
studies were conducted on transaldolase and transketolase (both involved in the pentose 
phosphate pathway for the biosynthesis of nucleic acids). Although no kinetic data was given 
by Le Marechal et al., it was reported that the homophosphonate analogue was a substrate for 
both these enzymes and the phosphonate analogue was a substrate for transaldolase. 
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The substitution of a phosphonate moiety for the phosphate moiety on E4P could have 
interesting effects on the way the substrate interacts with enzymes. For example, the 
phosphonate analogue of E4P would be shorter in length compared to E4P due to the deletion 
of the oxygen, whereas the homophosphonate analogue would be more similar in length. This 
could alter the way that the substrate binds to the active sites of enzymes. 
 
Phosphonate analogues of E4P have been of particular interest in our research group and it 
would be interesting to see how sensitive DAH7P synthases are to substitution of the 
phosphate moiety of E4P for a phosphonate group. The phosphonate group would be 
particularly important for the development of inhibitors because of the stability of the 
phosphonate group to resist cleavage by phosphatases in biological fluids. This chapter 
describes the attempts at synthesising the phosphonate analogue of E4P, D-erythrose 4-
phosphonate, and the synthesis of the analogue 2,3-dideoxy erythrose 4-phosphonate 4.38 
(Figure 4.2). 
 
 
Figure 4.2: D-Erythrose 4-phosphonate and 2,3-dideoxy erythrose 4-phosphonate 4.38. 
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4.2 Attempts to synthesise D-erythrose 4-phosphonate 
 
D-Erythrose 4-phosphonate was first synthesised by Le Marechal et al.141 in 1980 by the 
oxidative cleavage of D-glucose 6-phosphonate 4.14 using lead tetraacetate. This procedure is 
similar to the lead tetraacetate oxidative cleavage of D-glucose 6-phosphate for the 
preparation of E4P (Figure 4.3).89,90 Although the authors reported the synthesis of D-
erythrose 4-phosphonate, there was no experimental or spectroscopic data given in the paper 
for D-erythrose 4-phosphonate. Interestingly, the authors for the preparation of E4P from D-
glucose 6-phosphate using lead tetraacetate also did not give any form of data to confirm the 
synthesis of E4P. 
 
 
Figure 4.3: Lead tetraacetate oxidative cleavage of D-glucose 6-phosphonate 4.14 and D-glucose 6-phosphate. 
 
There are several disadvantages of synthesising D-erythrose 4-phosphonate using the lead 
tetraacetate procedure described by Le Marechal et al. and these disadvantages are analogous 
to the ones mentioned in Chapter 1 for the synthesis of E4P from D-glucose 6-phosphate. For 
example, Le Marechal et al. reported over and under oxidation of 4.14 producing the three 
carbon and five carbon phosphonate side-products glyceraldehyde 3-phosphonate and 
arabinose 5-phosphonate, respectively. 
 
Although no experimental data was given for the synthesis of compound 4.14 by Le 
Marechal et al., a reference for the synthesis of this compound was given to a report by 
Griffin et al.142 The synthesis of compound 4.14 by Griffin et al. is shown in Figure 4.4 and 
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starts with the compound 4.6. Unfortunately, there was hardly any spectroscopic data to 
confirm the synthesis of these compounds (Figure 4.4), only optical rotation and melting 
point data was presented.142 At this point a retrosynthetic analysis of compound 4.14 was 
carried out in order to develop a scheme for the synthesis of this compound. 
 
 
Figure 4.4: Synthetic scheme used by Griffin et al. to synthesise D-glucose 6-phosphonate 4.14. 
 
Shown in Figure 4.5 is the retrosynthetic analysis for the synthesis of compound 4.14. The 
retrosynthetic analysis shows that the C1–C4 secondary hydroxyls of D-glucose have to be 
protected first, whilst leaving the C6 hydroxyl of D-glucose available for chemical 
manipulation. This C6 hydroxyl is versatile and can be interconverted into many other 
functional groups, and in this case a halide. The halide can then be phosphonylated to give a 
phosphonate followed by deprotection steps of the protecting groups to give compound 4.14. 
 
 
Figure 4.5: Retrosynthetic analysis of D-glucose 6-phosphonate 4.14. 
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The conversion of the C6 halide group of glucose into a phosphonic acid moiety could be 
achieved by using the Arbuzov143,144 reaction (Figure 4.6). The first step in the Arbuzov 
reaction involves nucleophilic attack of the phosphorus on the alkyl halide, followed by 
dealkylation of resulting trialkoxyphosphonium salt to give a phosphonate. The Arbuzov 
reaction was also used for the synthesis of phosphonate 4.12 by Griffin et al.142 (Figure 4.4). 
 
 
Figure 4.6: The mechanism of the Arbuzov reaction.144 
 
4.2.1 Early approaches to the synthesis of D-glucose 6-phosphonate 4.14 
 
To synthesise D-erythrose 4-phosphonate an overall synthetic scheme was devised for the 
synthesis of the precursor 4.14 (Scheme 4.1). Scheme 4.1 was developed from the 
retrosynthetic analysis in Figure 4.5, with the incorporation of the synthetic scheme used by 
Griffin et al.142 for the synthesis of compounds 4.6, 4.12–4.14. Additionally, this synthetic 
scheme starts with the commercially available and cheap starting material D-glucose. By 
chemically manipulating the C6 hydroxyl group of D-glucose it was hoped that compound 
4.14 could be synthesised in nine steps. 
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Scheme 4.1: First attempts to synthesise D-glucose 6-phosphonate. Method 1. No modifications were made for the 
synthesis of compounds 4.6, 4.12–4.14 as described by Griffin et al.142 
 
Shown in Scheme 4.1 is the synthetic scheme that was devised to attempt to synthesise 
compound 4.14. The first two steps involve protecting the hydroxyl groups on D-glucose 
using acetyl groups followed by a base-assisted intramolecular displacement of the leaving 
group at the anomeric position to form the sugar 4.4. Sugar 4.4 is then treated with PBr5 to 
give the dibromo-derivative 4.5, which then undergoes a Koenigs-Knorr145-147 reaction to 
give bromide 4.6. Ethyl diphenyl phosphite is then reacted with bromide 4.6 to give the 
phosphonate 4.12 followed by two deprotection steps to give D-glucose 6-phosphonate 4.14. 
 
The first step of Scheme 4.1 was carried out following the literature procedure by Tsuji et 
al.148 The reaction was performed by refluxing D-glucose, Ac2O and NaOAc in benzene to 
give crude acetate 4.1. Purification of crude acetate 4.1 by recrystallisation from EtOH gave 
acetate 4.1 in 16% yield (lit.148 73%). The product was characterised by the 1H NMR 
spectrum showing five acetyl group methyl resonances between 2.10–2.00 ppm. The 
experimental data for acetate 4.1 also matched those reported by Tsuji et al.148 Attempts were 
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made to improve the yield of acetate 4.1 and the reaction was repeated, but the solvent was 
switched to toluene. By doing this, the yield of acetate 4.1 was increased to 44% (Figure 4.7). 
Although the yields of this reaction were low, D-glucose is a readily available and cheap 
starting material, and the low yield was not considered to be a major drawback in the 
synthesis of acetate 4.1. 
 
 
Figure 4.7: Synthesis of acetate 4.1. 
 
Following the procedure by Montgomery et al.149, acetate 4.1 was treated with p-TsOH and 
phenol. The homogenous melt that formed was heated in vacuo at 100°C for 1 hour. The 
mixture was worked up, and purified by recrystallisation from EtOH to give the β-
phenylglycoside 4.2 in 32% yield (lit.149 64%) (Figure 4.8). The spectroscopic data for the β-
phenylglycoside 4.2 were identical to those reported by Montgomery et al., with signals 
corresponding to the phenyl proton resonances between 7.34–7.25 ppm in the 1H NMR 
spectrum. 
 
 
Figure 4.8: Synthesis of β-phenylglycoside 4.2. 
 
In an attempt to increase the yield of β-phenylglycoside 4.2 the reaction was repeated but the 
heating time was varied (2 hours). Unfortunately, during this time a black tar mixture had 
formed that was hard to stir and after purification only a 28% yield of β-phenylglycoside 4.2 
was obtained. This indicated that the reaction time and maybe even the temperature had to be 
optimised in the future if a better yield was to be obtained. With the combined yields of both 
reactions it was decided to carry on investigating the overall synthetic scheme despite the low 
yields for the synthesis of β-phenylglycoside 4.2. 
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The β-phenylglycoside 4.2 was subjected to a base-assisted intramolecular displacement 
reaction of the anomeric phenyl group following the procedure by Lu et al.150 (Figure 4.9) to 
give the sugar 4.4 as a white solid. The 1H NMR spectrum obtained for sugar 4.4 matched 
that reported in literature.151 Numerous attempts were made to synthesise the sugar 4.4 with 
varying results. In some attempts the reaction would proceed smoothly producing sugar 4.4 in 
11–39% yield. In subsequent reactions, under exactly the same reaction conditions, the 
reaction would produce a black tar-like mixture with multiple unidentifiable products, as 
indicated by TLC analysis. No product or starting material could be recovered from this black 
mixture. The varying result made the synthesis of sugar 4.4 extremely difficult and the 
maximum yield obtain from these trials was 39% (lit.150 73%). 
 
 
Figure 4.9: Synthesis of sugar 4.4. 
 
The synthesis of the dibromo-derivative 4.5 was accomplished by heating sugar 4.4 with PBr5 
at 80–90°C under solvent-free and anhydrous conditions as described by Irvine et al.152 Care 
has to be taken when handling phosphorous pentabromide as it is highly corrosive and reacts 
violently with water. The synthesis was carried out and the dibromo-derivative 4.5 was 
synthesised in 34% yield (Figure 4.10). Mass spectrometry detected the sodiated dibromo-
derivative 4.5 as a compound with a monoisotopic mass of 452.9158 (calc. C12H16Br2NaO7 
[M+Na]+: 452.9155). 
 
 
Figure 4.10: Synthesis of the dibromo-derivative 4.6. 
 
Although the yield was low, Irvine et al. only reported a 50% maximum yield for the 
dibromo-derivative 4.5. No attempts were made at this stage to increase this yield. 
 
Chapter 4: Phosphonate analogues of E4P  100 
Benzylation of the anomeric position of dibromo-derivative 4.5 gave bromide 4.6 in 18% 
yield (Figure 4.11). 1H NMR spectroscopy detected the presence of the aromatic proton 
resonance between 7.39–7.29 ppm in the spectrum. Additionally, mass spectrometry detected 
the sodiated bromide 4.6 as a compound with a monoisotopic mass of 481.0478 (calc. 
C19H23BrNaO6 [M+Na]+: 481.0469). 
 
 
Figure 4.11: Synthesis of bromide 4.6. 
 
The reaction shown in Figure 4.11 is a Koenigs-Knorr reaction which favours nucleophilic 
attack of the alkoxide ion at the anomeric position. The Koenigs-Knorr reaction (Scheme 4.2) 
can be understood by assuming that the dibromo-derivative 4.5 undergoes a spontaneous loss 
of Br− forming an oxocarbenium ion (that is stabilised by the lone pair of electrons on 
oxygen) to give the intermediate 4.7. Intermediate 4.7 then undergoes an internal reaction 
with the ester group at C2 to form an oxonium ion intermediate 4.8. Back-side attack by the 
alcohol at C1 gives bromide 4.9 and regenerates the acetate at C2. 
 
Although the Koenigs-Knorr reaction is favoured, two possible reasons for the low yielding 
reaction are shown in Scheme 4.2. Side-product 4.10 is formed by the alcohol attacking at the 
C6 position and not the anomeric position. Side-product 4.11 would result from the 
hydrolysis of the dibromo-derivative 4.5. Although the reaction was carried out under 
anhydrous conditions, even small amounts of water will lead to side-product 4.11.153 TLC 
analysis of the reaction mixture after work-up, showed multiple compounds indicating other 
products aside from bromide 4.6 had been formed. These other products could possibly be the 
side-products 4.10 and 4.11 but were not isolated or investigated. 
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Scheme 4.2: Proposed side-products for the benzylation of dibromo-derivative 4.5. 
 
The phosphonylating reagent, ethyl diphenylphosphate (EDPP), required for the 
phosphonylation of bromide 4.6 was synthesised from the precursor ethyl dichlorophosphite 
(EDCP).154,155 EDCP was synthesised by reacting ethanol with phosphorous trichloride at 
−20°C to give EDCP in 14–19% yield after purification by distillation (lit.155 42%). EDCP 
was then reacted with phenol and triethylamine to afford EDPP in 73% yield (lit.156 85%). 
The NMR spectral data for EDCP and EDPP were in accordance with the literature 
reports.154-156 
 
 
Figure 4.12: Synthesis of EDCP and EDPP. 
 
Due to the limited amounts of bromide 4.6, a small scale trial reaction of the phosphonylating 
reagent EDPP with ethyl bromoacetate was setup to ascertain the viability of the reagent and 
to test the Arbuzov method for synthesising phosphonates. The small scale test was 
successful and produced ethyl diphenylphosphonoacetate (Figure 4.13) with a 1H NMR 
spectrum in accordance with that reported in the literature.157 
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Figure 4.13: Synthesis of ethyl diphenylphosphonoacetate using the phosphonylating reagent EDPP. 
 
When EDPP was reacted with bromide 4.6, no phosphonate 4.12 could be detected by TLC 
and only starting material and reagent could be observed (Figure 4.14). This was contrary to 
what Griffin et al.142 had reported when they had reacted EDPP with bromide 4.6. 
Unfortunately, at this point of the synthesis all of the bromide 4.6 (Figure 4.14) had been 
used up and due to the difficulties in synthesising sugar 4.4, coupled with the low yields of 
compounds 4.1, 4.2, 4.4–4.6 in Scheme 4.1, this synthetic scheme was not investigated 
further and abandoned. Other methods for the preparation of D-glucose 6-phosphonate 4.14 
were investigated. 
 
 
Figure 4.14: Attempt at synthesising phosphonate 4.12. 
 
4.2.2 Synthesis of precursor phenylmethyl 6-bromo-6-deoxy-2,3,4-tris-O-
(phenylmethyl)-β-D-glucopyranoside 4.18 
 
Due to the failed attempts to phosphonylated bromide 4.6 (Scheme 4.1 and Figure 4.14) 
alternative methods for the synthesis of precursor 4.14 were investigated. The retrosynthetic 
analysis in the previous section (Figure 4.5) contains three key steps for the synthesis of the 
precursor 4.14: protection of the C1–C4 secondary hydroxyl groups of D-glucose, chemically 
manipulate the C6 hydroxyl group to give a halide, and phosphonylation of this halide 
(Figure 4.15). With these three key steps in mind, and after an extensive review of the 
literature, the synthetic scheme used by Lu et al.158 was employed to synthesise the alcohol 
4.17 (Figure 4.16). Alcohol 4.17 meets the criteria mentioned before. The C1–C4 secondary 
hydroxyl groups of D-glucose are protected as the benzyl ethers leaving the C6 hydroxyl 
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group free to be chemically manipulated into the halide. Phosphonylation of this halide would 
give the phosphonate moiety. 
 
 
Figure 4.15: Key steps for the synthesis of precursor 4.14. 
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Figure 4.16: Synthetic scheme used by Lu et al. to synthesise the alcohol 4.17. 
 
The approach used by Lu et al.158 to synthesise alcohol 4.17 involved the selective 
debenzylation-acetolysis of the β-perbenzylated glucose 4.15 to give acetate 4.16. Acetate 
4.16 is then deprotected under Zemplen conditions159,160 to give alcohol 4.17 (Figure 4.16). 
 
D-Glucose was benzylated using NaH and BnBr. After 24 hours the reaction was quenched 
carefully with MeOH. Purification by flash chromatography followed by recrystallisation 
from EtOH gave β-perbenzylated glucose 4.15 in 32% yield. The 1H NMR spectrum detected 
a doublet at 4.54 ppm, corresponding to the anomeric proton resonance with a large coupling 
constant (3J = 7.7 Hz). This large coupling constant corresponded to the β-isomer of 
compound 4.15, and was consistent with the data reported by Lu et al.158 
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Although the yield of 32% was consistent with the initial findings of Lu et al.158 (25–30% 
yield), it was also reported that by adding the reagents NaH and BnBr portionwise over 
several hours gave β-perbenzylated glucose 4.15 in 60–66%. Unfortunately, when the exact 
method described by Lu et al.158 was carried out and repeated several times in our laboratory, 
the yields for the synthesis of β-perbenzylated glucose 4.15 were only 13–32% (Figure 4.17). 
 
 
Figure 4.17: Synthesis of β-perbenzylated glucose 4.15. 
 
The selective C6 debenzylation and acetolysis of β-perbenzylated glucose 4.15 was carried 
out using ZnCl2 in a solution of AcOH-Ac2O (1:5).158,161,162 Purification by flash 
chromatography gave acetate 4.16 in 64% yield (lit.158 78%) (Figure 4.18). 1H NMR 
spectroscopy detected the presence of the acetyl group methyl resonance at 2.07 ppm in the 
spectrum. 
 
 
Figure 4.18: Selective debenzylation and acetolysis of 4.15. 
 
Deprotection of acetate 4.16 under Zemplen conditions gave the alcohol 4.17 in 96% yield 
(lit.158 97%) (Figure 4.19). 1H NMR spectroscopy showed that deprotection had occurred, 
with the disappearance of the acetyl group methyl resonance at 2.07 ppm in the spectrum. 
Alternatively, alcohol 4.17 was also prepared by subjecting crude 4.16 (after precipitation 
and drying) to NaOMe. Using this approach pure 4.17 was obtained in 50–70% yield 
following flash chromatography. 
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Figure 4.19: Deprotection of acetate 4.16 under Zemplen conditions. 
 
With the successful synthesis of alcohol 4.17 the C6 hydroxyl group could now be converted 
into a halide. Several attempts at brominating alcohol 4.17 were employed and the successes 
and failures of these methods are described below. A summary of these results can be found 
in Table 4.1. 
 
The first attempt to brominate alcohol 4.17 involved using the method by Ruiz et al.163 
Alcohol 4.17 was stirred with PBr3 for 16 hours at room temperature and monitored 
periodically using TLC analysis. Unfortunately, only starting material was detectable by TLC 
(Figure 4.20). 
 
 
Figure 4.20: Attempts to brominated alcohol 4.17 using PBr3. 
 
The second attempt used a method employed by Vidal et al.164 where the primary hydroxyl 
group of the alcohol 4.17 is first tosylated (to form a better leaving group) followed by 
bromination using LiBr. The reaction was carried out on a small scale, and the reaction 
mixture was monitored by TLC. Initial TLC analysis after an hour indicated a new 
compound, presumably the tosylated compound, had formed along with residual starting 
material. At this point the reaction was worked up and LiBr was added to this crude mixture. 
The reaction was stirred for a further 24 hours at room temperature and monitored by TLC. 
Unfortunately, there was no indication of any halide 4.18 being formed by TLC (Figure 4.21) 
and this method was not investigated further. 
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Figure 4.21: Attempts to brominated alcohol 4.17 using LiBr. 
 
The third attempt proved to be successful in brominating alcohol 4.17 and involved 
bromine.165 Although this reaction worked the yield of halide 4.18 was only 9% after 
purification by flash chromatography. 
 
 
Figure 4.22: Bromination of alcohol 4.17 using bromine. 
 
The method used by Berkowitz et al.166 was also used for the synthesis of halide 4.18 and 
involved the reagents NBS and Ph3P. The method was conducted and halide 4.18 was 
obtained in 27% yield which was considerably better than the 9% yield obtained in the 
reaction using bromine (Figure 4.22). Mass spectrometry detected the sodiated halide 4.18 as 
a compound with a monoisotopic mass of 625.1573 (calc. C34H35NaO5Br [M+Na]+: 
625.1566). By increasing the amount of NBS and Ph3P used in the reaction to three 
equivalents each, halide 4.18 was obtained in 87–92% yield (Figure 4.23). 
 
 
Figure 4.23: Bromination of alcohol 4.17 using NBS. 
 
Care had to be taken when performing the reaction shown in Figure 4.23 on a large scale as 
the reaction becomes highly exothermic on the addition of NBS to a solution of Ph3P in 
CH2Cl2. The addition of NBS to the solution was done slowly, portionwise and at 0°C in 
order to maintain control of the reaction. 
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Reaction Bromination method Results
 
PBr3, DCM NR 
p-TsCl, LiBr NR 
Br2, Ph3P 9% yield
NBS, Ph3P 92% yield
Table 4.1: Summary of the bromination methods used to synthesise halide 4.18. NR = no reaction. 
 
With the successful synthesis of halide 4.18, halide 4.18 now needed to phosphonylated to 
form the phosphonate ester. Two methods were employed, the Cs2CO3 method by Cohen et 
al.167 and the Arbuzov method. Due to the limited amounts of the starting material, small 
scale tests of each method were trialled on the precursor 4.18 to ascertain the viability of each 
method and the results of these small scale trial reactions are discussed in the next two 
sections. 
 
4.2.2.1 The Cohen method 
 
Shown in Figure 4.24 is the general method used by Cohen et al.167 to synthesise 
phosphonate analogues. A dialkyl phosphite ester 4.19 is deprotonated using cesium 
carbonate to generate the phosphonate anion 4.20 in situ. Subsequent alkylation of anion 4.20 
with an alkyl halide produces the corresponding phosphonate 4.21. 
 
 
Figure 4.24: General reaction scheme by Cohen et al. 
 
Two different phosphite ester reagents were chosen to phosphonylate halide 4.18: diethyl 
phosphite and dibenzyl phosphite (Figure 4.25). 
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Figure 4.25: Phosphonylation reagents: diethyl phosphite and dibenzyl phosphite. 
 
Diethyl phosphite was reacted with halide 4.18 under similar conditions described by Cohen 
et al.167 and phosphonate 4.22 was obtained in 41% after stirring for three days at room 
temperature and purification by flash chromatography (Figure 4.26). 31P-13C coupling on the 
resonance of C6 was observed in the 13C NMR spectrum of phosphonate 4.22, with a large 
1JPC coupling of 143 Hz at 28.4 ppm. 
 
 
Figure 4.26: Synthesis of phosphonate 4.22. 
 
Phosphonate 4.23 was synthesised using dibenzyl phosphite under similar conditions 
described by Cohen et al. (Figure 4.27). The reaction was periodically monitored by TLC, 
and after five days, it was decided to stop the reaction even though not all the starting 
material had been consumed. Following purification by flash chromatography the yield for 
phosphonate 4.23 was 36%. A large amount of starting material 4.18 was also recovered 
(56% recovered). 31P-13C coupling on the resonance of C6 was observed in the 13C NMR 
spectrum of phosphonate 4.23, with a large 1JPC coupling of 143 Hz at 29.1 ppm. 
 
 
Figure 4.27: Synthesis of phosphonate 4.23. 
 
The diethyl phosphite route had the advantage of being slightly better yielding, 41%, 
compared to the dibenzyl phosphite route of 36% (Figure 4.28). This better yield may be due 
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to steric factors with the ethyl ester groups being smaller and less cumbersome than the bulky 
benzyl groups, whereas diethyl phosphite would have easier access to the C6-Br on halide 
4.18. Reaction conditions, such as heating the reaction, could be investigated in the future to 
optimise the yields for the synthesis of phosphonate 4.22 or 4.23. 
 
The disadvantage of the diethyl phosphite route is that there would be three overall steps to 
synthesise compound 4.14 from halide 4.18. The dibenzyl phosphite route would take only 
two steps, avoiding the extra deprotection step of the ethyl ester groups on phosphonate 4.22 
(Figure 4.28). Both reagents were chosen due to their availability in our laboratory, and for 
the ease of deprotection of the phosphonate esters later on in the synthesis. Overall, 
phosphonylation reactions of halide 4.18 using either diethyl or dibenzyl phosphite were 
successful. 
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Figure 4.28: Summary for the synthesis of phosphonates 4.23 and 4.24 using two different phosphonylating reagents. 
 
4.2.2.2 The Arbuzov method 
 
Halide 4.18 was reacted with a large excess of triethyl phosphite (50 equiv.), stirred and 
heated to 140°C on an oil bath. The reaction was monitored by TLC and after three days the 
reaction was worked up and purified by flash chromatography to give 69% yield of 
phosphonate 4.22 (Figure 4.29). This yield for phosphonate 4.22 was better than that 
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achieved using the diethyl phosphite method employed by Cohen et al.167 (c.f. 41%, Figure 
4.26). 
 
 
Figure 4.29: Synthesis of phosphonate 4.22 via the Arbuzov method. 
 
4.2.2.3 Summary 
 
Both methods employed for the phosphonylation of the halide 4.18 were successful in 
synthesising the phosphonates 4.22 and 4.23, depending on the phosphite reagent used, and a 
summary of these results can be found in Table 4.2 below. 
 
Entry Phosphite Reagent Method used Conditions Time (days) Yield of phosphonate 
1 (BnO)2P(O)H Cohen Room temp. 5 36% (4.23) 
2 (EtO)2P(O)H Cohen Room temp. 3 41% (4.22) 
3 P(OEt)3 Arbuzov Heat 140°C 3 69% (4.22) 
Table 4.2: Summary of the Cohen and Arbuzov methods for phosphonylation of halide 4.18. 
 
The use of both methods to synthesise the phosphonate analogues 4.22 and 4.23 had their 
advantages and disadvantages. The reaction in Table 4.2, entry 1, has the advantage of having 
one less step in the overall synthesis of compound 4.14 (Figure 4.28), but this reaction was 
lower yielding compared to those depicted in entries 2 and 3. This is probably due to the fact 
that the dibenzyl phosphite reagent is sterically bulky making it difficult to displace the C6-
Br group on halide 4.18. This was also indicated by the recovery of a large amount of starting 
material after purification (56% recovered). 
 
In summary, although the Cohen method is carried out under very mild conditions making it 
a suitable method for substrates that could thermally degrade under Arbuzov conditions, the 
Arbuzov method was deemed the most successful for the synthesis of phosphonate 4.22 due 
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to the higher yield. Subsequently, this method was chosen for repeating this synthesis of 
phosphonate 4.22 from halide 4.18. 
 
4.2.3 Synthesis of D-glucose 6-phosphonate 4.14 
 
With the successful synthesis of the phosphonate 4.22, the final steps to synthesise the 
precursor 4.14 was carried out and the synthetic scheme used is shown in Scheme 4.3. 
 
 
Scheme 4.3: Synthesis of D-glucose 6-phosphonate 4.14. 
 
Phosphonate 4.22 was deprotected using TMSBr followed by hydrolysis to give the 
phosphonic acid 4.24 in 98% yield (Figure 4.30). 1H NMR spectroscopy showed that the 
phosphonate ester group had been cleaved, due to the disappearance of the ethyl resonances 
at 4.13 and 1.34 ppm in the spectrum. 
 
 
Figure 4.30: Synthesis of phosphonic acid 4.24. 
 
The benzyl ethers were removed from the phosphonic acid 4.24 by hydrogenation using a 
palladium on carbon catalyst. When the conventional solvent MeOH was used for 
hydrogenation the reaction was completed in 4 days (100% yield). 1H NMR spectroscopy 
showed the disappearance of all aromatic proton resonances between 7.43–7.03 ppm in the 
spectrum. By switching from the conventional solvent MeOH to AcOH, the hydrogenation 
reaction was completed in 2 days (Figure 4.31). This is due to the fact that polar protic 
solvents such as AcOH help to facilitate the reaction by protonating the oxygen on the benzyl 
ether.103 
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Figure 4.31: Hydrogenation of phosphonic acid 4.24 in acetic acid. 
 
The hydrogenation reaction product mixture was then purified using a reverse phase C18 
silica column to give compound 4.14 as a sugary semi-solid (100% yield). Both α- and β-
anomers were present in a 1:1.3 ratio respectively, and were assigned by their coupling 
constants (α-anomer: 5.07 ppm, d, 3J = 3.3 Hz; β-anomer: 4.53 ppm, d, 3J = 7.7 Hz). 
 
4.2.4 Attempts to synthesise D-erythrose 4-phosphonate 
 
With the successful synthesis of the D-glucose 6-phosphonate 4.14, this compound was then 
subjected to oxidative cleavage by lead tetraacetate in the hopes of affording D-erythrose 4-
phosphonate. This method is similar to the method used by Simpson et al.90 and Sieben et 
al.89 to synthesise E4P from D-glucose 6-phosphate, although no NMR or mass spectrometry 
data was given for E4P by either author. The reaction was carried out, worked up by filtering 
through celite and continuously extracted with ether to remove solid impurities and acetic 
acid, respectively. The aqueous layer after the ether extraction was then analysed without 
further purification. Unfortunately, when the reaction was carried out there was no indication 
of D-erythrose 4-phosphonate being formed (Figure 4.32), and by this stage of the synthesis 
all of precursor 4.14 had been used up. 
 
 
Figure 4.32: Lead tetraacetate oxidative cleavage of D-glucose 6-phosphonate 4.14. Attempt to synthesise D-erythrose 
4-phosphonate. 
 
The reaction with Pb(OAc)4 is a long and laborious experimental procedure with difficulties 
in monitoring the reaction as it progresses. 1H NMR spectroscopy was used in an attempt to 
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monitor the reaction periodically, from start to work-up, but peaks in the spectrum were 
extremely broad and overlapping peaks made interpretation of the spectrum impossible. 
Overlapping of peaks in the 1H NMR spectrum were probably due to the side-products 
glyceraldehyde 3-phosphonate (from over oxidation) and arabinose 5-phosphonate (from 
under oxidation). Standard TLC monitoring techniques could not be used to monitor the 
reaction as the compounds were extremely polar and remained on the baseline. Highly polar 
solvent systems for TLC analysis such as 10% MeOH:DCM, 1:6:3:0.2 
water:isopropanol:ethyl acetate: acetic acid and 80:60:30:3:5 chloroform:methanol:acetic 
acid:water were also used to visualise the reaction but with no success. The authors Simpson 
et al.90 and Sieben et al.89 did not mention how they monitored their reactions either. 
Attempts to find the mass of D-erythrose 4-phosphonate using mass spectrometry were 
unsuccessful. The mass for the side-product arabinose 5-phosphonate was detected as its 
dimethyl acetal (calc. C7H16O8P [M−H]−: 259.0583; found: 259.0579, sample was run in 
MeOH), indicating that under oxidation had occurred. 
 
As stated earlier in the introduction of this chapter, D-erythrose 4-phosphonate was first 
synthesised by Le Marechal et al.141 but no experimental procedure and spectroscopic data 
was given for this compound. The compound was however tested as a substrate on 
transaldolase and found to be a substrate for this enzyme. With this in mind, it was decided to 
do a quick test on two enzymes, E. coli (phe) and N. meningitidis DAH7P synthase, to see if 
the crude mixture contained a substrate. Unfortunately, it was found that the crude mixture 
was not a substrate for either synthase. Had the crude mixture been found to contain 
substrate, this would suggest that D-erythrose 4-phosphonate had been synthesised, although 
it is also possible it is not a substrate, or was not synthesised at all. The thiobarbituric acid 
assay could also be used to provide evidence for the synthesis of D-erythrose 4-phosphonate. 
This assay provided evidence for the synthesis of 6-deoxyDAH7P from the reaction between 
PEP and 3-deoxyE4P catalysed by M. tuberculosis DAH7P synthase in Chapter 2. 
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4.3 2,3-Dideoxy erythrose 4-phosphonate 
 
The synthesis of 2,3-dideoxy erythrose 4-phosphonate 4.38 was investigated primarily for 
method development. It was also predicted that this analogue would not be a substrate for 
DAH7P synthase due to past substrate experiments on 2,3-dideoxy erythrose 4-
phosphate.65,168 
 
Past substrate studies on 2,3-dideoxy erythrose 4-phosphate found that this analogue was not 
a substrate for E. coli DAH7P synthase (phe), as at least one hydroxyl group on E4P is 
required to bind E4P to the enzyme and orientate it in the active site for catalysis c.f. 2- and 
3-deoxyE4P results (Chapter 2). However, the synthesis of this compound was expected to be 
more straightforward than for the synthesis of the full E4P analogue. 
 
Shown in Figure 4.33 is the retrosynthetic analysis for compound 4.38. Compound 4.38 can 
be synthesised from the very cheap and commercially available starting material butan-1,4-
diol. This diol can then be converted into compound 4.38 by first orthogonally protecting one 
end of the diol, followed by three key chemical manipulation steps of bromination, 
phosphonylation and oxidation. 
 
 
Figure 4.33: The retrosynthetic analysis of 2,3-dideoxy erythrose 4-phosphonate 4.38. 
 
Two protecting groups were chosen to monoprotect butan-1,4-diol, the benzyl ether 
protecting group (Bn) and the tert-butyldimethylsilyl ether (TBDMS) group. Both groups 
were used in parallel in an attempt to synthesise target compound 4.38. The synthetic scheme 
used to synthesise compound 4.38 is shown in Scheme 4.4. 
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Scheme 4.4: The synthetic route used to synthesise compound 4.38. Both Bn and TBDMS protecting groups were 
used in parallel to synthesise compound 4.38. 
 
Monoprotection of butan-1,4-diol using the benzyl ether protection groups afforded 
compound 4.26 in 75% yield following purification by flash chromatography (Figure 4.34). 
The 1H and 13C NMR spectra of compound 4.26 matched those reported in the literature.169 
 
 
Figure 4.34: Monoprotection of butan-1,4-diol using the Bn group. 
 
The TBDMS protecting group was also used to monoprotect butan-1,4-diol giving compound 
4.31 in 70% yield (Figure 4.35). The 1H and 13C spectra of compound 4.31 were in 
accordance with those reported in literature.170-172 Small scale trials using DMF, THF and 
DCM as the solvents were investigated with the yields of compound 4.31 varying depending 
on the solvent used. When DMF was chosen as the solvent for the monoprotection of butan-
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1,4-diol a 33% yield was obtained for compound 4.31, THF gave a 56% yield and DCM gave 
the highest yield of 70%. Contamination of the solvents due to water was probably a factor 
for these yields as THF and DCM were freshly distilled before use, whereas DMF was used 
from a bottle that had been prepared a few weeks prior. With the success of the high yielding 
DCM trial, the DMF and THF trials were not investigated further. 
 
 
Figure 4.35: Monoprotection of butan-1,4-diol using the TBDPS group. 
 
Bromination of both monoprotected compounds 4.26 and 4.31 using N-bromosuccinimide 
(NBS) and triphenylphosphine, gave halide 4.27 in 86% and halide 4.32 in 31% yield 
respectively (Figure 4.36). The 1H and 13C NMR spectra of halides 4.27173 and 4.32172,174 
were in accordance with those reported in the literature. 
 
 
Figure 4.36: Synthesis of halides 4.27 and 4.32. 
 
Several brominating reagents were also trialled to increase the yield of halide 4.32. These 
reagents included oxalyl bromide, NBS and dimethyl sulphide, and phosphorus tribromide 
but unfortunately the use of these conditions resulted in the degradation of the starting 
material 4.31 as observed by TLC. TLC analysis showed that after 30 minutes of stirring the 
reaction (using any of the brominating methods mentioned before) at 0°C the starting 
material starts to degrade with the formation of a compound at the baseline (30% EtOAc:Pet 
ether, KMnO4 stain). Testing each reaction with pH paper showed that the pH of the solutions 
were between 1 and 2. The solutions of each bromination reaction were probably too acidic 
and this acidity was able to hydrolysis the TBDMS protecting group giving butan-1,4-diol 
which would remain on the baseline of the TLC plate. The use of a more bulky silyl 
protecting group such as TBDPS or TIPS could possibly increase the yield, as the bulkier the 
substituent on the silicon the more stable it is towards acid or base hydrolysis.103 
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Phosphonylation of the halides 4.27 and 4.32 was carried out using the method employed by 
Cohen et al.167 to produce 4.28, 4.29 and 4.33. The Arbuzov reaction was also employed as 
an alternate method to produce 4.28. 
 
Two different phosphite ester reagents were chosen to phosphonylate halide 4.27 using the 
method employed by Cohen et al., diethyl phosphite and dibenzyl phosphite, producing the 
phosphonates 4.28 and 4.29 in 83% and 49% yields, respectively (Figure 4.37). NMR 
spectroscopy detected phosphonate 4.28 and 4.29 with the formation of the phosphonate ester 
group ethyl resonances at 4.09 and 1.32 ppm and the aromatic proton resonances between 
7.47–7.20 ppm in the 1H NMR spectrum respectively. A large 1JPC coupling of 141 and 140 
Hz in the 13C NMR spectrum was also observed, due to 31P-13C coupling on the resonance of 
C4, for phosphonates 4.28 and 4.29 respectively. 
 
Phosphonylation of halide 4.32 was carried out using the method employed by Cohen et al. 
Halide 4.32 was phosphonylated to give the phosphonate 4.33 in 49% yield following flash 
chromatography (Figure 4.37). 31P-13C coupling was observed for the signal corresponding to 
the C4 secondary carbon resonance of phosphonate 4.33, with a large 1JPC coupling of 141 
Hz in the 13C NMR spectrum. The Arbuzov method was not trialled as it was thought the 
reaction conditions would be too harsh for the TBDMS protecting group to survive. 
 
 
Figure 4.37: Synthesis of phosphonates 4.28 , 4.29 and 4.33 via the method employed by Cohen et al. 
 
When halide 4.27 was phosphonylated using the Arbuzov method the reaction produced a 
persistent side-product 4.30 that was inseparable from phosphonate 4.28 (Figure 4.38). The 
31P NMR spectrum showed two peaks at 32 ppm and 34 ppm corresponding to phosphonate 
4.28 and side-product 4.30175,176 respectively. Side-product 4.30 would form by the reaction 
of ethyl bromide (a side-product of the Arbuzov reaction, Figure 4.6) with P(OEt)3. Although 
the two compounds were inseparable by flash chromatography it was decided to carry 
through to the next step in hope that the mixture could be separate after hydrogenation. This 
is because the product, alcohol 4.34, would be more polar than the side-product 4.30 after 
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hydrogenation of the mixture. The mixture of compounds 4.28 and 4.30 were hydrogenated 
using hydrogen and Pd/C to give alcohol 4.34 (two steps, 20% yield) and side-product 4.30, 
both compounds were separated following flash chromatography (Figure 4.37). 1H NMR 
spectroscopy showed that deprotection of phosphonate 4.28 had taken place, due to the 
disappearance of the aromatic proton resonances between 7.37–7.26 ppm in the spectrum. 
The NMR spectral data for side-product 4.30 matched those reported in literature.175,176 Due 
to the low yield for this reaction, formation of side-product 4.30 and the success of 
synthesising phosphonate 4.28 using the method employed by Cohen et al., this method was 
not investigated further. 
 
 
Figure 4.38: Synthesis of alcohol 4.34 via the hydrogenation of a mixture of phosphonate 4.28 and side-product 4.30. 
 
Deprotection of phosphonates 4.28 and 4.33 by hydrogenation or TBAF (respectively) gave 
alcohol 4.34 in 24% (from 4.28) and 52% (from 4.33) (Figure 4.39). Although the yield for 
the deprotection of phosphonate 4.33 using TBAF is a modest yield, it was an improvement 
on synthesising 4.34 using the benzyl ether route. 1H NMR spectroscopy confirmed the 
deprotection had occurred with the disappearance of the silyl methyl resonances at 0.89 and 
0.04 ppm in the spectrum for phosphonate 4.33. 1H NMR spectroscopy confirmed the 
deprotection of phosphonate 4.28 with the disappearance of the aromatic proton resonances 
between 7.37–7.26 ppm in the spectrum. No attempts were made to optimise the yields of 
these two reactions. 
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Figure 4.39: Synthesis of compound 4.34. 
 
Alcohol 4.34 was subsequently oxidised using DMP to give aldehyde 4.36 in 73% yield 
following flash chromatography (Figure 4.40). The presence of the product was confirmed by 
a 1H NMR spectrum showing the aldehyde resonance at 9.79 ppm. 
 
 
Figure 4.40: Synthesis of aldehyde 4.36. 
 
The aldehyde group on aldehyde 4.36 was protected as its dimethyl acetal to prevent any side 
reactions as aldehyde groups are highly reactive.103 Aldehyde 4.36 was protected using 
trimethyl orthoformate and concentrated H2SO4 to give acetal 4.37 in 72% yield (Figure 
4.41). 1H NMR spectroscopy confirmed the disappearance of the aldehyde resonance at 9.79 
ppm in the spectrum. 
 
 
Figure 4.41: Synthesis of acetal 4.37. 
 
Treatment of acetal 4.37 with TMSBr was used to cleave off the ester groups followed by 
hydrolysis using Dowex-H+ resin to remove the dimethyl acetal groups, afforded the target 
compound 4.38 (Figure 4.42). The solution was evaporated to dryness and then made up to 
1.0 mL in H2O and used without further purification for enzyme assays. In contrast to the 
attempted synthesis of 2-methylE4P (Chapter 3), deprotection of the phosphonate group 
esters was successful here because the deprotection was of a stable phosphonate group and 
not a phosphate group. Phosphonate groups are more stable towards hydrolysis than 
phosphate groups as mentioned in the introduction of this chapter. In addition, the base Et3N 
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was added to neutralise the acidic conditions generated by the TMSBr in the reaction. 1H 
NMR spectroscopy detected the formation of the aldehyde resonance at 9.60 ppm in the 
spectrum. Additionally, compound 4.38 was detected by mass spectrometry as the protonated 
compound with a molecular mass of 153.0311 (calc. C4H9O4P [M+H]+: 153.0311). 
 
 
Figure 4.42: Synthesis of 2,3-dideoxy erythrose 4-phosphonate 4.38. 
 
An alternative route to compound 4.38 was also trialled. Phosphonate 4.29 was deprotected 
by hydrogenation to afford the phosphonic acid 4.35 in 100% yield (Figure 4.43). 1H NMR 
spectroscopy showed that deprotection had occurred, with the disappearance of the aromatic 
proton resonances between 7.47–7.20 ppm in the spectrum. Unfortunately, all attempts to 
oxidise compound 4.35 directly to compound 4.38 using DMP failed, and was probably due 
to solubility issues of 4.35. 
 
 
Figure 4.43: Synthesis of compound 4.35 and attempts to synthesis 4.38. 
 
Due to the highly polar nature of compound 4.35, this compound did not dissolve in the 
solvents CHCl3, DCM, acetone or CH3CN. Although it was not soluble in any of these 
solvents, it was thought that maybe the suspension of compound 4.35 and DMP in each 
solvent could still work and small scale reactions were trialled (Table 4.3). 1H NMR 
spectroscopy was used to monitor the reactions. Crude samples were taken periodically, 
worked up (filtered and evaporated to dryness) and dissolved in CD3OD, then scanned for 
any formation of an aldehyde resonance at around 9.70–9.40 ppm in the 1H spectra (as 
previously synthesised analogues, such as the 2- and 3-deoxyE4P substrates, had aldehyde 
groups at around this range). Unfortunately, there was no indication of any aldehyde 
functionality being formed. 
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Reagent 
1 
Reagent 
2 
Solvent Dielectric 
constant 
(ε)177 
Time 
(hours) 
Reaction 
conditions 
Analysis of crude 
samples by 1H NMR 
for aldehyde group 
signal 
4.35 DMP CHCl3 4.7 72 RT  
DCM 8.9 72 RT  
Acetone 20.7 72 RT  
Acetone 20.7 7 reflux  
CH3CN 36.2 108 RT  
Table 4.3: Solvent trials on the oxidation of phosphonate 4.35 with DMP. RT = room temperature. Samples were 
made up in CD3OD before analysis by NMR. 
 
4.3.1 Initial enzyme assays with E. coli DAH7P synthase (phe) 
 
Standard assay conditions were used to first determine whether 2,3-dideoxy erythrose 4-
phosphonate 4.38 was a substrate for E. coli DAH7P synthase or not. 
 
To determine whether compound 4.38 was a substrate or not, reaction mixtures contained 
compound 4.38 (2–150 µL, unknown concentration), MnSO4 (100 µM) and PEP (150 µM) in 
50 mM BTP buffer at pH 6.8. In each case, the reaction was initiated by the addition of 
purified E. coli DAH7P synthase (3–30 µL, 5.86 mg/mL). All assays were carried out at 25°C 
in a total volume of 1.0 mL and the loss of PEP was monitored at 232 nm. Initial readings 
showed that compound 4.38 was not a substrate for E. coli DAH7P synthase, as no PEP loss 
was observed at 232 nm. 
 
To confirm the enzyme was capable of catalysing the reaction between PEP and the substrate, 
selected samples were spiked with the natural substrate E4P. Absorption loss of PEP was 
observed immediately indicating the enzyme was catalysing the reaction between E4P and 
PEP and not between compound 4.38 and PEP. 
 
Preliminary studies also indicated that compound 4.38 was not an inhibitor of E. coli DAH7P 
synthase. Standard enzyme conditions with compound 4.38 (5–100 µL, unknown 
concentration), E4P (150 µM) and PEP (150 µM) were initiated with E. coli DAH7P 
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synthase (5 µL, 5.86 mg/mL) and the initial rate of PEP loss was measured. The initial rate of 
PEP loss was also measured for a second sample that contained only E4P and PEP. The rates 
were found to be the same (within 10% error), indicating that compound 4.38 was not an 
inhibitor of E. coli DAH7P synthase at the concentrations tested, although as the precise 
concentration was unknown, the detection limit could not be determined. A discussion on 
why compound 4.38 was not a substrate for E. coli DAH7P synthase can be found in  
Chapter 5. 
 
4.4 Summary 
 
The summary for the attempted synthesis of D-erythrose 4-phosphonate starting from D-
glucose is shown below (Figure 4.44). 
 
OHO
HO
OH
OHOH
OBnO
BnO
OBn
OBn
OBn
NaH (excess)
BnBr (excess)
AcOH-Ac2O (1:5)
ZnCl2 OBnO
BnO
OAc
OBn
OBn
OBnO
BnO
OH
OBn
OBn
OBnO
BnO
Br
OBn
OBn
NBS, Ph3POBnO
BnO
P
OBn
OBn
O
EtO
EtO P(OEt)3
140oC
D-glucose 4.15
32%
4.16
64%
4.17
96%
4.18
92%
4.22
69%
1. TMSBr
2. MeOH
OBnO
BnO
P
OBn
OBn
O
HO
HO Pd/C, H2
AcOH OHO
HO
P
OHOH
O
HO
HO
Pb(OAc)4
4.24
98%
4.14
100%
D-erythrose 4-phosphonate
O2-O3P
OH
OH
NaOMe
 
Figure 4.44: Attempts at synthesising D-erythrose 4-phosphonate. 
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Although the synthesis of D-erythrose 4-phosphonate was not completed, due to the difficult 
chemistry involved, the characterisation and methodology for the syntheses of compounds 
4.14, 4.15–4.18, 4.22 and 4.24 have been well documented in this thesis. This synthetic route 
could be used in the future for the synthesis of D-erythrose 4-phosphonate if an alternative 
method (other than Pb(OAc)4) for the cleavage of two carbon atoms in compound 4.14 can be 
found, or if a method for monitoring the reaction can be developed. Additionally, future 
attempts to synthesise D-erythrose 4-phosphonate could involve starting with the compound 
meso-tartaric acid (Figure 4.45). The structure of meso-tartaric acid has certain advantages for 
the synthesis of D-erythrose 4-phosphonate over the D-glucose method. These include starting 
with the right number of carbons (therefore avoiding the Pb(OAc)4 procedure) and having a 
very similar structure to the target compound (see Chapter 5 for further discussion). 
 
 
Figure 4.45: Structures of meso-tartaric acid compared to D-erythrose 4-phosphonate and E4P. 
 
The synthesis of 2,3-dideoxy erythrose 4-phosphonate 4.38 was synthesised primarily for 
method development and was predicted not to be a substrate for E. coli DAH7P synthase 
(phe) due to previous substrate studies on 2,3 dideoxy erythrose 4-phosphate.65,168 Synthesis 
of compound 4.38 was achieved in overall eight steps using two different protection groups 
(Bn and TBDMS) concurrently (Figure 4.46). All steps were moderate to high yielding with 
the exception of compound 4.32 with a low 31% yield. The low yield of compound 4.32 was 
due to the desilylation of the silyl group owing to the highly acidic reaction conditions. The 
use of a more robust silyl protecting group such as the TBDPS or TIPS group, or even the 
addition of a mild base (e.g. Et3N) to counteract the acidity of the reaction conditions could 
help increase the yield in future. Standard enzyme assays showed that compound 4.38 was 
not a substrate for E. coli DAH7P synthase (phe), as was predicted. 
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Figure 4.46: Overall synthetic scheme for the synthesis of compound 4.38. 
 
A discussion on why compound 4.38 was not a substrate for DAH7P synthase and the 
predicted outcome for D-erythrose 4-phosphonate can be found in Chapter 5. 
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Chapter 5:  Discussion, conclusions and future directions 
 
The aim of this project was to synthesise a range of alternative non-natural four carbon 
analogues of E4P to help to probe the substrate specificity of the different types of DAH7P 
synthases. This aim has been achieved, with a number of new analogues being designed, 
synthesised and evaluated as alternative substrates for DAH7P synthases during the course of 
this project (Figure 5.1). From comparison of these molecules (2-deoxyE4P, 3-deoxyE4P, 3-
methylE4P and compound 4.38), new insights into the substrate specificity of DAH7P 
synthase can be obtained. 
 
 
Figure 5.1: A summary of E4P analogues synthesised for evaluation on DAH7P synthase and the structure of E4P for 
comparison. 
 
As was discussed in Chapter 2, both (3S)-2-deoxyE4P and (2R)-3-deoxyE4P were found to 
be substrates for the type II DAH7P synthase from M. tuberculosis. These results indicate 
that removal of either the C2 or C3 hydroxyl groups of E4P does not completely disrupt 
catalysis, and that the presence of the C3 hydroxyl group appears to be more important for 
efficient catalysis than the C2 hydroxyl group. In addition, the studies carried out on rac-2-
deoxyE4P showed that only the (3S)-enantiomer is utilised by this type II enzyme; with the 
presence of (3R)-enantiomer having no effect on the kinetic parameters of the enzyme. 
Furthermore, studies on rac-3-deoxyE4P showed that the (2R)-enantiomer was utilised but 
the (2S)-enantiomer was likely to be acting as a competitive inhibitor. 
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Chapter 3 describes the attempts to synthesise 2-methylE4P, and the successful synthesis and 
evaluation of 3-methylE4P as a substrate for type Iα E. coli DAH7P synthase (phe). This 
compound was found not to be a substrate for this enzyme. 
 
The synthesis and evaluation of 2,3-dideoxy erythrose 4-phosphonate 4.38 on the type Iα E. 
coli DAH7P synthase (phe), and the attempts to synthesise D-erythrose 4-phosphonate are 
described in Chapter 4. The synthesis of compound 4.38 was relatively straightforward, and 
no evidence was found that this compound could act as a substrate for the enzyme. In 
contrast, the attempts to synthesise D-erythrose 4-phosphonate from D-glucose were fraught 
with challenges, and ended in this analogue not being synthesised during this project. 
 
5.1 Role of the E4P hydroxyl groups in DAH7P synthase 
 
A summary of available kinetic data for E4P substrate analogues with various DAH7P 
synthases is presented in Table 5.1 (page 127). The data presented in Table 5.1 indicate that 
the C2 and C3 hydroxyl groups of E4P are not essential for binding of the aldehydic substrate 
or catalysis for type Iα, Iβ and II DAH7P synthase from E. coli, P. furiosus and M. 
tuberculosis respectively. 
 
Although there have been no structures solved of DAH7P synthase with E4P bound in the 
active site in a catalytically competent manner, modelling studies that shall be detailed in this 
section shed some light on the way in which E4P hydroxyl groups interact with the enzyme. 
 
 
C
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127 
Substrate DAH7P synthase source 
E. coli (phe) (type Iα) P. furiosus (type Iβ) M. tuberculosis (type II) 
KM (µM) kcat (s-1) kcat/KM (s-1µM-1) KM (µM) kcat (s-1) kcat/KM (s-1µM-1) KM (µM) kcat (s-1) kcat/KM (s-1µM-1) 
 
39±4 26±2 0.67 9±1 1.4±0.1 0.16 37±2 5.4±0.1 0.15 
(3S)-2-deoxyE4P
 
410±40 19±1 0.05 6±1 3.0±0.1 0.49 46±5 4.9±0.2 0.11 
(2R)-3-deoxyE4P
 
2700±140 4.5±0.1 0.002 200±30 2.1±0.1 0.01 77±9 2.4±0.1 0.031 
3-methylE4P
 
NS   ND   ND   
 
 
NS   ND   ND   
Table 5.1: Kinetic parameters of type Iα, Iβ and II DAH7P synthases with four carbon sugar analogues of E4P. Kinetic data for (3S)-2-deoxy and (2R)-3-deoxyE4P with E. coli 
DAH7P synthase (phe) were determined by Dr Pietersma66; P. furiosus DAH7P synthase kinetic data were determined by Dr Schofield.32 ND = not determined. NS = not a substrate. 
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Figure 5.7: Proposed cyclic mechanism of DAH7P synthase. 
 
5.2 Methyl analogues of E4P 
 
5.2.1 3-MethylE4P 
 
Modelling studies with E4P bound in the active site of P. furiosus DAH7P synthase can be 
used to rationalise why 3-methylE4P is not a substrate for E. coli DAH7P synthase (phe) 
(Figure 5.2). As mentioned previously, the C3 hydroxyl group on E4P binds to an Asp 
residue and removal of this interaction as in 3-deoxyE4P causes a large decrease in affinity of 
the substrate. However, 3-deoxyE4P is still a substrate, although a poor one, so loss of this 
hydrogen bond alone cannot explain why 3-methylE4P is not a substrate. 
 
Not only is hydrogen bonding at the C3 position not possible, the structure of 3-methylE4P is 
more hydrophobic compared to E4P making it more difficult for 3-methylE4P to bind in the 
hydrophilic active site. The C3 methyl group of 3-methylE4P is also sterically bulkier 
compared to the C3 hydroxyl group of E4P. This increase in size on the C3 position could 
have adverse consequences in the active site, as the C3 methyl group would sterically clash 
with the Asp residue that binds the C3 hydroxyl group of E4P. Overall, it is not surprising 
that the sterically bulky and hydrophobic methyl group may seriously disrupt binding of the 
aldehydic substrate. 
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Future work that could be investigated on 3-methylE4P would involve testing the analogue 
on the type Iβ and II DAH7P synthases from P. furiosus and M. tuberculosis. This is because 
these enzymes have been shown to be more promiscuous than the type Iα enzyme from E. 
coli, and therefore 3-methylE4P might be utilised as a substrate. Inhibitor studies on 3-
methylE4P could also be investigated in the future on E. coli DAH7P synthase (phe) to 
determine whether 3-methylE4P is acting as an inhibitor on this enzyme. 
 
5.2.2 2-MethylE4P 
 
Although 2-methylE4P was not synthesised during this project, the results obtained from the 
studies with 2-deoxyE4P, 3-deoxyE4P and 3-methylE4P could be used to predict whether 2-
methylE4P would be a substrate for DAH7P synthase or not. 
 
Generally, DAH7P synthases has been observed to be more tolerant to changes in the C2 
position of E4P than the C3 position. These observations can be used to predict that 2-
methylE4P might be a substrate for DAH7P synthase, as changes made on the C2 position of 
E4P has a significantly less detrimental effect on binding and catalysis in the enzyme. This is 
particularly true of the type Iβ and II DAH7P synthases that can accept 2-deoxyE4P, but for 
the more C2 specific type Iα enzyme, 2-methylE4P would be predicted to be a much poorer 
substrate, if at all. 
 
A future synthesis of 2-methylE4P could involve using a more robust protecting group for the 
aldehyde functionality (Figure 5.8). This is because deprotection of compound 3.38 using 
TMSBr results in the loss of the acyclic aldehyde protecting group, due to the acidic reaction 
conditions (described in Chapter 3). The cyclic acetal protecting group seen in compound 5.1 
could be employed, as this protecting group is more robust and resistant to hydrolysis than 
the acyclic acetal protecting group on compound 3.38, therefore increasing the resistance of 
compound 5.1 to hydrolysis during the TMSBr deprotection step.103 Additionally, the base 
Et3N could also be added to decrease the acidity of the reaction. This would aid in preventing 
the unwanted hydrolysis of the cyclic acetal protecting group in compound 5.1 during the 
TMSBr step. 
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Figure 5.8: (A) The original route, from Chapter 3, used to attempt to synthesise 2-methylE4P. This route utilised the 
acyclic acetal protecting group (compound 3.38). (B) Proposed synthesis of 2-methylE4P from compound 5.1. 
 
5.3 Phosphonate analogues of E4P 
 
5.3.1 D-Erythrose 4-phosphonate 
 
The synthesis of the phosphonate analogue of E4P was primarily done for method 
development and to pave the way for the synthesis of the homophosphonate analogue of E4P, 
as previous substrate specificity studies reported that DAH7P synthase only accepted four 
carbon and five carbon sugar analogues of E4P (Chapter 1).24,32,47 Therefore it was decided to 
attempt to synthesise the phosphonate analogue of E4P to begin with, and examine this 
compound on DAH7P synthase, before investigating the homophosphonate analogue of E4P. 
Unfortunately, due to unforeseeable difficulties in the synthesis of the phosphonate analogue 
of E4P, the synthesis of the homophosphonate analogue of E4P was not investigated. 
 
Although D-erythrose 4-phosphonate was not synthesised during this project, prior studies 
using D-glyceraldehyde 3-phosphate 1.24 (Figure 5.9) can be used to predict whether this 
analogue would be a substrate for DAH7P synthase or not.24,32,47 
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Figure 5.9: Structures of D-erythrose 4-phosphonate and D-glyceraldehyde 3-phosphate 1.24 
 
Studies carried out on compound 1.24, a substrate that is one carbon shorter than E4P, has 
shown that it is not a substrate for the type Iα E. coli DAH7P synthase (phe) and was due to 
the molecule being too short. The contracted chain of compound 1.24 would not allow the C1 
carbonyl to be sufficiently close enough to interact with the metal atom (which activates the 
E4P for attack by PEP) and PEP in the active site resulting in catalysis not occurring. These 
results suggest that D-erythrose 4-phosphonate would not be a substrate for the enzyme as 
substitution of a phosphate moiety in E4P for a phosphonate would shorten the structure due 
to the loss of a bridging oxygen atom. The synthesis and testing of the homophosphonate 
analogue may help resolve whether chain length or phosphonate moiety is responsible for a 
lack of reactivity in DAH7P synthases. 
 
For future investigations where D-erythrose 4-phosphonate is required, D-erythrose 4-
phosphonate could be synthesised from the commercially available sugar: meso-tartaric acid 
(Figure 5.10). The structure of meso-tartaric acid is very similar to that of the target 
compound. It has the right number of carbons and the synthesis would not involve the 
cleavage of any carbons (c.f. the synthesis from D-glucose 6-phosphonate 4.14), making it an 
ideal starting material. The conversion of meso-tartaric acid to D-erythrose 4-phosphonate 
would involve four key chemical manipulation steps of reduction, oxidation, bromination and 
phosphonylation. 
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Figure 5.10: Attempts to synthesis D-erythrose 4-phosphonate from D-glucose 6-phosphonate 4.14 (Chapter 4), and 
the retrosynthetic analysis of D-erythrose 4-phosphonate to give meso-tartaric acid. 
 
5.3.2 2,3-Dideoxy erythrose 4-phosphonate 4.38 
 
Structures of DAH7P synthase with E4P modelled into the active site was used to infer 
information about why phosphonate 4.38 was not a substrate for the E. coli DAH7P synthase 
(phe) (Figure 5.2).32,61 As mentioned previously, each hydroxyl group on E4P, either on C2 
or C3, is not essential for binding and catalysis in the enzyme, and that the C3 hydroxyl 
group is more important than the C2 hydroxyl group. The hydroxyl groups however, seem to 
be required for the orientation and the positioning of E4P in a catalytically competent manner 
to allow E4P to be close enough to PEP and the metal ion. By removing both hydroxyls of 
E4P, the substrate would not be positioned and orientated in a competent manner, and 
compound 4.38 would not be utilised by DAH7P synthase. These results were parallel with 
the results reported for 2,3-dideoxy erythrose 4-phosphate, as this substrate was also found 
not to be a substrate for E. coli DAH7P synthase (phe) (Figure 5.11).65,168 Although it should 
be noted that compound 4.38 is not really a particularly good test of the ability of 
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phosphonate groups to be incorporated in aldehydic substrates and was primarily synthesised 
for method development. 
 
 
Figure 5.11: Compound 4.38 and 2,3-dideoxy erythrose 4-phosphate. 
 
5.4 Future directions 
 
The investigations into the substrate specificity of DAH7P synthase has revealed a number of 
interesting insights which could now be used in the proposal of future studies in order to 
complete and advance the research presented here. 
 
5.4.1 Isosteric phosphonates 
 
The unique properties of phosphonate analogues of the natural phosphoric acid esters make 
them suitable for use in a continuously increasing variety of applications.179 Replacement of a 
C-O-P moiety by a C-P group (non-isosteric phosphonates) or a C-CH2-P group 
(homophosphonates) in a biologically-active molecule might be expected to have interesting 
biological effects.139 This modification can confer greater stability on these analogues as the 
C-P bond that replaces the C-O-P bond is resistant to degradation by phosphatase enzymes 
and could aid in the development of prodrugs.138 
 
Work conducted by Kabak et al.180 and Shopsis et al.181 demonstrated that the 
homophosphonate analogue of D-glycerol 3-phosphate (G3P) was a substrate for glycerol 3-
phosphate dehydrogenase from E. coli, but the phosphonate analogue 5.4 was not (Figure 
5.12). These studies concluded that the corresponding size of the analogue to the natural 
substrate was the deciding factor for activity i.e. compound 5.5 has a similar chain length to 
G3P.136 
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Figure 5.12: Phosphonate analogues of G3P. 
 
To resolve whether chain length or phosphonate moiety is responsible for a lack of reactivity 
in DAH7P synthase, the homophosphonate analogue of E4P could be synthesised (Figure 
5.13). The homophosphonate analogue of E4P would have a similar chain length to E4P, 
unlike the phosphonate analogue where the oxygen group is not present, as the oxygen group 
is replaced with a CH2 group. 
 
 
Figure 5.13: Homophosphonate analogue of E4P. 
 
The retrosynthetic analysis of the homophosphonate analogue E4P is shown below (Figure 
5.14). This analogue of E4P could be synthesised starting from meso-tartaric acid. The 
hydroxyl groups on tartaric acid would have to be protected, followed by reduction to give 
compound 5.2, similar to the retrosynthetic analysis for the future synthesis of 2-methylE4P 
(Figure 5.10). One of the two primary hydroxyl groups on compound 5.2 would then undergo 
a homologation reaction, to extend the carbon chain length by one carbon. This homologation 
reaction can be achieved by first oxidising the primary hydroxyl group to give an aldehyde 
group followed by a Wittig reaction using the reagent (PhO)2P(O)CH=PPh3.182-184 The other 
primary hydroxyl group would then be oxidised to give the aldehyde functionality. 
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Figure 5.14: Retrosynthetic analysis of the homophosphonate analogue of E4P. 
 
Other isosteric phosphonates could also be synthesised to probe the substrate specificity of 
DAH7P synthases and include the (3S)-2- and (2R)-3-deoxy erythrose 4-homophosphonates 
(Figure 5.15). This would allow further investigation into the requirements for E4P for 
catalysis and binding in DAH7P synthase. As we have seen both compound 4.38 and 2,3-
dideoxy erythrose 4-phosphate were not substrates for DAH7P synthase, but the 2- and 3-
deoxyE4P were, indicating removal of both hydroxyl groups of E4P stops binding and 
catalysis in DAH7P synthase, but removal of only one of the hydroxyl groups of E4P does 
not. Therefore, it would be interesting to see how DAH7P synthases would react to the 
homophosphonate analogues of 2- and 3-deoxyE4P. 
 
 
Figure 5.15: Homophosphonate analogues of 2- and 3-deoxyE4P. 
 
The potential synthesis of (3S)-2-deoxy erythrose 4-homophosphonate could start with 
compound 2.14 that was used for the synthesis of (3S)-2-deoxyE4P in Chapter 2. The 
proposed synthetic scheme for the synthesis of the target compound (Figure 5.16) would 
require first synthesising compound 2.14 starting from -hydroxy--butyrolactone, followed 
by oxidation of the primary hydroxyl to give aldehyde 5.8. A subsequent homologation 
Chapter 5: Discussion, conclusions and future directions 141 
reaction of aldehyde 5.8 using a Wittig reaction, followed by deprotection steps would give 
(3S)-2-deoxy erythrose 4-homophosphonate. 
 
 
Figure 5.16: Proposed synthetic scheme for the synthesis of (3S)-2-deoxy erythrose 4-homophosphonate. 
 
5.4.2 Fluorinated E4P analogues 
 
Introduction of fluorine into a certain position of a bioactive compound can have strong 
influence on its activity185, often caused by mimicking and blocking effects.186 Because of the 
similarity in size of fluorine (van der Waals radius = 1.47 Å) to oxygen (van der Waals radius 
= 1.52 Å) and even hydrogen (van der Waals radius = 1.20 Å), it has been shown that 
microorganisms and enzymes often do not recognise the difference between a natural 
substrate and its analogue wherein a C-O or C-H bond of the substrate has been replaced with 
a C-F bond. This observation is the basis of what is regarded as the mimic effect of 
fluorine.186,187 The blocking effect is the phenomenon that where the high electronegativity of 
a fluorine atom lowers the surrounding electron density, which prevents certain reactions, 
such as oxidation of hydroxyl or amino groups, from occurring. For example, fluticasone 
propionate (Flixotide™), an anti-inflammatory steroid for the treatment of asthma contains 
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fluorine at the 9α position. The role of the 9α-fluorine is to increase the acidity of the 
hydroxyl group at the 11 position, which promotes better binding to the enzyme active site 
and inhibits undesirable oxidation (Figure 5.17).186 
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Figure 5.17: Fluticasone propionate (Flixotide™). 
 
The synthesis of fluorinated analogues of E4P, 2- and 3-deoxyfluoroE4P, could prove to be 
very useful in probing the substrate specificity of DAH7P synthase. This is because fluorine 
has a similar electronegativity as a hydroxyl group, without the ability to be a hydrogen-bond 
donor, and is a similar size. The replacement of the C2 or C3 hydroxyl group of E4P with a 
fluorine would increase the acidity of the adjacent hydroxyl (blocking effect), potentially 
promoting better binding in the active site. Additionally, the increased electronic effects due 
to the incorporation of fluorine would draw electron density away from the carbonyl group of 
2- or 3-deoxyfluoroE4P, further activating the carbonyl group for attack by PEP during the 
aldol reaction. This could potentially increase the catalytic efficiency of the enzyme catalysed 
reaction and would be more prevalent for 2-deoxyfluoroE4P due to the proximity of the 
fluorine group to the carbonyl group. 
 
 
Figure 5.18: 2- and 3-DeoxyfluoroE4P analogues. 
 
The retrosynthetic analysis of 2-deoxyfluoroE4P is shown in Figure 5.19. Both 2- and 3-
deoxyfluoroE4P can both be synthesised from malic acid. The key step is the electrophilic 
fluorination of malic acid and could be achieved via a number of commercially available 
fluorinating reagents such N-fluorobenzenesulfonimide (NFSI) and Selectfluor® (Figure 
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5.20).188-190 Methods for controlling the stereochemistry of this key step would have to be 
investigated, if enantiopure fluorinated analogues of E4P are required. 
 
 
Figure 5.19: Retrosynthetic analysis of 2-deoxyfluoroE4P. 
 
 
Figure 5.20: Electrophilic fluorinating regents. 
 
5.5 Conclusions 
 
This project describes the synthesis of a number of E4P analogues (2- and 3-deoxyE4P, 3-
methylE4P and 2,3-dideoxy erythrose 4-phosphonate 4.38) and the attempts to synthesise 2-
methylE4P and D-erythrose 4-phosphate. The substrate specificity investigations of 2- and 3-
deoxyE4P, 3-methylE4P and compound 4.38 on DAH7P synthases were also evaluated. 
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Chapter 6:  Experimental 
 
6.1 General chemical procedures 
 
6.1.1 Reaction conditions and work up 
 
All reactions were performed under an inert atmosphere of dry nitrogen (N2), argon (Ar) or 
hydrogen (H2) and were performed in oven- or flame-dried glassware unless otherwise stated. 
Crude organic extracts were dried with magnesium sulfate or sodium sulfate unless otherwise 
stated. Evaporations were performed on a rotary evaporator with the water bath temperature 
not exceeding 40°C unless otherwise stated. When necessary, a high vacuum pump (~0.1 
mmHg) was used to remove the last traces of solvent from purified compounds. −78, −20 and 
−10°C cold baths were made using carbon dioxide/acetone, ice/salt and methanol/ice 
mixtures respectively. 
 
6.1.2 Solvents and reagents 
 
All chemical reagents and solvents used for experiments were purchased from commercially 
available sources and used as supplied unless otherwise noted. 
 
Solvents were dried by standard methods prior to use.177,191 Dimethylformamide (DMF) was 
sequentially dried over three batches of 3 Å molecular sieves (5% w/v, 12 hrs). 
Dichloromethane (DCM), toluene and diisopropylamine was distilled from CaH2. Petroleum 
ether (pet ether) was distilled and the fraction at 40–60°C was collected for use. Ethyl acetate 
was distilled from CaH2. Tetrahydrofuran and diethyl ether were freshly distilled from 
sodium wire/benzophenone. Pyridine was distilled from CaH2 and stored over 4 Å molecular 
sieves. Cyclohexane was distilled, discarding the forerun, and stored over 4 Å molecular 
sieves. Analytical grade and HPLC grade acetone, methanol, and ethanol were used as 
supplied from commercial sources. 
 
Silver oxide (Ag2O) was freshly prepared using the published procedure94: A solution of 6.90 
g (0.172 mol) of sodium hydroxide in 200 mL of water was heated to 80–90°C and added to a 
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solution of 30 g (0.177 mol) of silver nitrate in 200 mL of water, also heated to 80–90°C. The 
resulting hot suspension was quickly filtered, and the filter cake was washed with 200 mL of 
hot water and 200 mL of absolute ethanol (2x). The Ag2O was dried under high vacuum 
overnight, weighed to give 17.8–18.3 g of Ag2O (87–89%). Drying of Ag2O was achieved by 
heating the wet Ag2O at 45°C under high vacuum overnight before use. 
 
2-Iodoxybenzoic acid (IBX) was prepared by oxidation of 2-iodobenzoic acid with Oxone® 
as previously described.121 Dess-Martin periodinane was prepared by acetylation of IBX with 
hot Ac2O and p-toluenesulfonic acid as previously described.120 Cyclohexanone was dried 
over magnesium sulfate, filtered and distilled. Methyl iodide was poured through a short 
column of alumina to remove iodine then dried over calcium chloride before distillation. 
Benzyl alcohol was fractionally distilled under reduced pressure. Benzyl 2,2,2-
trichloroacetimidate (BTCA) was freshly prepared using published procedures.111,192 Butan-
1,4-diol was distilled and stored over 4 Å molecular sieves. N-bromosuccinimide (NBS) was 
recrystallised from water, dried under high vacuum overnight and stored in the dark. Triethyl 
phosphite was distilled from sodium and stored over 3 Å or 4 Å molecular sieves. Lead 
tetraacetate (Pb(OAc)4) was recrystallised using hot glacial acetic acid, any lead oxide was 
removed by filtration, and the white crystals of Pb(OAc)4 was stored in a vacuum desiccator 
containing P2O5 overnight prior to use. Acetic acid was dried using Ac2O (5% v/v) and 
distilled. Zinc chloride was subjected to high vacuum for 24 hrs prior to use. Lithium 
diisopropylamine (LDA) was prepared in situ according to the procedure by Seebach et al.107 
pH measurements were made using Whatman’s full range pH paper. 
 
Molecular sieves, 3 Å and 4 Å, were activated by heating under high vacuum using a hot air 
gun for 5–10 minutes, allowed to cool ~10 minutes (whilst still under high vacuum) and then 
repeated two more times. Rapid activation of molecular sieves was alternatively achieved by 
microwave irradiation (see Microwave); molecular sieves were subjected to microwave 
irradiation, on high for 30 sec, transferred to a dry glass container and then this process was 
repeated three to four times or till no condensation was seen forming on the glass container. 
 
To prepare Dowex resin in its acidic form (Dowex-H+), dowex resin was stirred in H2O for 
15 minutes then filtered and washed with H2O. The resin was then stirred in 1.2 M HCl for 15 
minutes and then filtered and washed with 1.2 M HCl. The resin was then washed with H2O 
until the filtrate ran neutral to pH paper, then air-dried before use. Dowex resin in their 
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potassium form were prepared by washing the acidic resin well with 10% w/v KOH, then 
with H2O until the filtrate ran neutral to pH paper, then air-dried. 
 
Commercial solutions of n-butyllithium (n-BuLi) were quantified as required by a 
modification of a literature procedure193: titration of n-BuLi using a known quantity of 
diphenylacetic acid (~0.50 g) dissolved in 10 mL of dry THF, using an accurate syringe. The 
solution went from colourless to pale yellow at the end point of titration. A white precipitate 
sometimes formed as the end point approached. Titrations were performed at room 
temperature, under nitrogen with vigorous stirring and the concentration was taken from a 
mean of two concordant results. 
 
6.1.3 Chromatography 
 
Thin layer chromatography (TLC) was performed on Merck Kieselgel 60F254 pre-coated 
aluminium-backed plates. Visualisation of the plates was achieved using a UV lamp (254 
nm), followed routinely by staining with basic aqueous potassium permanganate dip and 
heating with a hot air gun. Other visualisation dips included acidified ethanolic vanillin, 
ethanolic phosphomolybdic acid (PMA), acidified aqueous ammonium molybdate and 50% 
ethanolic H2SO4.177,191 
 
Flash column chromatography was performed using Silica 60 230-400 mesh. 
Chromatographic EtOAc was distilled prior to use from CaH2; Pet ether was distilled; 
analytical grade CHCl3 and MeOH was used as supplied. 
 
For acid sensitive compounds the silica was deactivated (reducing its acidity) before the 
sample was loaded. A solvent system containing 1-3% triethylamine was prepared.  The 
column was packed using this system and flushed with solvent equal to the volume of the 
silica, and the eluant was discarded. 
 
Reverse phase C18 column chromatography were carried out on reverse phase C18 silica, 
kindly donated by Professor Murray Munro of the Marine group at the University of 
Canterbury. C18 silica was loaded into a column using a MeOH slurry, followed by washing 
the column through with (1) 50% MeOH:H2O; (2) 30% MeOH:H2O and finally with 10% 
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MeOH:H2O. Samples dissolved in water or MeOH was loaded onto the column. Gradient 
elution, usually 10% MeOH:H2O to 100% methanol, was used to elute samples. Reverse 
phase C18 TLC plates were used to monitor the fractions unless otherwise stated. 
Regeneration of reverse phase C18 silica was accomplished by flushing the column with 
CH3CN followed by several flushes with MeOH. The reverse phase C18 silica can be air 
dried or can be dried by careful use of a rotary evaporator. All solvents were HPLC grade; 
water was distilled. 
 
6.1.4 Microwave 
 
Microwave irradiations were performed in a domestic 1100 W microwave oven, modified to 
include a reflux condenser and inert gas source. 
 
6.1.5 Hydrogenator 
 
Hydrogenation reactions that require high pressures were carried out in a Parr series 4842 
hydrogenator. 
 
6.1.6 NMR spectroscopy 
 
Proton (1H) nuclear magnetic resonance spectra (H) were recorded on a Varian INOVA 300 
(300 MHz) or a Varian VNMR 500 (500 MHz) spectrometer and were calibrated according 
to the chemical shift of residual protons in the deuterated solvent stated. 13C NMR spectra 
(C) were recorded on a Varian INOVA 300 (75 MHz) or a Varian VNMR 500 (125 MHz) 
spectrometer and were calibrated according to the chemical shift of the deuterated solvent 
stated. 31P NMR spectra (P) were recorded on a Varian INOVA 300 (121 MHz) 
spectrometer and were calibrated to 85% phosphoric acid in the deuterated solvent stated. 2D 
NMR experiments were carried out on a Varian VNMR 500 (500 MHz) spectrometer. 
Assignment of 1H and 13C NMR signals were determined by COSY, HSQC and HMBC. All 
chemical shifts are quoted in parts per million (ppm) and coupling constants (J) in hertz (Hz). 
For acid sensitive compounds, 0.1% (v/v) of C5D5N (deuteropyridine) was added to the 
CDCl3 solvent. 
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6.1.7 Mass spectrometry 
 
High-resolution mass spectra were recorded on a Bruker maXis 3G with electrospray 
ionisation (positive or negative ion electrospray ionisation (ESI) techniques) or a Micromass 
LCT spectrometer (ESI+ or ESI−), both at the University of Canterbury. 
 
6.1.8 Melting points 
 
Melting points (mp) were recorded on an Electrothermal IA6304 melting point block and are 
uncorrected. 
 
6.1.9 Freeze drying/lyophilisation 
 
Samples to be freeze dried were frozen using liquid nitrogen and placed for 1–2 days on a 
Christ® freeze dryer, model Alpha I/5. 
 
6.2 General biochemical procedures 
 
6.2.1 UV-Visible spectrometry 
 
UV-Visible spectrophotometry was carried out on a Varian Cary® One UV-Visible 
spectrophotometer at 25 or 30°C (as indicated) in a stoppered quartz cell. The temperature 
was continuously controlled using a jacketed multicell holder, connected to an external 
Varian Peltier temperature controller filled with water or ethylene glycol. 
 
6.2.2 Buffers 
 
Chemicals used for buffer preparation were purchased from commercially available sources. 
 
MilliQ H2O used to make aqueous buffers was treated with Chelex® resin for one hour then 
filtered through a 0.2 µm membrane before use. 
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BTP (bis-tris propane) buffers were prepared by dissolving sufficient BTP in MilliQ water to 
give a 50 mM solution and the solution was adjusted to the appropriate pH using HCl or 
NaOH solutions. The resulting mixture was treated with Chelex® resin for two hours, filtered 
through a 0.2 μm membrane, snap frozen using liquid nitrogen and stored at −20°C till 
required. The following buffers were used in standard assays for the following enzymes: 
 
E. coli DAH7P synthase (phe) – 50 mM BTP, pH 6.8 at 25°C 
M. tuberculosis DAH7P synthase – 50 mM BTP, 1 mM TCEP, pH 7.5 at 30°C 
N. meningitidis DAH7P synthase – 50 mM BTP, pH 6.8 at 25°C 
 
Stock solutions of PEP and E4P were prepared from monopotassium-PEP (Sigma) and 
sodium-E4P (Sigma) respectively, in BTP buffers. The stock solutions were filtered through a 
0.2 μm membrane. Both PEP and E4P solutions were frozen and stored at −20°C. Stock 
solutions of manganese (II) sulfate were prepared in MilliQ H2O at 10 mM and were filtered 
through a 0.2 µM membrane and stored frozen at −20°C. 
 
6.2.3 Enzymes 
 
Purified E. coli DAH7P synthase were kindly supplied by Penelope Cross, Dmitri Joseph and 
Dr Steve McNabb. Purified M. tuberculosis DAH7P synthase was kindly supplied by Dr 
Richard Hutton. N. meningitidis DAH7P synthase was kindly supplied by Penelope Cross. 
These enzymes were kept in aliquots by flash freezing in liquid nitrogen and stored at −80°C. 
 
6.2.4 pH measurements 
 
The pH of buffers used in this project were measured using a UB10 Ultrabasic Benchtop pH 
meter from Denver Instrument Company. For pH measurements in narrow containers e.g. test 
tubes, 1 mL eppendorf tubes; a pH micro glass-body combination pH electrode was used 
(Denver Instrument Company). The pH of solutions was adjusted using 1–10 M NaOH or 1–
12 M HCl. pH probes were calibrated before use. 
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6.2.5 Standard enzyme assays 
 
All standard enzyme assays were performed in a total volume of 1 mL, in 1 cm path length 
quartz cuvettes. Enzyme activity was monitored by UV-Visible spectrophotometry, following 
the decrease in absorbance at 232 nm as the enol alkene of PEP is consumed (ε = 2.8 x 103 
M-1cm-1 at 25°C). Standard reaction mixtures contained PEP, E4P (or alternative substrate), 
metal and buffer in the cuvette. Cuvettes were mixed by inverting the stoppered cuvette three 
times and then incubated in the spectrophotometer for five minutes before initiation with 
enzyme. Assays were carried at 25°C for E. coli, N. meningitidis and 30°C for M. 
tuberculosis. One unit (1 U) of activity is defined as the loss of 1 μmol of PEP per minute at 
the stated temperature. Specific activity (U/mg) is defined as the loss of 1 μmol of PEP per 
minute at the stated temperature per mg of protein. KM and kcat values were determined by 
fitting the data to the Michaelis–Menten equation using GraFit (Erithacus Software). 
Allowance was made for the change in absorbance due to initiation by addition of the 
enzyme. 
 
6.2.6 Determination of substrate concentrations 
 
2-DeoxyE4P, 3-deoxyE4P and E4P substrate concentrations were determined using standard 
enzyme assays. For example, to determine the concentration of 2-deoxyE4P a reaction 
mixture consisting of <100 µM PEP, ~100 µM MnSO4 and ~5 µL 2-deoxyE4P solution (of 
unknown concentration) is made up in BTP buffer and initiated with enzyme to give a final 
volume of 1 mL. The reaction is allowed to go to completion and the difference between the 
absorbance before initiation and the absorbance after completion (∆A1) is measured. An 
identical reaction is set up in the absence of 2-deoxyE4P to determine how much change in 
absorbance is due to the addition of the enzyme (∆A2). The correct change in absorbance is 
given by ∆A1 + ∆A2. To convert absorbance into concentration Beer’s Law is applied (A = 
ε.c.l. where l = 1 cm and εPEP = 2.8 x 103 M-1cm-1). 
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6.2.7 Lanzetta assay for the detection of phosphates 
 
The Lanzetta reagent was prepared fresh prior to use by the following preparations93: 
 
3 parts 0.045% w/v malachite green oxalate in H2O 
1 part 4.2% w/v ammonium molybdate in 4 M HCl 
0.1 parts 1.5% v/v Triton X-100 
 
The components were mixed in the dark and stirred for 30 minutes before filtering through a 
0.45 µM filter before use (pale yellow solution). For qualitative detection of products, 25 µL 
of Lanzetta reagent was added to 150 µL of sample and incubated for 30 minutes. The change 
in absorbance due to organic phosphate cleavage in an acidic environment was detected 
visually over a white surface (green for positive test). For quantitative analysis of substrate 
solutions, 300 µL of sample is mixed with 10 µL of calf alkaline phosphatase solution (10 
units/mL, in 4 mM MgCl2) and incubated for at least three hours. A 100 µL digest sample 
was then mixed with 700 µL of Lanzetta reagent, mixed and left at room temperature for 20 
minutes before the absorbance was determined at 630 nm. A calibration curve for the 
determination of phosphate concentration was obtained from analogous analysis using 
samples of appropriate concentrations (5–150 µM) of KH2PO4 which had been dried in high 
vacuum for at least three hours before use. As a control, a glucose 6-phosphate (G6P) 
solution of known concentration was also digested with calf alkaline phosphatase and 
analysed. 
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6.2.8 Determination of the utilisation of racemic substrates by M. tuberculosis 
and E. coli DAH7P synthase 
 
Rac-3-deoxyE4P 
 
A solution containing G6P (mono-sodium salt) (25µL, ~4 mM in D2O), rac-3-deoxyE4P (25 
µL from a 6-fold diluted solution in H2O, pH = 7.5, unknown concentration) and 200 µL of 
D2O was added to a 3 mm NMR tube. A standard 31P NMR (1H-decoupled, 202 MHz, 
relaxation delay (d1) = 1 s, acquisition time = ~19 hours) spectrum was collected and the 
peaks due to rac-3-deoxyE4P (3.35 ppm) and G6P (1.73 ppm) were integrated to give a 
relative concentration of 1(G6P):1.56(rac-3-deoxyE4P). 
 
G6P (above solution, ~4 mM in D2O) was diluted 4-fold with H2O (~1 mM) and its pH 
adjusted to 7–8 using NaOH(aq). A Lanzetta assay was run on this sample to determine an 
accurate concentration of G6P. 
 
The amount of 3-deoxyE4P can be calculated using the concentration of G6P and the relative 
concentration of 3-deoxyE4P to G6P in the 31P NMR spectrum and accounting for all 
dilutions: 1.56 x 4.29 x 6 = 40.15 mM. This is the concentration of both enantiomers of rac-3-
deoxyE4P in solution.  
 
Assays with M. tuberculosis DAH7P synthase contained an unknown concentration of rac-3-
deoxyE4P (5 µL of the original undiluted solution), PEP (300 µM) and MnSO4 (100µM) in 
50 mM BTP buffer containing mM TCEP at pH 7.5. Reactions were initiated by the 
addition of M. tuberculosis DAH7P synthase (3 µL, 1.4 mg/mL) to give a final volume of 1 
mL. Assays were carried out at 30°C. The control assays used to determine the absorbance 
increase due to the addition of enzyme used 5 µL of buffer in the place of the 5 µL of rac-3-
deoxyE4P but were otherwise identical to the experimental assays. The decrease in 
absorbance due to the loss of PEP was monitored at 232 nm (ε= 2.8 x 103 M-1cm-1 at 25°C) 
to completion and the concentration of rac-3-deoxyE4P consumed by the enzyme calculated 
from the change in absorbance observed after correction for the blank assay containing no 
rac-3-deoxyE4P. Assays were carried out in duplicate and averaged. 
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Results: 
[G6P] determined from Lanzetta assay   = 4.29 mM 
Average [rac-3-deoxyE4P] determined from enzyme assay = 22.86 mM 
[rac-3-deoxyE4P] determined from 31P NMR experiment = 40.15 mM 
 
From these results we can see that the concentration determined from the use of 3-deoxyE4P 
in solution is approximately half (0.57) that of the total concentration, consistent with the 
enzyme (M. tuberculosis DAH7P synthase) only using one enantiomer. 
 
Determination of the utilisation of racemic substrates by E. coli DAH7P synthase 
 
Assays with DAH7P synthase contained an unknown concentration of rac-3-deoxyE4P (5 
µL), PEP (300 µM) and MnSO4 (100µM) in 50 mM BTP buffer at pH 6.8. Reactions were 
initiated by the addition of E. coli DAH7P synthase (3 µL, 5.86 mg/mL) to give a final 
volume of 1 mL. Assays were carried out at 25°C. The decrease in absorbance due to the loss 
of PEP was monitored at 232 nm (ε= 2.8 x 103 M-1cm-1 at 25°C) to completion. The change 
in absorbance (∆A1= 0.74) was recorded. A similar assay was carried out on rac-3-deoxyE4P 
(5 µL, unknown concentration), PEP (300 µM) and MnSO4 (100µM) in 50 mM BTP buffer 
containing mM TCEP at pH 7.5, 30°C), but initiated with M. tuberculosis DAH7P synthase 
(3 µL, 1.4 mg/mL) and the change in absorbance (∆A2 = 0.34) was recorded. The absorbance 
loss using the same amount of rac-3-deoxyE4P with E. coli DAH7P synthase was 2.2 times 
higher than that observed when the M. tuberculosis enzyme was employed, indicating that in 
contrast to M. tuberculosis DAH7P synthase, E. coli DAH7P synthase utilises both 
enantiomers of the racemic mixture. 
 
Rac-2-deoxyE4P 
 
Rac-2-deoxyE4P was diluted 4-fold with H2O and its pH adjusted to 7–8 using NaOH(aq). A 
Lanzetta assay was run on this sample. 
 
Assays with DAH7P synthase contained an unknown concentration of rac-2-deoxyE4P (10 
µL of the original solution), PEP (300 µM) and MnSO4 (100  µM) in 50 mM BTP buffer 
containing mM TCEP at pH 7.5. Reactions were initiated by the addition of M. tuberculosis 
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DAH7P synthase (3 µL, 1.4 mg/mL) to give a final volume of 1 mL. Assays were carried out 
at 30°C. The control assays used to determine the absorbance increase due to the addition of 
enzyme contained no rac-2-deoxyE4P, but were otherwise identical to the experimental 
assays. The decrease in absorbance due to the lost of PEP was monitored at 232 nm (ε= 2.8 x 
103 M-1cm-1 at 25°C) to completion and the concentration of 2-deoxyE4P consumed by the 
enzyme calculated from the change in absorbance observed after correction for the blank 
assay containing no 2-deoxyE4P. Assays were carried out in duplicate and averaged. 
 
Results: 
Average [rac-2-deoxyE4P] determined from enzyme assay = 13.2 mM 
[rac-2-deoxyE4P] determined from Lanzetta assay  = 23.6 mM 
 
From these results we can see that the concentration determined from the use of 2-deoxyE4P 
in solution is approximately half (0.56) that of the total concentration consistent with the 
enzyme (M. tuberculosis DAH7P synthase) only using one enantiomer of the racemic 
mixture. 
 
6.2.9 Thiobarbituric assay 
 
Thiobarbituric acid assay reagents: 
 
25 mM sodium periodate (NaIO4) in 0.0625 M H2SO4 
Sodium metaarsenite (NaAsO2) 2% w/v in 0.5 N HCl 
Thiobarbituric acid solution (0.36 % w/v, pH = 9 adjusted with NaOH) 
 
A standard enzyme assay was carried out with 3-deoxyE4P (~150 µM), PEP (200 µM) and 
MnSO4 (100 µM). The reaction was initiated with enzyme (3 µL). When the assay had 
completed, an aliquot (100 µL) of the assay mixture was transferred to a small round bottom 
flask. Water (50 µL) and NaIO4 (100 µL in 0.0625 M H2SO4) were added. The mixture was 
stirred and heated at 60°C for one hour. The excess oxidising agent was reduced by the 
addition of 200 µL of NaAsO2. Following the disappearance of the yellow colour, 1 mL of 
thiobarbituric acid solution was added and the reaction mixture was then stirred and heated at 
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100°C for 10 minutes. Once the sample was cool, the absorbance at 549 nm was measured 
(ε= 1.03 x 105M-1cm-1).24,96 
6.2.10 Biological structures 
 
All protein structures were drawn from files downloaded from the Protein Data Bank and 
drawn using the PyMol Molecular Graphics System Version 1.3, Schrödinger, LLC. 
 
6.3 Experimental procedures 
 
6.3.1 Experimental for Chapter 2 
 
Synthesis of 2.1 
 
 
 
SOCl2 (2.40 mL) was added dropwise to a solution of DL-malic acid (2.0024 g, 15 mmol) in 
MeOH (20 mL) at 0°C. The solution was stirred at room temperature for 24 hours then 
concentrated under reduced pressure. Flash chromatography (1:1 EtOAc:Pet ether) gave 2.1 
(2.4034 g, 99%) as a light yellow oil with spectral data in accordance with the literature.194,195 
 
1H NMR (500 MHz, CDCl3) ppm 4.52 (q, J = 5.5 Hz, 1H, H2), 3.82 (s, 3H, OCH3), 3.72 (s, 
3H, OCH3), 2.95-2.74 (m, 2H, H3). 
13C NMR (126 MHz, CDCl3)  ppm 173.9, 171.2, 67.4, 53.1, 52.2, 38.6. 
HRMS (ESI): calc. C6H10NaO5 [M+Na]+: 185.0420; found: 185.0427. 
Rf (1:1 EtOAc:Pet ether) = 0.3. 
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Synthesis of 2.2 
 
 
 
Alcohol 2.1 (1.0063 g, 6.0 mmol) was dissolved in DCM (40 mL) and cyclohexane (20 mL) 
and cooled to 0°C. Benzyl 2,2,2-trichloroacetimidate (BTCA, 2.90 mL, 16 mmol) was added 
followed by dropwise addition of TfOH (270 µL, 3.0 mmol). The mixture was stirred 
overnight at room temperature before additional BTCA (1.2 mL, 6.0 mmol) and TfOH (140 
µL, 1.6 mmol) were added at 0°C. After a further 24 hours of stirring at room temperature the 
reaction was quenched by the addition of sat. NaHCO3, extracted with DCM, dried and 
concentrated. Flash chromatography (10 to 20% EtOAc:Pet ether) gave 2.2 (1.1746 g, 75%) 
as an oil with spectral data in accordance with the literature.102 
 
1H NMR (500 MHz, CDCl3)  ppm 7.48-7.20 (m, 5H, Ph), 4.77 (d, J = 11.4 Hz, 1H, CH2Ph), 
4.54 (d, J = 11.4 Hz, 1H, CH2Ph), 4.40 (dd, J = 5.1, 7.7 Hz, 1H, H2), 3.77 (s, 3H, OCH3), 
3.69 (s, 3H, OCH3), 2.89-2.75 (m, 2H, H3). 
13C NMR (126 MHz, CDCl3)  ppm 172.1, 170.7, 137.4, 128.6, 128.3, 128.2, 74.7 (C2), 73.3 
(CH2Ph), 52.5 (OCH3), 52.2 (OCH3), 38.0 (C3). 
HRMS (ESI): calc. C13H16NaO5 [M+Na]+: 275.0890; found: 275.0897. 
Rf (20% EtOAc:Pet ether) = 0.3. 
 
Synthesis of 2.3 
 
 
 
LiAlH4 (0.9351 g, 25 mmol) was suspended in THF (30 mL) and cooled to 0°C. Compound 
2.2 (2.0692 g, 8.0 mmol) in THF (20 mL) was added dropwise to this cooled suspension over 
10 minutes. The reaction was then heated to reflux for four hours. After cooling to 0°C the 
solution was quenched slowly by the addition of ice, followed by 3 M NaOH, until 
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effervescence had ceased and a white solid had formed. The mixture was filtered through 
celite, the celite washed with ether and the filtrate dried and evaporated. Flash 
chromatography (3:1 EtOAc:Pet ether) gave 2.3 (1.0082 g, 63%) with spectral data in 
accordance with the literature.102 
 
1H NMR (500 MHz, CDCl3)  ppm 7.54-7.22 (m, 5H, Ph), 4.66-4.59 (m, 2H, CH2Ph), 3.83-
3.70 (m, 4H, H1, H2, H4a), 3.62 (dd, J = 4.4, 11.7 Hz, 1H, H4b), 1.96-1.79 (m, 2H, H3). 
13C NMR (126 MHz, CDCl3)  ppm 138.3, 128.8, 128.2, 128.1, 78.0 (C2), 71.9 (CH2Ph), 
64.2 (C4), 59.8 (C1), 34.1 (C3). 
HRMS (ESI): calc. C11H16NaO3 [M+Na]+: 219.0992; found: 219.0996. 
Rf (2:1 EtOAc:Pet ether) = 0.1. 
 
Synthesis of 2.4 
 
 
 
To a solution of diol 2.3 (0.2236 g, 1.14 mmol) in DCM (10 mL) was added 
diphenylchlorophosphate (210 µL, 1.01 mmol) and imidazole (0.3099 g, 4.55 mmol) at 0°C. 
The solution was allowed to warm slowly to room temperature by allowing the cooling bath 
to melt, and stirred overnight. The reaction was quenched with H2O and washed with sat. 
NaHCO3, sat. NaCl and extracted with DCM. The combined organic extracts were dried over 
MgSO4 and the solvent removed in vacuo. Flash chromatography (gradient elution 30 to 75% 
EtOAc:Pet ether) gave 2.4 (87.2 mg, 18%) as well as the diphosphorylated compound 2.6 
(45.6 mg, 6%, Rf (2:1 EtOAc:Pet ether) = 0.8), a further monophosphorylated compound 2.5 
(28.7 mg, 6%, Rf (2:1 EtOAc:Pet ether) = 0.4) and starting material 2.3 (52.8 mg, 24% 
recoverd). 
 
1H NMR (500 MHz, CDCl3)  ppm 7.51-7.05 (m, 15H, Ph), 4.53 (ABq, J = 11.4 Hz, 2H, 
CH2Ph), 4.44-4.36 (m, 2H, H4), 3.75 (dd, J = 3.7, 11.7 Hz, 1H, H1), 3.65 (dq, J = 4.2, 8.0 
Hz, 1H, H2), 3.50 (dd, J = 4.8, 11.7 Hz, 1H, H1), 2.07-1.89 (m, 2H, H3), 1.62 (br. s, 1H, 
OH). 
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13C NMR (126 MHz, CDCl3)  ppm 150.7 (d, J = 7.4 Hz), 138.2, 130.0, 128.8, 128.1, 128.0, 
125.6, 120.3 (d, J = 5.1 Hz), 76.0 (C2), 72.3 (CH2Ph), 66.2 (d, 2JPOC = 6.1 Hz, C4), 63.9 
(C1), 32.3 (d, 3JPOCC = 7.0 Hz , C3). 
31P NMR (121 MHz, CDCl3)  ppm −11.90. 
HRMS (ESI): calc. C23H25NaO6P [M+Na]+: 451.1281; found: 451.1296. 
Rf (2:1 EtOAc:Pet ether) = 0.5. 
 
Synthesis of 2.7 
 
 
 
Compound 2.4 (0.2090 g, 0.49 mmol) was dissolved in DCM (15 mL) and freshly prepared 
Dess-Martin periodinane (0.4184 g, 0.99 mmol) was added. The mixture was stirred 
overnight at room temperature before an additional portion of Dess-Martin periodinane 
(0.2088 g, 0.49 mmol) was added. After a further five hours of stirring, sat. Na2S2O3 and sat. 
NaHCO3 were added and stirred till the solution was clear. The aqueous layer was extracted 
with DCM (3x) and the combined organic extracts were dried over MgSO4. Removal of the 
solvent in vacuo, followed by flash chromatography (30 to 50% EtOAc:Pet ether) gave 2.7 
(0.1762 g, 85%). 
 
1H NMR (500 MHz, CDCl3)  ppm 9.62 (s, 1H, H1), 7.47-7.10 (m, 15H, Ph), 4.64 (d, J = 
11.4 Hz, 1H, CH2Ph), 4.52 (d, J = 11.4 Hz, 1H, CH2Ph), 4.46-4.39 (m, 2H, H4), 3.92 (dd, J = 
4.0, 8.4 Hz, 1H, H2), 2.19-2.09 (m, 1H, H3a), 2.02-1.93 (m, 1H, H3b). 
13C NMR (126 MHz, CDCl3)  ppm 202.5, 150.4 (d, J = 7.4 Hz), 136.9, 129.8, 128.6, 128.3, 
128.1, 125.5, 120.1 , 79.6 (C2), 73.1 (CH2Ph), 64.6 (d, 2JPOC = 6.0 Hz, C4), 31.0 (d, 3JPOCC = 
7.0 Hz, C3). 
31P NMR (121 MHz, CDCl3)  ppm −11.99. 
HRMS (ESI): calc. C23H23NaO6P [M+Na]+: 449.1124; found: 449.1138. 
Rf (30% EtOAc:Pet ether) = 0.2. 
Synthesis of 2.8 
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To 2.7 (0.1673 g, 0.39 mmol) in MeOH (8.0 mL) was added trimethyl orthoformate (430 µL, 
3.93 mmol) and conc. H2SO4 (4.20 µL, 0.079 mmol). After stirring overnight, the mixture 
was transferred into a separating funnel containing sat. NaHCO3 and Et2O. The aqueous layer 
was washed with Et2O (3x). The combined organic extracts were washed with sat. NaCl, 
dried (MgSO4) and the solvent removed in vacuo. Flash chromatography using deactivated 
silica (30% EtOAc:Pet ether) gave 2.8 (0.1735 g, 94%). 
 
1H NMR (500 MHz, CDCl3)  ppm 7.41-7.09 (m, 15H, Ph), 4.69 (d, J = 11.0 Hz, 1H, 
CH2Ph), 4.49 (d, J = 11.4 Hz, 1H, CH2Ph), 4.43-4.38 (m, 2H, H4), 4.24 (d, J = 5.1 Hz, 1H, 
H1), 3.63-3.57 (m, 1H, H2), 3.43 (s, 3H, OCH3), 3.39 (s, 3H, OCH3), 2.13-2.03 (m, 1H, 
H3a), 1.90-1.80 (m, 1H, H3b). 
13C NMR (126 MHz, CDCl3)  ppm 150.8 (d, J = 7.4 Hz), 138.5, 130.0, 128.6, 128.2, 127.9, 
125.5, 120.3 (d, J = 5.1 Hz), 106.9 (C1), 75.8 (C2), 73.6 (CH2Ph), 66.3 (d, 2JPOC = 6.5 Hz, 
C4), 56.0 (OCH3), 55.5 (OCH3), 31.2 (d, 3JPOCC = 7.4 Hz, C3). 
31P NMR (121 MHz, CDCl3)  ppm −11.94. 
HRMS (ESI): calc. C25H29NaO7P [M+Na]+: 495.1543; found: 495.1553. 
Rf (1:1 EtOAc:Pet ether) = 0.6. 
 
Synthesis of rac-3-deoxyE4P 
 
 
 
To the protected analogue 2.8 (0.1028 g, 0.22 mmol) in MeOH (5.0 mL) was added PtO2 
(0.0491 g, 0.22 mmol). After three vacuum/H2 cycles, to flush the flask with H2, the mixture 
was vigorously stirred at room temperature under hydrogen (balloon) till TLC analysis 
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showed no UV active compound was on the TLC plate (2 days). The PtO2 was filtered 
through a fine sintered funnel and the funnel washed with a small quantity of MeOH. The 
filtrate was then concentrated in vacuo, giving a clear colourless oil (56.8 mg). The oil was 
dissolved in H2O (0.70 mL) and heated to 40°C. The solution was stirred overnight and 
transferred into an eppendorf tube and made up to a final volume of 1.0 mL. The tube was 
snap frozen using liquid nitrogen and stored at −80°C. Standard enzyme assay conditions 
using E. coli DAH7P synthase (phe) determined the presence and yield of rac-3-deoxyE4P to 
be 28% over two steps. 
 
HRMS (ESI): calc. C4H9NaO6P [M+Na]+: 207.0029; found: 207.0038. 
 
Synthesis of 2.11 
 
 
 
β-Hydroxy-γ-butyrolactone (0.1191 g, 6.0 mmol) was dissolved in a mixture of DCM (20 
mL) and cyclohexane (10 mL), then cooled to 0°C. BTCA (460 µL, 2.48 mmol) was added 
followed by dropwise addition of TfOH (50 µL, 0.51 mmol). The mixture was stirred 
overnight at room temperature before the reaction was quenched by the addition of sat. 
NaHCO3 and extracted with DCM. The organic layer was dried with anhydrous Na2SO4, 
concentrated under reduced pressure and flash chromatography (30% EtOAc:Pet ether) 
afforded 2.11 (0.1583 g, 71%) as an oil. 
 
1H NMR (500 MHz, CDCl3)  ppm 7.41-7.24 (m, 5H, Ph), 4.53 (ABq, J = 11.0 Hz, 2H, 
CH2Ph), 4.41-4.32 (m, 3H, H3, H4), 2.73-2.59 (m, 2H, H2). 
13C NMR (126 MHz, CDCl3)  ppm 175.6 (C1), 137.1, 128.8, 128.3, 127.9, 74.0 (C4), 73.3 
(C3), 71.3 (CH2Ph), 35.1 (C2). 
HRMS (ESI): calc. C11H12NaO3 [M+Na]+: 215.0679; found: 215.0686. 
Rf (30% EtOAc:Pet ether) = 0.2. 
 
Synthesis of 2.12 
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Compound 2.11 (0.4876 g, 2.53 mmol) was dissolved in dry DCM (40 mL) and cooled to 
−78°C. DIBALH (3.0 mL, 1 M in THF) was added dropwise and the solution was stirred at 
−78°C. Once the starting material was undetectable by TLC (1:1 EtOAc:Pet ether, KMnO4), 
the reaction was quenched by the addition of 10% HCl (5.0 mL) and allowed to warm to 
room temperature. The solution was diluted with sat. NaHCO3 and extracted with DCM. The 
organic layer was washed with sat. Rochelle’s salt, water and finally sat. NaCl. The combined 
aqueous extracts were extracted with DCM and the combined organic extracts were dried 
with anhydrous MgSO4 and the solvent removed in vacuo. The product was purified by flash 
chromatography (30% EtOAc:Pet ether to 100% EtOAc) to give 2.12 (0.3045 g, 62%) as a 
pair of inseparable diastereoisomers (ratio 3:2). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.50-7.17 (m, 5H, Ph), 5.84-5.61 (m, 1H, H1), 4.56 
(ABq, J = 11.7 Hz, 2H), 4.36-4.30 (m, 1H, H3), 4.07 (dd, J = 4.8, 9.5 Hz, 1H, H4a), 3.97 
(ap.d, J = 9.5 Hz, 1H, H4b), 3.07 (br. s, 1H, OH), 2.28-2.18 (m, 1H, H2a), 2.15-2.07 (m, 1H, 
H2b). 
13C NMR (126 MHz, CDCl3)  ppm 137.5, 128.8, 128.7, 128.2, 127.9, 127.9, 98.8 (C1), 78.5 
(C3), 71.6 (CH2Ph), 71.3 (C4), 39.8 (C2). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.44-7.22 (m, 5H, Ph), 5.43 (dd, J = 5.1, 10.6 Hz, 1H, 
H1’), 4.48 (s, 2H, CH2Ph), 4.27 (d, J = 9.9 Hz, 1H, H4a’), 4.23 (t, J = 4.6 Hz, 1H, H3’), 3.88 
(dd, J = 4.0, 9.9 Hz, 1H, H4b’), 3.73 (ap.d, J = 11.0 Hz, 1H, OH), 2.27-2.18 (m, 1H, H2a’), 
2.00 (td, J = 5.0, 13.8 Hz, 1H, H2b’). 
13C NMR (126 MHz, CDCl3)  ppm 138.1, 128.8, 128.7, 128.2, 127.9, 127.9, 99.1 (C1’), 
78.3 (C3’), 72.6 (C4’), 71.6 (CH2Ph), 40.6 (C2’). 
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HRMS (ESI): calc. C11H14NaO3 [M+Na]+: 217.0835; found: 217.0837. 
Rf (1:1 EtOAc:Pet ether) = 0.4. 
 
Synthesis of 2.14 
 
 
 
Neopentyl glycol (0.2088 g, 2.0 mmol) and TMSCl (560 µL, 4.41 mmol) were dissolved in 
dry DCM (20 mL) at 0°C and stirred for 15 minutes at this temperature. Lactol 2.12 (0.1911 
g, 0.98 mmol) in DCM (15 mL) was then added to the reaction mixture and stirred for two 
hours at 0°C. The reaction was quenched by the addition of sat. NaHCO3. The solution was 
extracted with DCM (3x) and the organic extracts were washed with water and sat. NaCl. The 
combined aqueous extracts were extracted with DCM and the combined organic extracts 
were dried with anhydrous MgSO4. The solvent was removed in vacuo and flash 
chromatography (30 to 50% EtOAc:Pet ether) gave 2.14 (0.2178 g, 79%). 
 
1H NMR (500 MHz, CDCl3)  ppm 7.39-7.25 (m, 5H, Ph), 4.65-4.53 (m, 3H, CH2Ph, H1), 
3.80-3.71 (m, 2H, H3, H4a), 3.63-3.53 (m, 3H, H4b, H5/7), 3.41 (dd, J = 11.0, 16.9 Hz, 2H, 
H5/7), 2.19 (br. s, 1H, OH), 2.08-2.00 (m, 1H, H2a), 1.87 (td, J = 5.7, 14.3 Hz, 1H, H2b), 
1.19 (s, 3H, CH3), 0.72 (s, 3H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 138.6, 128.7, 128.1, 128.0, 99.9 (C1), 77.4 (C5/7), 76.0 
(C3), 71.8 (CH2Ph), 64.6 (C4), 36.8 (C2), 30.3 (C6), 23.3 (CH3), 22.1 (CH3). 
HRMS (ESI): calc. C16H24NaO4 [M+Na]+: 303.1567; found: 303.1572. 
Rf (1:1 EtOAc:Pet ether) = 0.5. 
  
Chapter 6: Experimental   163 
Synthesis of 2.16 
 
 
 
To a solution of 2.14 (0.0917 g, 0.33 mmol) in anhydrous DCM (5.0 mL) was added 
diphenylchlorophosphate (140 µL, 0.68 mmol) and imidazole (0.0458 g, 0.67 mmol) at 0°C. 
The reaction was stirred overnight at room temperature before additional 
diphenylchlorophosphate (70 µL, 0.33 mmol) and imidazole (0.0215 g, 0.32 mmol) was 
added and stirred for a further six hours before quenching with sat. NH4Cl. The reaction was 
extracted with DCM, dried with MgSO4 and the solvent removed in vacuo. The product was 
purified by two flash columns (20 to 30% EtOAc:Pet ether followed by 20% EtOAc:Pet ether 
for the second column) to give 2.16 (0.1588 g, 95%) as an oil. 
 
1H NMR (500 MHz, CDCl3)  ppm 7.37-7.14 (m, 15H, Ph), 4.62 (d, J = 11.4 Hz, 1H, 
CH2Ph), 4.54 (dd, J = 4.0, 6.2 Hz, 1H, H1), 4.50 (d, J = 11.7 Hz, 1H, CH2Ph), 4.47-4.38 (m, 
1H, H4a), 4.24 (td, J = 6.4, 11.0 Hz, 1H, H4b), 3.94-3.88 (m, 1H, H3), 3.60-3.52 (m, 2H, 
H5/7), 3.38 (d, J = 11.4 Hz, 1H, H5/7), 3.32 (d, J = 11.0 Hz, 1H, H5/7), 1.96 (ddd, J = 3.9, 
7.7, 14.1 Hz, 1H, H2a), 1.85 (td, J = 5.7, 14.2 Hz, 1H, H2b), 1.16 (s, 3H, CH3), 0.71 (s, 3H, 
CH3). 
13C NMR (126 MHz, CDCl3)  ppm 150.8 (d, J = 7.4 Hz), 138.4, 130.1, 130.0 (d, J = 2.8 
Hz), 128.6, 128.1, 127.9, 126.2, 125.5, 120.3, 99.4, 77.4 (C5/7), 77.3 (C5/7), 74.0 (d, 3JPOCC 
= 7.9 Hz, C3), 72.4 (CH2Ph), 70.8 (d, 2JPOC = 6.5 Hz, C4), 36.8 (C2), 30.3 (C6), 23.2 (CH3), 
22.1 (CH3). 
31P NMR (121 MHz, CDCl3)  ppm −11.85. 
HRMS (ESI): calc. C28H33NaO7P [M+Na]+: 535.1856; found: 535.1870. 
Rf (30% EtOAc:Pet ether) = 0.4. 
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Synthesis of (3S)-2-deoxyE4P 
 
 
 
To compound 2.16 (0.1512 g, 0.30 mmol) in MeOH (8.0 mL) was added PtO2 (66 mg, 0.29 
mmol). After three vacuum/H2 cycles, to flush the flask with H2, the mixture was vigorously 
stirred at room temperature under hydrogen (balloon) overnight. The PtO2 was filtered 
through a small pad of celite and the pad washed with MeOH. The filtrate was then 
concentrated in vacuo, giving a clear colourless oil (98 mg). At this point, a small sample was 
taken for 1H NMR and mass spectrometry analysis which confirmed the deprotected 
intermediate 2.17. The clear colourless oil (82.7 mg) was dissolved in water (1.0 mL) and 
freshly activated Dowex-H+ resin was added to give a pH of 2. The solution was heated at 
40°C overnight and the Dowex-H+ resin removed by filtration. The pH of the filtrate was 
adjusted using 1 M NaOH to give a pH of 6.8 and final volume of 1.0 mL. The solution was 
frozen till use in enzyme assays. Standard enzyme assay conditions using E. coli DAH7P 
synthase (phe) determined the presence and yield of (3S)-2-deoxyE4P to be 22% over two 
steps. 
 
Intermediate 2.17: 
Crude 1H NMR (500 MHz, D2O)  ppm 4.64-4.60 (m, 1H, H1), 3.89-3.81 (m, 1H), 3.81-
3.74 (m, 1H), 3.71-3.62 (m, 1H), 3.57-3.40 (m, 5H), 1.68 (ap.t, J = 5.9 Hz, 2H, H2), 0.98 (s, 
3H, CH3), 0.59 (s, 3H, CH3). 
HRMS (ESI): calc. C9H17Na3O7P [M+Na]+: 337.0399; found: 337.0405. 
 
(3S)-2-DeoxyE4P: 
HRMS (ESI): calc. C4H8O6P [M−H]−: 183.0064; found: 183.0060. 
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6.3.2 Experimental for Chapter 3 
 
Synthesis of 3.1 
 
 
 
n-BuLi (1.50 M in hexane, 90 mL, 135 mmol) was slowly added to a solution of 
diisopropylamine (22 mL, 156 mmol) in THF (200 mL) at −78°C. The solution was then 
allowed to warm by removing the dry ice bath. After 45 minutes the solution was cooled to 
−78°C and a solution of 2.1 (10.0255 g, 62 mmol) in THF (5 mL) was added dropwise over 
10 minutes. The dry ice cooling bath was then replaced by an ice–salt bath (−15 to −20°C) 
and the solution was stirred at this temperature for one hour. The solution was cooled to 
−78°C and MeI (4.30 mL, 69 mmol) was added dropwise over five minutes. The solution was 
then stirred overnight as the temperature rises from −78°C to room temperature. The reaction 
mixture was quenched by the addition of glacial acetic acid (40 mL) in ether (40 mL) at 
−78°C and is then poured into a separating funnel containing ether (500 mL) and H2O (70 
mL). The organic layer is washed successively with sat. NaHCO3 (40 mL), sat. NaCl (40 mL) 
and the aqueous phases were extracted with ether (2x 200 mL). The combined ethereal 
solutions were dried using MgSO4 and the solvent removed in vacuo. Flash chromatography 
(30% EtOAc:Pet ether) gave 3.1 (7.2182 g, 66%) as a pair of inseparable diastereoisomers 
(ratio 6:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 4.25 (d, J = 3.7 Hz, 1H, H2), 3.77 (s, 3H, OCH3), 3.66 
(s, 3H, OCH3), 3.01 (qd, J = 3.7, 7.2 Hz, 1H, H3), 1.26 (d, J = 7.3 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3)  ppm 173.9, 173.7, 72.7 (C2), 53.0 (OMe), 52.3 (OMe), 43.4 
(C3), 13.3 (CH3). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 4.59 (d, J = 3.7 Hz, 1H, H2’), 3.78 (s, 3H, OCH3’), 3.70 
(s, 3H, OCH3’), 2.94-2.87 (m, 1H, H3’), 1.14 (d, J = 7.3 Hz, 3H, CH3’). 
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13C NMR (75 MHz, CDCl3)  ppm 173.9, 173.7, 71.7 (C2'), 53.1 (OMe’), 52.4 (OMe’), 43.2 
(C3’), 10.9 (CH3’). 
 
HRMS (ESI): calc. C7H12NaO5 [M+Na]+: 199.0582; found: 199.0575. 
Rf (30% EtOAc:Pet ether) = 0.2. 
 
Synthesis of 3.2 
 
 
 
To a solution of 3.1 (6.08 g, 35 mmol) in anhydrous DCM (100 mL) was added Ag2O 
(27.9918 g, 121 mmol), BnBr (14.5 mL, 121 mmol) and KI (0.20 equiv.). The mixture was 
stirred for three days before another portion of Ag2O (4.01 g, 17 mmol), BnBr (2.10 mL, 18 
mmol) and KI (0.20 equiv.) were added and stirred for a further two days. The mixture was 
filtered through celite and the filtrate washed successively with sat. NaHCO3, H2O, and sat. 
NaCl. The organic extracts were dried (MgSO4) and the solvent removed in vacuo. Flash 
chromatography (10 to 20% EtOAc:Pet ether) afforded 3.2 (7.22 g, 79%) as a pair of 
inseparable diastereoisomers (ratio 6:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.35-7.26 (m, 5H, Ph), 4.72 (d, J = 11.7 Hz, 1H, CH2Ph), 
4.48 (d, J = 11.7 Hz, 1H, CH2Ph), 4.15 (d, J = 7.0 Hz, 1H, H2), 3.75 (s, 3H, OCH3), 3.68 (s, 
3H, OCH3), 2.99 (q, J = 7.2 Hz, 1H, H3), 1.15 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 173.6, 171.6, 137.3, 128.6, 128.3, 128.2, 80.1 (C2), 73.3 
(CH2Ph), 52.2, 43.1 (C3), 13.1 (CH3). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.35-7.26 (m, 5H, Ph), 4.78 (d, J = 11.7 Hz, 1H, CH2Ph), 
4.45 (d, J = 11.7 Hz, 1H, CH2Ph), 4.37 (ap.d, J = 5.1 Hz, 1H, H2’), 3.77 (s, 3H, OCH3’), 3.63 
(s, 3H, OCH3’), 1.22 (d, J = 7.3 Hz, 3H, CH3’). 
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13C NMR (126 MHz, CDCl3)  ppm 173.6, 171.6, 137.3, 128.6, 128.3, 128.2, 78.7 (C2’), 
73.3 (CH2Ph), 52.2, 42.7 (C3’), 11.6 (CH3’). 
 
HRMS (ESI): calc. C14H19O5 [M+H]+: 267.1232; found: 267.1228. 
Rf (20% EtOAc:Pet ether) = 0.3. 
 
Synthesis of 3.3 
 
 
 
LiAlH4 (2.3152 g, 61 mmol) was suspended in THF (20 mL) and cooled to 0°C. Compound 
3.2 (5.36 g, 20 mmol) in THF (30 mL) was added dropwise to this suspension over 10 
minutes. The reaction was then heated to reflux for three hours. After cooling to 0°C the 
solution was quenched slowly by the addition of ice, followed by 3 M NaOH until 
effervescence had ceased and a white solid had formed. The mixture was filtered through 
celite, the celite washed with ether (3x 20 mL) and the filtrate was dried over MgSO4. The 
solvent was removed in vacuo and flash chromatography (1:1 to 2:1 EtOAc:Pet ether) gave 
3.3 (3.44 g, 81%). 
 
1H NMR (500 MHz, CDCl3)  ppm 7.39-7.29 (m, 5H, Ph), 4.67 (d, J = 11.4 Hz, 1H, CH2Ph), 
4.58 (d, J = 11.7 Hz, 1H, CH2Ph), 3.87 (dd, J = 3.7, 12.1 Hz, 1H, H1), 3.69-3.59 (m, 3H, H1, 
H4), 3.49-3.45 (m, 1H, H2), 3.22 (br. s, 2H, OH), 2.10-2.01 (m, 1H, H3), 0.95 (d, J = 7.0 Hz, 
3H, CH3). 
13C NMR (126 MHz, CDCl3 ppm 138.0, 128.8, 128.2, 128.1, 83.3 (C2), 72.5 (CH2Ph), 
65.8 (C4), 61.6 (C1), 37.1 (C3), 14.2 (CH3). 
HRMS (ESI): calc. C12H19O3 [M+H]+: 211.1334; found: 211.1344. 
Rf (2:1 EtOAc:Pet ether) = 0.3. 
  
Chapter 6: Experimental   168 
Synthesis of 3.4 
 
 
 
To a solution of 3.3 (1.0104 g, 4.80 mmol) in anhydrous DCM (20 mL) was added 
diphenylchlorophosphate (900 µL, 4.4 mmol) and imidazole (1.2983 g, 19 mmol) at 0°C. The 
solution was allowed to warm slowly to room temperature. After stirring overnight, the 
solution was diluted with DCM, quenched with water and washed with sat. NaHCO3 and sat. 
NaCl. The combined aqueous extracts were extracted with DCM. The combined organic 
extracts were dried over MgSO4 and the solvent removed in vacuo. Flash chromatography 
(30 to 45% EtOAc:Pet ether) gave 3.4 (0.4599, 22%) as a pair of inseparable 
diastereoisomers (ratio 3:1), the diphosphorylated compound 3.6 (0.6681 g, 21%, Rf (1:1 
EtOAc:Pet ether) = 0.6) and 3.3 (0.2967 g, 30% recovered). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.38-7.15 (m, 15H, Ph), 4.57-4.46 (m, 2H, CH2Ph), 4.43-
4.27 (m, 2H, H4), 3.81 (dd, J = 3.3, 12.1 Hz, 1H, H1a), 3.67-3.61 (m, 1H, H1b), 3.41 (td, J = 
3.8, 7.9 Hz, 1H, H2), 2.50 (br. s, 1H, OH), 2.24-2.16 (m, 1H, H3), 1.00 (d, J = 7.0 Hz, 3H, 
CH3). 
13C NMR (75 MHz, CDCl3)  ppm 150.8 (m), 138.4, 130.1, 128.8, 128.1, 125.7, 120.3 (d, J 
= 4.4 Hz, Ph), 80.4 (C2), 72.7 (CH2Ph), 71.5 (d, 2JPOC = 6.6 Hz, C4), 61.2 (C1), 35.6 (d, 
3JPOCC = 7.6 Hz, C3), 13.5 (CH3). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.38-7.15 (m, 15H, Ph), 4.69 (ap.d, J = 11.0 Hz, 1H, 
CH2Ph), 4.48-4.44 (m, 1H, CH2Ph), 4.42-4.28 (m, 2H, H4’), 3.66-3.52 (m, 3H, H1’, H2’), 
2.50 (br. s, 1H, OH), 2.02-1.92 (m, 1H, H3’), 0.91 (d, J = 7.0 Hz, 3H, CH3’). 
13C NMR (75 MHz, CDCl3)  ppm 150.8 (m), 137.9, 130.1, 128.8, 128.1, 125.7, 120.3 (d, J 
= 4.4 Hz), 81.5 (d, J = 7.2 Hz), 73.1 (CH2Ph’), 69.1 (d, 2JPOC = 6.1 Hz, C4’), 65.6 (C1’), 36.9 
(C3’), 14.0 (CH3’). 
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31P NMR (121 MHz, CDCl3 ppm −10.42, −10.64. 
HRMS (ESI): calc. C24H28O6P [M+H]+: 443.1624; found: 443.1626. 
Rf (1:1 EtOAc:Pet ether) = 0.3. 
 
Synthesis of 3.7 
 
 
 
3.4 (1.0328 g, 2.35 mmol) was dissolved in DCM (40 mL) and freshly prepared DMP 
(2.4761 g, 5.84 mmol) was added. The mixture was stirred overnight at room temperature 
before an additional portion of DMP (0.4970 g, 1.17 mmol) was added. After a further five 
hours of stirring, sat. Na2S2O3 and sat. NaHCO3 were added and stirred till the solution was 
clear. The aqueous layer was extracted with DCM and the combined organic extracts were 
dried over MgSO4. Removal of the solvent in vacuo, followed by flash chromatography (30% 
EtOAc:Pet ether) gave 3.7 (0.8290 g, 81%), a clear colourless oil, as a pair of inseparable 
diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 9.60 (d, J = 2.6 Hz, 1H, H1), 7.35-7.17 (m, 10H, Ph), 
4.63 (d, J = 11.4 Hz, 1H, CH2Ph), 4.48 (d, J = 11.7 Hz, 1H, CH2Ph), 4.35-4.27 (m, 1H, H4), 
3.63 (dd, J = 2.6, 5.9 Hz, 1H, H2), 2.35 (spt, J = 6.4 Hz, 1H, H3), 1.00 (d, J = 7.3 Hz, 3H, 
CH3). 
13C NMR (126 MHz, CDCl3)  ppm 203.4 (C1), 150.7, 137.2, 130.1, 128.8, 128.7, 128.4, 
128.3, 128.2, 125.7, 120.3, 84.4 (C2), 73.5 (CH2Ph), 69.4 (d, 2JPOC = 6.2 Hz, C4), 36.4 (d, 
3JPOCC = 8.1 Hz, C3), 13.1 (CH3). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 9.69 (d, J = 1.8 Hz, 1H, H1’), 7.35-7.17 (m, 15H, Ph), 
4.68 (d, J = 11.4 Hz, 1H, CH2Ph), 4.54-4.46 (m, 1H, H4a’), 4.49 (d, J = 11.4 Hz, 1H, 
CH2Ph), 4.35-4.27 (m, 1H, H4b’), 3.86-3.82 (m, 1H, H2’), 2.75-2.68 (m, 1H, H3’), 1.07 (d, J 
= 7.3 Hz, 3H, CH3’). 
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13C NMR (126 MHz, CDCl3)  ppm 203.0 (C1’), 150.7, 137.5, 130.1, 128.8, 128.7, 128.4, 
128.3, 128.2, 125.7, 120.3, 78.2 (d, J = 7.9 Hz, C2’), 72.7 (CH2Ph), 67.6 (d, 2JPOC = 6.4 Hz, 
C4’), 47.8 (C3’), 10.6 (CH3’). 
 
31P NMR (121 MHz, CDCl3 ppm −11.68, −12.14. 
HRMS (ESI): calc. C24H26O6P [M+H]+: 441.1467; found: 441.1481. 
Rf (30% EtOAc:Pet ether) = 0.2. 
 
Synthesis of 3.8 
 
 
 
To 3.7 (1.5379 g, 3.49 mmol) in MeOH (50 mL) was added trimethyl orthoformate (3.90 mL, 
35.6 mmol) and conc. H2SO4 (40 µL, 0.75 mmol). After stirring overnight, the mixture was 
transferred into a separating funnel containing sat. NaHCO3 and Et2O. The aqueous layer was 
washed with Et2O (3x). The combined organic extracts were washed with sat. NaCl, dried 
(MgSO4) and the solvent removed in vacuo. Flash chromatography using deactivated silica 
(20% EtOAc:Pet ether) gave 3.8 (1.4817 g, 87%), a clear colourless oil, as a pair of 
inseparable diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.34-7.16 (m, 15H, Ph), 4.77 (d, J = 11.4 Hz, 1H, 
CH2Ph), 4.51 (d, J = 11.4 Hz, 1H, CH2Ph), 4.44-4.39 (m, 1H, H4a), 4.37-4.34 (m, 1H, H1), 
4.23 (td, J = 6.6, 9.9 Hz, 1H, H4b), 3.44 (s, 3H, OCH3), 3.40 (s, 3H, OCH3), 3.39-3.36 (m, 
1H, H2), 2.33-2.23 (m, 1H, H3), 1.02 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 150.9, 138.8, 130.0, 128.5, 128.1, 127.8, 125.5, 120.3, 
106.5 (C1), 81.2 (C2), 74.6 (CH2Ph), 71.2 (d, 2JPOC = 6.6 Hz, C4), 56.2 (OCH3), 55.8 
(OCH3), 35.8 (d, 3JPOCC = 7.8 Hz, C3), 14.3 (CH3). 
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Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.34-7.16 (m, 15H, Ph), 4.65 (d, J = 11.4 Hz, 1H, 
CH2Ph), 4.54-4.48 (m, 1H, H4a’), 4.46 (d, J = 11.4 Hz, 1H, CH2Ph), 4.37-4.34 (m, 1H, H1’), 
4.34-4.28 (m, 1H, H4b’), 3.71-3.66 (m, 1H, H2’), 3.34 (s, 3H, OCH3’), 3.32 (s, 3H, OCH3’), 
2.12 (dq, J = 6.6, 12.9 Hz, 1H, H3’), 0.92 (d, J = 7.0 Hz, 3H, CH3’). 
13C NMR (126 MHz, CDCl3)  ppm 150.9, 138.5, 130.0, 128.5, 128.1, 127.8, 125.5, 120.3, 
106.1 (C1’), 79.2 (d, J = 7.9 Hz, C2’), 72.8 (CH2Ph), 69.7 (d, 2JPOC = 6.6 Hz, C4’), 55.6 
(OCH3’), 54.9 (OCH3’), 38.2 (C3’), 10.2 (CH3’). 
 
31P NMR (121 MHz, CDCl3 ppm −11.70, −11.97. 
HRMS (ESI): calc. C26H32O7P [M+H]+: 487.1886; found: 487.1901. 
Rf (30% EtOAc:Pet ether) = 0.3. 
 
Synthesis of 3-methylE4P 
 
 
 
To the protected analogue 3.8 (1.4645 g, 3.01 mmol) in MeOH (40 mL) was added PtO2 
(0.2946 g, 1.29 mmol). After three vacuum/H2 cycles, to flush the flask with H2, the mixture 
was vigorously stirred at room temperature under hydrogen (balloon) for three days. The 
PtO2 was filtered through a small pad of celite and the pad washed with MeOH (3x). The 
filtrate was then concentrated in vacuo to give intermediate 3.9 as a clear colourless oil. The 
oil was dissolved in H2O and heated overnight at 40°C to afford 3-methylE4P that was used 
in enzyme assays without further purification. 
 
Intermediate 3.9: 
HRMS (ESI): calc. C7H16O7P [M−H]−: 243.0634; found: 243.0623. 
 
3-MethylE4P: 
HRMS (ESI): calc. C5H10O6P [M−H]−: 197.0215; found: 197.0223. 
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Synthesis of 3.11 
 
 
To a suspension of DL-malic acid (5.0557 g, 37.7 mmol) in dry THF (50 mL) containing 4 Å 
molecular sieves was added, dropwise via syringe, freshly distilled cyclohexanone (12 mL, 
115.9 mmol) and BF3.Et2O (10 mL, 78.9 mmol) at 0°C. The ice bath was then removed and 
the mixture was stirred at room temperature overnight. The reaction mixture was quenched 
with water and the molecular sieves were filtered off. The filtrate was diluted with ether and 
washed with sat. NaCl. The combined aqueous phases were extracted with ether (3x) and the 
combined organic phases dried over anhydrous MgSO4. Removal of the solvent in vacuo 
followed by flash chromatography (10 to 30% EtOAc:Pet ether) gave 3.11 (5.31 g, 66%), 
with spectral data in accordance with the literature.126,127 
 
1H NMR (500 MHz, CDCl3)  ppm 4.72 (dd, J = 3.9, 6.4 Hz, 1H, H2), 3.00, 2.85 (d of ABq, 
J = 3.9, 6.6, 17.2 Hz, 1H, H3), 1.93-1.80 (m, 2H, cyclic CH2’s), 1.80-1.57 (m, 6H, cyclic 
CH2’s), 1.55-1.46 (m, 1H, cyclic CH2’s), 1.46-1.33 (m, 1H, cyclic CH2’s). 
13C NMR (126 MHz, CDCl3)  ppm 174.5, 172.2, 112.5, 70.2, 36.4, 36.3, 35.6, 24.7, 23.3, 
23.2. 
HRMS (ESI): calc. C10H14NaO5 [M+Na]+: 237.0733; found: 237.0737. 
Rf (30% EtOAc:Pet ether) = 0.3. 
 
Synthesis of 3.12 
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To a solution of 3.11 (5.0023 g, 23.4 mmol) in anhydrous DMF (20 mL) was added K2CO3 
(4.8493 g, 35.1 mmol) and MeI (2.90 mL, 46.6 mmol) and stirred at room temperature 
overnight. K2CO3 (1.5169 g, 11 mmol) and MeI (0.80 mL, 12.8 mmol) were added and the 
solution was stirred for a further 24 hours before quenching with sat. NaHCO3. The mixture 
was diluted with EtOAc and the organic layer washed with H2O (3x). The combined aqueous 
phases were extracted with EtOAc (3x) and the combined organic phases dried over 
anhydrous MgSO4. Removal of the solvent in vacuo followed by flash chromatography (10% 
EtOAc:Pet ether) gave 3.12 (5.0734 g, 95%). 
 
1H NMR (500 MHz, CDCl3)  ppm 4.70 (dd, J = 4.0, 6.2 Hz, 1H, H1), 3.71 (s, 3H, OCH3), 
2.91, 2.78 (ABq x2, J = 3.7, 7.0, 16.9 Hz, 1H, H3), 1.92-1.77 (m, 2H, cyclic CH2’s), 1.77-
1.55 (m, 6H, cyclic CH2’s), 1.53-1.43 (m, 1H, cyclic CH2’s), 1.42-1.32 (m, 1H, cyclic 
CH2’s). 
13C NMR (126 MHz, CDCl3)  ppm 172.3, 169.8, 112.2, 70.4, 52.3, 36.4, 36.4, 35.5, 24.6, 
23.2, 23.1. 
HRMS (ESI): calc. C11H16NaO5 [M+Na]+: 251.0890; found: 251.0902. 
Rf (20% EtOAc:Pet ether) = 0.4. 
 
Synthesis of 3.22 
 
 
 
Diester 2.1 (5.0145 g, 30.9 mmol) was dissolved in THF (50 mL) at 0°C. BH3.SMe2 (4.0 mL, 
10 M in Me2S) was added dropwise as gas evolved. The solution was stirred at 0°C for 30 
minutes before the addition of NaBH4 (41.1 mg, 1.1 mmol). The ice bath was removed and 
the solution was stirred for one hour at room temperature before quenching with EtOH (2.0 
mL). The solution was concentrated in vacuo and flash chromatography (2:1 EtOAc:Pet ether 
to 5% MeOH:EtOAc) gave 3.22 (3.91 g, 94%) as a clear oil, with spectral data in accordance 
with the literature.131 
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1H NMR (500 MHz, CDCl3)  ppm 4.18-4.09 (m, 1H, H3), 3.71 (s, 3H, OCH3), 3.67 (dd, J = 
3.3, 11.4 Hz, 1H, H4a), 3.52 (dd, J = 6.4, 11.6 Hz, 1H, H4b), 3.09 (br. s, 2H, OH), 2.59-2.47 
(m, 2H, H2). 
13C NMR (126 MHz, CDCl3)  ppm 173.3, 68.7, 65.9, 52.2, 37.6. 
HRMS (ESI): calc. C5H10NaO4 [M+Na]+: 157.0471; found: 157.0475. 
Rf (5% MeOH:EtOAc) = 0.6. 
 
Synthesis of 3.29 
 
 
 
A mixture of 3.22 (0.8647 g, 6.45 mmol), tert-butyldiphenylchlorosilane (TBDPSCl, 2.10 
mL, 8.08 mmol) and imidazole (0.5712 g, 8.39 mmol) in DCM (100 mL) was stirred at room 
temperature for 2.5 hours. The reaction was then quenched with sat. NH4Cl (30 mL) and 
transferred to a separating funnel. The organic layer was washed with water and sat. NaCl, 
dried over MgSO4 and the solvent removed in vacuo. Flash chromatography (20% EtOAc:Pet 
ether) gave 3.29 (2.1522 g, 90%) as a clear oil. 
 
1H NMR (500 MHz, CDCl3)  ppm 7.70-7.62 (m, 4H, Ph), 7.48-7.35 (m, 6H, Ph), 4.21-4.14 
(m, 1H, H3), 3.70 (s, 3H, OCH3), 3.68-3.61 (m, 2H, H4), 2.61-2.50 (m, 2H, H2), 1.07 (s, 9H, 
SiC(CH3)3). 
13C NMR (126 MHz, CDCl3)  ppm 172.7 (C=O), 135.8, 133.2, 130.1, 128.0 (Ph), 68.9 
(C3), 67.1 (C4), 52.0 (OCH3), 38.1 (C2), 27.1 (SiC(CH3)3), 19.5 (SiC(CH3)3). 
HRMS (ESI): calc. C21H29O4Si [M+H]+: 373.1835; found: 373.1837. 
Rf (20% EtOAc:Pet ether) = 0.2. 
 
Synthesis of 3.31 
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A mixture of 3.3 (0.1065 g, 0.51 mmol), triisopropylsilyl chloride (TIPSCl, 115 µL, 0.54 
mmol) and imidazole (67 mg, 0.98 mmol) in DMF (5.0 mL) was stirred at room temperature 
for 4.5 hours. The reaction was then quenched with sat. NH4Cl (2.0 mL) and H2O (5.0 mL). 
The solution was then transferred into a separating funnel containing ether (20 mL) and H2O 
(20 mL). The organic layer was washed with H2O (2x 30 mL) and the combined aqueous 
extracts were washed with Et2O (2x 20 mL). The combined organic extracts were then dried 
over MgSO4 and the solvent was removed in vacuo. Flash chromatography (15% EtOAc:Pet 
ether) gave 3.31 (95.4 mg, 51%) as a colourless oil, the disilylated compound 3.33 (53.9 mg, 
20%, Rf (1:9 EtOAc:Pet ether) = 0.58) and starting material 3.4 (30 mg, 28% recovered). 
Compound 3.31 was isolated as pair of inseparable diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.37-7.26 (m, 5H, Ph), 4.82-4.73 (m, 1H, CH2Ph), 4.64-
4.54 (m, 1H, CH2Ph), 3.82-3.77 (m, 1H, H1a), 3.80-3.74 (m, 1H, H4a), 3.73-3.68 (m, 1H, 
H4b), 3.67-3.60 (m, 1H, H1b), 3.59-3.54 (m, 1H, H2), 2.10-2.02 (m, 1H, H3), 1.12-1.05 (m, 
21H, SiCH(CH3)2, SiCH(CH3)2), 0.98 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 138.8, 128.7, 128.2, 128.0, 127.9, 81.2 (C2), 72.3 
(CH2Ph), 65.3 (C4), 61.8 (C1), 37.9 (C3), 18.2 (SiCH(CH3)2), 13.4 (CH3), 12.2 
(SiCH(CH3)2). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 7.37-7.26 (m, 5H, Ph), 4.82-4.73 (m, 1H, CH2Ph), 4.64-
4.54 (m, 1H, CH2Ph), 3.93-3.88 (m, 1H, H1a’), 3.85-3.80 (m, 1H, H1b’), 3.70-3.63 (m, 1H, 
H4a’), 3.62-3.57 (m, 1H, H4b’), 3.48 (q, J = 5.1 Hz, 1H, H2’), 2.03-1.97 (m, 1H, H3’), 1.12-
1.05 (m, 21H, SiCH(CH3)2, SiCH(CH3)2), 0.99 (d, J = 7.0 Hz, 1H, CH3’). 
13C NMR (126 MHz, CDCl3ppm 138.8, 128.7, 128.2, 128.0, 127.9, 84.9 (C2’), 73.3 
(CH2Ph), 66.2 (C4’), 64.4 (C1’), 36.9 (C3’), 18.2 (SiCH(CH3)2), 14.2 (CH3’), 12.2 
(SiCH(CH3)2). 
 
HRMS (ESI): calc. C21H39O3Si [M+H]+: 367.2668; found: 367.2655. 
Rf (1:9 EtOAc:Pet ether) = 0.1. 
 
Synthesis of 3.34 
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To a solution of 3.31 (0.3618 g, 0.99 mmol) in anhydrous DCM (7.0 mL) was added diethyl 
chlorophosphate (360 µl, 2.49 mmol) and imidazole (0.1680 g, 2.48 mmol) at 0°C. The 
solution was allowed to warm slowly to room temperature. After stirring overnight, 
additional diethyl chlorophosphate (140 µL, 0.97 mmol) was added. The solution was stirred 
overnight before it was diluted with DCM, quenched with H2O and washed with sat. 
NaHCO3 and sat. NaCl. The combined aqueous extracts were extracted with DCM (3x). The 
combined organic extracts were dried over MgSO4 and the solvent removed in vacuo. Flash 
chromatography (20 to 50% EtOAc:Pet ether) gave 3.34 (0.3548 g, 72%) as a pair of 
inseparable diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 7.37-7.24 (m, 5H, Ph), 4.79-4.71 (m, 1H, CH2Ph), 4.61-
4.50 (m, 1H, CH2Ph), 4.30 (ddd, J = 2.8, 5.6, 11.1 Hz, 1H, H1a), 4.17-4.14 (m, 1H, H1b), 
4.14-4.06 (m, 4H, OCH2CH3), 3.73 (ap.dd, J = 5.3, 1.3 Hz, 2H, H4), 3.68-3.62 (m, 1H, H2), 
2.03-1.96 (m, 1H, H3), 1.31 (t, J = 7.3 Hz, 6H, OCH2CH3), 1.09-1.04 (m, 21H, SiCH(CH3)2, 
SiCH(CH3)2), 0.98 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3ppm 138.8, 128.5, 128.0, 127.7, 79.6 (d, 3JPOCC = 7.4 Hz, 
C2), 72.9 (CH2Ph), 68.2 (d, 2JPOC = 6.5 Hz, C1), 65.1 (C4), 63.9 (m, OCH2CH3), 38.1 (C3), 
18.3 (SiCH(CH3)2), 16.4 (m, OCH2CH3), 13.6 (CH3), 12.2 (SiCH(CH3)2). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 7.37-7.24 (m, 5H, Ph), 4.79-4.72 (m, 1H, CH2Ph), 4.61-
4.51 (m, 1H, CH2Ph), 4.17-4.06 (overlap. m, 6H, OCH2CH3, H1’), 3.92-3.87 (m, 1H, H4a’), 
3.83-3.78 (m, 1H, H4b’), 3.46-3.41 (m, 1H, H2’), 2.20-2.11 (m, 1H, H3’), 1.31 (t, J = 7.3 Hz, 
6H, OCH2CH3), 1.09-1.04 (overlap. m, 24H, SiCH(CH3)2, SiCH(CH3)2, CH3’). 
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13C NMR (126 MHz, CDCl3ppm 139.0, 128.5, 128.0, 127.7, 81.4 (C2’), 73.1 (CH2Ph), 
69.8 (d, 2JPOC = 6.0 Hz, C1’), 64.2 (C4’), 63.9 (m, OCH2CH3), 36.9 (C3’), 18.3 
(SiCH(CH3)2), 16.4 (m, OCH2CH3), 13.9 (CH3’), 12.2 (SiCH(CH3)2). 
31P NMR (121 MHz, CDCl3 ppm −0.33 (br. s). 
HRMS (ESI): calc. C25H48O6SiP [M+H]+: 503.2958; found: 503.2937. 
Rf (1:1 EtOAc:Pet ether) = 0.4. 
 
Synthesis of 3.35 
 
 
 
A solution of 3.34 (0.0918 g, 0.18 mmol) in THF (2.5 mL) was treated with tetra-n-
butylammonium fluoride (TBAF, 280 µL, 1 M solution in THF, 0.28 mmol). After stirring at 
room temperature for one hour the reaction mixture was quenched with H2O and the aqueous 
mixture extracted with Et2O (3x). The combined organic extracts were washed with sat. 
NaCl, dried (MgSO4) and the solvent removed in vacuo. Flash chromatography (2:1 
EtOAc:Pet ether to 100% EtOAc) gave 3.35 (56.7 mg, 90%) as a pair of inseparable 
diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 7.45-7.20 (m, 5H, Ph), 4.82-4.73 (m, 1H, CH2Ph), 4.65-
4.52 (m, 1H, CH2Ph), 4.36-4.30 (m, 1H, H1a), 4.17-4.06 (overlap. m, 5H, OCH2CH3, H1b), 
3.83 (dd, J = 3.5, 11.9 Hz, 1H, H4a), 3.69-3.64 (m, 1H, H4b), 3.63-3.57 (m, 1H, H2), 2.06-
1.99 (m, 1H, H3), 1.36-1.30 (m, 6H, OCH2CH3), 0.96 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3ppm 137.9, 128.8, 128.3, 128.2, 128.1, 128.0, 82.0 (d, 3JPOCC 
= 7.0 Hz, C2), 73.0 (CH2Ph), 67.3 (d, 2JPOC = 6.0 Hz, C1), 64.1 (m, OCH2CH3), 61.4 (C4), 
36.8 (C3), 16.4 (m, OCH2CH3), 14.0 (CH3). 
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Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 7.45-7.20 (m, 5H, Ph), 4.82-4.73 (m, 1H, CH2Ph), 4.65-
4.52 (m, 1H, CH2Ph), 4.17-4.06 (overlap. m, 6H, OCH2CH3, H1’), 3.70-3.57 (m, 2H, H4’), 
3.52-3.46 (m, 1H, H2’), 2.25-2.16 (m, 1H, H3’), 1.36-1.30 (m, 6H, OCH2CH3), 1.03 (d, J = 
7.0 Hz, 3H, CH3’). 
13C NMR (126 MHz, CDCl3ppm 138.4, 128.8, 128.3, 128.2, 128.1, 128.0, 80.5 (C2’), 
72.7 (CH2Ph), 69.6 (d, 2JPOC = 6.0 Hz, C1’), 66.0 (C4’), 64.1 (m, OCH2CH3), 35.5 (d, J = 7.4 
Hz, C3’), 16.4 (m, OCH2CH3), 13.4 (CH3’). 
 
Rf (2:1 EtOAc:Pet ether) = 0.2. 
 
Synthesis of 3.36 
 
 
 
Compound 3.35 (0.1877 g, 0.54 mmol) was dissolved in DCM (10 mL) and freshly prepared 
DMP (0.5754 g, 1.36 mmol) was added. The mixture was stirred for 2.5 hours, after which 
DCM, sat. NaHCO3 and sat. NaS2O3 were added and the mixture was stirred till the solution 
was clear. The mixture was transferred to a separating funnel and the aqueous layer extracted 
with DCM (3x). The combined organic extracts were washed with sat. NaCl, dried (MgSO4) 
and the solvent removed in vacuo. Flash chromatography (2:1 EtOAc:Pet ether) gave 
aldehyde 3.36 (0.1347 g, 72%) as a pair of inseparable diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 9.74 (d, J = 1.5 Hz, 1H, H1), 7.38-7.26 (m, 5H, Ph), 
4.79-4.69 (m, 1H, CH2Ph), 4.63-4.53 (m, 1H, CH2Ph), 4.30 (ddd, J = 4.0, 6.3, 10.9 Hz, 1H, 
H4a), 4.19-4.01 (overlap. m, 5H, OCH2CH3, H4b), 3.88-3.83 (m, 1H, H3), 2.76 (quin, J = 6.6 
Hz, 1H, H2), 1.36-1.28 (m, 6H, OCH2CH3), 1.13 (d, J = 7.3 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3 ppm 203.2 (C1), 137.7, 130.0, 128.7, 128.6, 128.5, 128.3, 
128.1, 128.0, 127.8, 78.2 (d, 3JPOCC = 7.9 Hz, C3), 72.6 (CH2Ph), 66.0 (d, 2JPOC = 6.0 Hz, 
C4), 64.3 (m, OCH2CH3), 47.9 (C2), 16.3 (m, OCH2CH3), 10.5 (CH3). 
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Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 9.70 (d, J = 1.8 Hz, 1H, H1’), 7.38-7.26 (m, 5H, Ph), 
4.79-4.69 (m, 1H, CH2Ph), 4.63-4.53 (m, 1H, CH2Ph), 4.19-4.01 (overlap. m, 5H, OCH2CH3, 
H4’), 3.69 (dd, J = 2.2, 5.1 Hz, 1H, H3’), 2.88 (quin, J = 7.1 Hz, 1H, H2’), 1.37-1.28 (m, 6H, 
OCH2CH3), 1.06 (d, J = 7.3 Hz, 3H, CH3’). 
13C NMR (126 MHz, CDCl3 ppm 203.2 (C1’), 137.7, 130.0, 128.7, 128.6, 128.5, 128.3, 
128.1, 128.0, 127.8, 79.5 (d, 3JPOCC = 7.9 Hz, C3’), 73.4 (CH2Ph), 66.6 (d, 2JPOC = 6.0 Hz, 
C4’), 64.3 (m, OCH2CH3), 41.7 (C2’), 16.3 (m, OCH2CH3), 13.2 (CH3’). 
 
HRMS (ESI): calc. C16H26O6P [M+H]+: 345.1467; found: 345.1475. 
Rf (2:1 EtOAc:Pet ether) = 0.3. 
 
Synthesis of 3.37 
 
 
 
To 3.36 (0.1341 g, 0.39 mmol) in MeOH (8.0 mL) was added trimethyl orthoformate (430 
µL, 3.93 mmol) and conc. H2SO4 (10 µL, 0.19 mmol). After stirring overnight, the mixture 
was transferred to a separating funnel containing sat. NaHCO3 and Et2O. The aqueous layer 
was extracted with Et2O (3x). The combined organic extracts were washed with sat. NaCl, 
dried (MgSO4) and the solvent removed in vacuo. Flash chromatography using deactivated 
silica, (1:1 EtOAc:Pet ether) gave 3.37 (0.1177 g. 77%) as a pair of inseparable 
diastereoisomers (ratio 2:1). 
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Major diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 7.37-7.26 (m, 5H, Ph), 4.72 (d, J = 11.7 Hz, 1H, CH2Ph), 
4.52 (d, J = 11.7 Hz, 1H, CH2Ph), 4.38 (ap.t, J = 5.9 Hz, 1H, H1), 4.28 (ddd, J = 3.1, 5.7, 
11.0 Hz, 1H, H4a), 4.14-4.07 (overlap. m, 5H, OCH2CH3, H4b), 3.69-3.62 (m, 1H, H3), 3.36 
(s, 3H, OMe), 3.33 (s, 3H, OMe), 2.18-2.10 (m, 1H, H2), 1.32 (t, J = 7.0 Hz, 6H, OCH2CH3), 
0.94 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3 ppm 138.6, 128.5, 128.0, 127.8, 127.7, 106.2 (C1), 79.3 (d, 
3JPOCC = 7.4 Hz, C3), 72.7 (CH2Ph), 67.9 (d, 2JPOC = 6.0 Hz, C4), 63.9 (m, OCH2CH3), 55.6 
(OMe), 55.0 (OMe), 38.2 (C2), 16.4 (m, OCH2CH3), 10.0 (CH3). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3 ppm 7.37-7.26 (m, 5H, Ph), 4.80 (d, J = 11.4 Hz, 1H, CH2Ph), 
4.58-4.50 (m, 1H, CH2Ph), 4.38 (ap.t, J = 5.9 Hz, 1H, H1’), 4.19-4.05 (overlap. m, 5H, 
OCH2CH3, H4a’), 3.98 (td, J = 6.3, 9.8 Hz, 1H, H4b’), 3.47 (s, 3H, OMe), 3.43 (s, 3H, OMe), 
3.41-3.37 (m, 1H, H3’), 2.26-2.18 (m, 1H, H2’), 1.32 (t, J = 7.0 Hz, 6H, OCH2CH3), 1.04 (d, 
J = 7.0 Hz, 3H, CH3). 
13C NMR (126 MHz, CDCl3 ppm 138.9, 128.5, 128.0, 127.8, 127.7, 106.5 (C1’), 81.3 
(C3’), 74.6 (CH2Ph), 69.4 (d, 2JPOC = 6.0 Hz, C4’), 63.9 (m, OCH2CH3), 56.2 (OMe), 55.7 
(OMe), 35.8 (d, J = 7.9 Hz, C2), 16.4 (m, OCH2CH3), 14.3 (CH3’). 
 
31P NMR (121 MHz, CDCl3 ppm −0.76, −0.85. 
HRMS (ESI): calc. C18H32O7P [M+H]+: 391.1886; found: 391.1883. 
Rf (1:1 EtOAc:Pet ether) = 0.1. 
 
Synthesis of 3.38 
 
 
 
To the protected analogue 3.37 (0.1125 g, 0.29 mmol) in MeOH (8.0 mL) was added PtO2 
(0.0676 g, 0.30 mmol). After three vacuum/H2 cycles, to flush the flask with H2, the mixture 
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was vigorously stirred at room temperature under hydrogen (balloon) for three days. The 
PtO2 was filtered through a small pad of celite and the pad washed with MeOH (3x). The 
filtrate was concentrate in vacuo followed by flash chromatography (2:1 EtOAc:Pet ether) 
gave 3.38 (82.5 mg, 95%) as a pair of inseparable diastereoisomers (ratio 2:1). 
 
Major diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 4.37 (d, J = 5.1 Hz, 1H, H1), 4.19 (ddd, J = 2.9, 5.5, 11.0 
Hz, 1H, H4a), 4.15-4.07 (m, 4H, OCH2CH3), 4.00 (ap.td, J = 5.6, 11.1 Hz, 1H, H4b), 3.40-
3.37 (overlap. m, 7H, OMe, H3), 2.10-2.04 (m, 1H, H2), 1.73 (t, J = 7.2 Hz, 6H, OCH2CH3), 
0.91 (d, J = 7.3 Hz, 1H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 106.3, 79.8, 67.6, 64.0, 55.7, 55.0, 38.1, 16.4, 10.0 
(CH3). 
 
Minor diastereoisomer: 
1H NMR (500 MHz, CDCl3)  ppm 4.69 (d, J = 5.5 Hz, 1H, H1’), 4.55-4.47 (overlap. m, 5H, 
H4a’, OCH2CH3), 4.37-4.31 (m, 1H, H4b’), 3.84 (s, 3H, OMe), 3.80 (s, 3H, OMe), 3.62-3.53 
(m, 1H, H3’), 2.60-2.52 (m, 1H, H2’), 1.73 (t, J = 7.2 Hz, 6H, OCH2CH3), 1.42 (d, J = 7.0 
Hz, 1H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 106.4, 81.7, 76.6, 64.0, 55.7, 55.0, 35.8, 16.4, 14.3 
(CH3). 
 
31P NMR (121 MHz, CDCl3 ppm −0.77, −0.83. 
Rf (2:1 EtOAc:Pet ether) = 0.3. 
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6.3.3 Experimental for Chapter 4 
 
Preparation of E4P90 
 
 
 
D-Glucose 6-phosphate (0.34 g, 1.0 mmol) was moistened with 2.0 mL of H2O and 5.0 mL of 
glacial acetic acid was added to the reaction mixture. A 0.17 mL aliquot of 3 M H2SO4 and 
245 mL of glacial acetic acid were then added to the reaction mixture. A mixture containing 3 
M H2SO4 (0.60 mL), glacial acetic acid (40 mL), and lead tetraacetate (1.70 mmol) was 
prepared before use and added drop wise to the D-glucose 6-phosphate solution over 30 
minutes with vigorous stirring. The reaction mixture was then filtered through a celite pad. 
The celite was washed with 100 mL of H2O (3x) and the filtrate was concentrated until the 
volume of the solution reached approximately 20 mL. The concentrate was then extracted 
continuously with ether for 15 hours and the volume of the aqueous solution was reduced in 
vacuo to give a final volume of 25 mL. This solution was stored in the refrigerator or frozen 
and stored at −20ºC. Standard enzyme assay conditions determined the yield of E4P to be 
48%. 
 
Synthesis of 4.1 
 
 
 
Following the procedure by Tsuji et al.148: A mixture of D-glucose (30.13 g, 0.17 mol), Ac2O 
(100 mL), NaOAc (5.2104 g, 0.06 mol) and toluene (2.50 mL) was refluxed with stirring for 
three hours. H2O (100 mL) was added to this solution and the mixture was stirred and 
neutralised with a 3% (w/v) NaOH solution. The organic layer was concentrated to give 
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crude crystals. Recrystallisation from EtOH gave pure 4.1 (28.5932 g, 44%) as a white solid 
with spectral data in accordance with the literature.196 
 
1H NMR (300MHz, CDCl3)  ppm 5.70 (d, J = 7.8 Hz, 1H), 5.29-5.19 (m, 1H), 5.17-5.06 
(m, 2H), 4.28 (dd, J = 4.4, 12.7 Hz, 1H), 4.14-4.06 (m, 1H), 3.88-3.78 (m, 1H), 2.10 (s, 3H), 
2.07 (s, 3H), 2.02 (s, 6H), 2.00 (s, 3H). 
HRMS (ESI): calc. C16H22O11Na [M+Na]+: 413.1054; found: 413.1061. 
M.p. 126–128°C; lit.196 131°C.  
 
Synthesis of 4.2 
 
 
 
Following the procedure by Montgomery et al.149: A mixture of 4.1 (9.9895 g, 30 mmol), 
phenol (11.5182 g, 120 mmol), p-tolunesulfonic acid (0.1795 g, 0.94 mmol) was prepared in 
a Claisen flask. The mixture was heated at 100°C in vacuo for one hour where N2(g) was 
bubbled through the solution. The resulting dark red syrup was dissolved in 1,2 
dichloroethane, washed with 3 M NaOH and the organic layer collected and concentrated. 
Recrystallisation from EtOH gave 4.2 (3.5046 g, 32%) as a white solid with spectral data in 
accordance with the literature.197 
 
1H NMR (300MHz, CDCl3)  ppm 7.34-7.25 (m, 2H), 7.11-7.04 (m, 2H), 7.02-6.96 (m, 1H), 
5.32-5.27 (m, 1H), 5.21-5.13 (m, 1H), 5.11-5.06 (m, 1H), 4.30 (dd, J = 5.4, 12.2 Hz, 1H), 
4.17 (dd, J = 2.4, 12.2 Hz, 1H), 3.86 (ddd, J = 2.4, 5.2, 9.9 Hz, 1H), 2.08 (s, 2H), 2.06 (s, 
3H), 2.05 (s, 3H), 2.04 (s, 3H). 
M.p. 123–125°C; lit.197 124–125°C. 
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Synthesis of 4.4 
 
 
 
Following the procedure outlined by Lu et al.150: In a round bottom flask was added the β-
phenylglycoside 4.2 (8.7228 g, 20.6 mmol), 40 mL of a 3 M solution of NaOH (120 mmol) 
and the mixture was refluxed for 24 hours in an oil bath. After cooling, the mixture was 
neutralised with conc. H2SO4 and diluted with ice of the same volume. The solution was 
concentrated on a rotary evaporator, extracted with 50 mL of boiling EtOH, filtered, and the 
filter cake was washed with hot EtOH (2x 10 mL). The combined EtOH solution was 
concentrated and acetylised by heating at 100°C in an oil bath for one hour with 30 mL of 
Ac2O. The excess Ac2O was decomposed with 10 mL of H2O. AcOH was removed under 
reduced pressure. Then the mixture was extracted with CHCl3 (2x 20 mL). The salt 
suspended in the solution was washed off with water. The CHCl3 was removed under 
vacuum, and then 10 mL of EtOH was added to the residue. After 8–10 hrs in the fridge, a 
white solid was obtained with vacuum filtration. The mother liquid was concentrated, and 10 
mL ether was added. After crystallising in the fridge, more solid was obtained. The combined 
solids were triturated in 10 mL of 0°C ether and then filtered to give compound 4.4 (2.3239 
g, 39%). The spectral data was in accordance with that reported in the literature.151 
 
1H NMR (300MHz, CDCl3)  ppm 5.47 (br. s, 1H), 4.86 (ap.s, 1H), 4.66-4.56 (m, 3H), 4.10 
(d, J = 7.3 Hz, 1H), 3.81 (dd, J = 5.4, 7.8 Hz, 1H), 2.17 (s, 3H), 2.15 (s, 3H), 2.12 (s, 3H). 
M.p. 107–110°C; lit.151 110–112°C. 
 
Synthesis of 4.5 
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Following the procedure by Irvine et al.152: Sugar 4.4 (1.0807 g, 3.75 mmol) was heated on 
an oil bath at 80–90°C with PBr5 (2.3471 g, 5.45 mmol) with stirring. The flask was fitted 
with a reflux condenser and performed under nitrogen. When effervescence had nearly 
ceased, the contents of the flask were poured into crushed ice and thoroughly disintegrated by 
a glass rod. The solution was filtered, the filter cakes was washed with H2O until free of 
phosphoric acid and thereafter with EtOH until the washings were nearly colourless giving a 
fine white solid. Purification was effected by dissolving the solid in a small quantity of 
CHCl3 and precipitated with pet ether giving the dibromo-derivative 4.5 (0.5451 g, 34%) as a 
very light brown to white solid. 
 
1H NMR (500 MHz, CDCl3)  ppm 6.63 (d, J = 4.0 Hz, 1H, H1), 5.56 (t, J = 9.7 Hz, 1H, 
H3), 5.18 (t, J = 9.5 Hz, 1H, H4), 4.84 (dd, J = 4.0, 9.9 Hz, 1H, H2), 4.33 (ddd, J = 2.9, 4.8, 
9.9 Hz, 1H, H5), 3.57-3.52 (m, 1H, H6a), 3.47-3.42 (m, 1H, H6b), 2.10 (s, 3H, Ac), 2.08 (s, 
3H, Ac), 2.04 (s, 3H, Ac). 
13C NMR (126 MHz, CDCl3)  ppm 170.2, 170.0, 169.5, 86.4 (C1), 72.7 (C5), 70.8 (C2), 
70.3 (C3), 69.9 (C4), 30.3 (C6), 20.9 (Ac x3). 
HRMS (ESI): calc. C12H16Br2NaO7 [M+Na]+: 452.9155; found: 452.9158. 
M.p. 173–174°C; lit.152 173°C. 
 
Synthesis of 4.6 
 
 
 
In a round bottom flask containing freshly activated 4Å molecular sieves was added the 
dibromo-derivative 4.5 (0.2554 g, 0.59 mmol), Ag2O (0.1357 g, 0.59 mmol), BnOH (1 mL, 
9.65 mmol) and anhydrous DCM (5 mL). The solution was stirred at −10°C (MeOH/ice bath) 
and stirred for twohours. The mixture was then filtered through celite to remove silver salts. 
The filtrate was then washed with H2O, extracted with DCM and dried over Na2SO4. The 
solvent was removed in vacuo and the residue was purified by flash chromatography (1:1 
EtOAc:Pet ether) and then recrystallised from EtOH to give pure 4.6 (50 mg, 18%) as a white 
solid. 
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1H NMR (500 MHz, CDCl3)  ppm 7.39-7.29 (m, 5H, Ph), 5.17 (ap.t, J = 9.2 Hz, 1H, H3), 
5.09-5.03 (m, 1H, H2), 4.98 (t, J = 9.5 Hz, 1H, H4), 4.92 (d, J = 12.5 Hz, 1H, CH2Ph), 4.68 
(d, J = 12.1 Hz, 1H, CH2Ph), 4.55 (d, J = 8.1 Hz, 1H, H1), 3.67 (m, 1H, H5), 3.51-3.37 (m, 
2H, H6a, H6b), 2.05 (s, 3H, Ac), 2.01 (s, 3H, Ac), 2.00 (s, 3H, Ac). 
13C NMR (126 MHz, CDCl3)  ppm 136.7, 128.7, 128.3, 128.2, 99.0 (C1), 73.7 (C5), 72.9 
(C3), 71.6 (C2), 71.4 (C4), 70.8 (CH2Ph), 31.0 (C6), 20.9 (Ac x3). 
HRMS (ESI): calc. C19H23BrNaO6 [M+Na]+: 481.0469; found: 481.0478. 
Rf (1:1 EtOAc:Pet ether) = 0.7. 
 
Synthesis of 4.15 
 
 
 
Following the procedure by Lu et al.158: To a solution of D-glucose (9.65 g, 54 mmol) in dry 
DMF (250 mL) was added NaH (5.97 g, 249 mmol) at room temperature. This solution was 
stirred for 30 minutes then cooled in an ice bath. BnBr (21 mL, 177 mmol) was added 
dropwise over five minutes, and after ten minutes the ice bath was removed. After 2.5 hours 
stirring at room temperature additional NaH (5.94 g, 250 mmol) and BnBr (21 mL, 175 
mmol) was added and stirred. After another 2.5 hours the final batch of NaH (3.98g, 
165mmol) and BnBr (12 mL, 101 mmol) was added. The reaction mixture was stirred 
overnight, and then quenched slowly with MeOH. The solution was poured into H2O (500 
mL) and extracted with DCM (3x 150 mL). The combined organic layers were washed with 
H2O (3x 300 mL), then sat. NaCl (300 mL) and dried over MgSO4. The solvent was removed 
in vacuo to give the crude product. Flash chromatography (1:9 EtOAc:Pet ether) followed by 
recrystallisation from MeOH gave 4.15 (10.92 g , 32%) as a white solid with spectral data in 
accordance with the literature.158 
 
1H NMR (500 MHz, CDCl3)  ppm 7.47-7.16 (m, 25H, Ph), 5.03-4.55 (m, 10H, CH2Ph), 
4.54 (d, J = 7.7 Hz, 1H, H1), 3.81-3.71 (m, 2H, H6), 3.69-3.61 (m, 2H, H3, H4), 3.55 (m, 1H, 
H2), 3.49 (ddd, J = 1.8, 4.8, 9.5 Hz, 1H). 
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13C NMR (126 MHz, CDCl3)  ppm 138.8, 138.6, 138.4, 138.3, 137.7, 128.6, 128.4, 128.1, 
128.1, 128.0, 127.8, 102.8 (C1), 84.9, 82.5 (C2), 78.1, 75.9, 75.2 (C5), 75.1, 73.7, 71.4, 69.1 
(C6). 
HRMS (ESI): calc. C41H42NaO6 [M+Na]+: 653.2879; found: 653.2865. 
M.p.: 82–85°C, lit.198 83–83.5°C. 
Rf (1:9 EtOAC:Pet ether) = 0.2. 
 
Synthesis of 4.16 
 
 
 
Following the procedure from Lu et al.158: To freshly fused ZnCl2 (4.4385 g, 33 mmol) 
(under high vacuum overnight prior to use) was added AcOH:Ac2O (1:5, 30 mL). The 
mixture was cooled down to 0°C and then a solution of 4.15 (4.01 g, 6.4 mmol) in 
AcOH:Ac2O (1:5, 30 mL) was added dropwise. The reaction was stirred at room temperature 
for 1.5 hours and then 180 mL of ice-water was added. The resulting brownish precipitate 
was filtered and washed with H2O. Purification by flash chromatography (1:5:1 CHCl3:Pet 
ether:EtOAc) yielded 4.16 (2.3799 g, 64%) as a white solid. 
 
1H NMR (500 MHz, CDCl3)  pppm 7.40-7.24 (m, 20H, Ph), 5.00-4.55 (m, 8H, CH2Ph), 
4.52 (d, J = 8.1 Hz, 1H, H1), 4.41-4.23 (m, 2H, H6), 3.71-3.65 (m, 1H, H3), 3.60-3.49 (m, 
3H, H2, H4, H5), 2.07 (s, 3H, CH3). 
13C NMR (126 MHz, CDCl3)  ppm 171.0, 138.6, 138.4, 137.9, 137.3, 128.7, 128.6, 128.6, 
128.6, 128.4, 128.3, 128.2, 128.1, 127.9, 102.6 (C1), 84.9 (C3), 82.4, 77.6, 75.9, 75.2, 73.1, 
71.4, 63.3 (C6), 21.1 (CH3). 
HRMS (ESI): calc. C36H38NaO7 [M+Na]+: 605.2515; found: 605.2528. 
M.p. 112–113°C; lit.199 116–117°C. 
Rf (1:5:1 CHCl3:Pet ether: EtOAc) = 0.5. 
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Synthesis of 4.17 
 
 
 
Following the procedure from Lu et al.158: A suspension of 4.16 (2.3799 g, 4.1 mmol) in 20 
mL of 0.035 M NaOMe in MeOH was stirred for five hours at room temperature. The 
reaction mixture was then poured into 50 mL of ice-water and stirred for 30 minutes. The 
resulting precipitate was filtered and washed with sat. NaHCO3, H2O and then dried under 
high vacuum to give crude 4.17. Recrystallisation from EtOH gave 4.18 (2.1211 g, 96%) as 
white solid with spectral data in accordance with the literature.158 
 
1H NMR (500 MHz, CDCl3)  ppm 7.40-7.26 (m, 20H, Ph), 4.99-4.63 (m, 8H, CH2Ph), 4.59 
(d, J = 8.1 Hz, 1H, H1), 3.89 (ddd, J = 2.6, 5.9, 11.7 Hz, 1H, H6a), 3.75-3.66 (m, 2H, H6b, 
H3), 3.59 (t, J = 9.4 Hz, 1H, H4), 3.50 (t, J = 8.4 Hz, 1H, H2), 3.38 (ddd, J = 2.8, 4.4, 9.4 Hz, 
1H, H5), 1.86 (t, J = 6.8 Hz, 1H), 1.61 (br. s, 1H, OH). 
13C NMR (75 MHz, CDCl3)  ppm 138.8, 138.6, 138.3, 137.6, 128.9, 128.8, 128.7, 128.5, 
128.4, 128.3, 128.2, 128.1, 128.0, 103.2 (C1), 84.9, 82.7 (C2), 77.9, 76.1, 75.4, 72.0, 62.5 
(C6). 
HRMS (ESI): calc. C34H36NaO6 [M+Na]+: 563.2410; found: 563.2389. 
M.p. 101–103°C; lit.199 104–106°C. 
 
Synthesis of 4.18 
 
 
 
To a solution of 4.17 (2.001 g, 3.7 mmol) in dry DCM (20 mL) was added Ph3P (2.9142 g, 
11.1 mmol) at 0°C. To this cooled solution was added, portion wise and slowly, NBS (1.9797 
g, 11.1 mmol) at a rate to maintain the exothermic reaction. The solution was stirred over 
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night with a drying tube attached, concentrated and filtered through a pad of celite. The celite 
was washed with ether (3x 50 mL) and the combined organic extracts were concentrated in 
vacuo. Flash chromatography (1:9 EtOAc:Pet ether) gave 4.18 (2.0651 g, 92%) as a white 
solid. 
 
1H NMR (500 MHz, CDCl3)  ppm 7.42-7.26 (m, 20H, Ph), 5.01-4.89 (m, 4H, CH2Ph), 4.81-
4.64 (m, 4H, CH2Ph), 4.55 (d, J = 7.7 Hz, 1H, H1), 3.71-3.65 (m, 2H, H3, H6a), 3.58-3.45 
(m, 4H, H2, H4, H5, H6b). 
13C NMR (75 MHz, CDCl3)  ppm 138.8, 138.7, 138.2, 137.5, 128.9, 128.8, 128.8, 128.7, 
128.6, 128.5, 128.3, 128.1, 102.5 (C1), 84.9 (C3), 82.7 (C4), 80.0 (C2), 76.1, 75.6, 75.3, 74.4 
(C5), 71.5, 33.2 (C6). 
HRMS (ESI): calc. C34H35NaO5Br [M+Na]+: 625.1566; found: 625.1573. 
M.p. 103–106°C. 
Rf (1:9 EtOAc:Pet ether) = 0.3. 
 
Synthesis of 4.22 
 
 
 
A mixture of 4.18 (1.0034 g, 1.7 mmol) and triethyl phosphite (14.5 mL, 84.5 mmol) was 
heated and stirred at 140°C. After three days the solution was subjected to high vacuum 
overnight. Flash chromatography (1:1 to 2:1 EtOAc:Pet ether) gave 4.22 (0.7526 g, 69%). 
 
Alternative method: 
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To a solution of diethyl phosphite (50 µL, 0.33 mmol) in DMF (5 mL) was added 
tetrabutylammonium iodide (TBAI, 0.1888 g, 0.51 mmol) and Cs2CO3 (0.1785 g, 0.55 
mmol). The solution was stirred vigorously for one hour at room temperature before the 
addition of 4.18 (99.6 mg, 0.17 mmol) in DMF (5 mL). The reaction was stirred at room 
temperature for three days before the solution was poured into H2O (30 mL) and extracted 
with EtOAc (3x 30 mL). The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. Flash chromatography (30% EtOAc:Pet ether to 100% EtOAc) gave 
4.22 (44.7 mg, 41%) as a white solid. 
 
1H NMR (500 MHz, CDCl3)  ppm 7.51-7.14 (m, 20H, Ph), 5.04-4.90 (m, 4H, CH2Ph), 4.84-
4.70 (m, 3H, CH2Ph), 4.65 (d, J = 11.0 Hz, 1H, CH2Ph), 4.57 (d, J = 7.7 Hz, 1H, H1), 4.19-
4.07 (m, 4H, OCH2CH3), 3.77-3.64 (m, 2H, H3, H5 ), 3.60-3.52 (m, 1H, H2), 3.35 (t, J = 9.0 
Hz, 1H, H4), 2.33 (ap.dd., J = 16.9, 18.3 Hz, 1H, H6a), 1.92 (dt, J = 10.6, 15.6 Hz, 1H, H6b), 
1.39-1.29 (m, 6H, OCH2CH3). 
13C NMR (126 MHz, CDCl3)  ppm 138.6, 138.5, 138.0, 137.3, 128.6, 128.6, 128.5, 128.5, 
128.2, 128.2, 128.1, 128.0, 128.0, 127.8, 102.2 (C1), 84.7 (d, J = 2.6 Hz, C3), 82.5 (C2), 81.7 
(d, 3JPCCC = 14.8 Hz, C4), 75.8, 75.2, 74.9, 71.0, 70.6 (d, 2JPCC = 7.0 Hz, C5), 61.9 (d, 2JPOC = 
2.3 Hz, OCH2CH3), 61.8 (d, 2JPOC = 2.8 Hz, OCH2CH3’), 28.4 (d, 1JPC = 142.9 Hz, C6, C6’), 
16.8 (d, 3JPOCC = 4.19 Hz, OCH2CH3), 16.7 (d, 3JPOCC = 4.19 Hz, OCH2CH3’). 
31P NMR (121 MHz, CDCl3 ppm 29.57. 
HRMS (ESI): calc. C38H46O8P [M+H]+: 661.2930; found: 661.2961. 
M.p. 96–98°C. 
Rf (2:1 EtOAc:Pet ether) = 0.5. 
 
Synthesis of 4.23 
 
 
 
To a solution of dibenzyl phosphite (80 µL, 0.36 mmol) in DMF (5 mL) was added TBAI 
(0.1813 g, 0.49 mmol) and Cs2CO3 (0.1792 g, 0.55 mmol). The solution was stirred 
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vigorously for one hour at room temperature before the addition of 4.18 (102 mg, 0.17 mmol) 
in DMF (5 mL). The reaction was stirred at room temperature for five days before the 
solution was poured into H2O (50 mL) and extracted with EtOAc (3x 30 mL). The combined 
organic layers were dried over MgSO4 and concentrated in vacuo. Flash chromatograph (30% 
EtOAc:Pet ether to 100% EtOAc) gave 4.23 (48 mg, 36%) as a white solid.  
 
1H NMR (500 MHz, CDCl3)  ppm 7.39-7.22 (m, 30H, Ph), 5.11-5.00 (m, 4H, CH2Ph), 4.98-
4.88 (m, 4H, CH2Ph), 4.79 (t, J = 11.0 Hz, 2H, CH2Ph), 4.72 (d, J = 10.6 Hz, 1H, CH2Ph), 
4.61 (d, J = 11.0 Hz, 1H, CH2Ph), 4.53 (d, J = 11.7 Hz, 1H, CH2Ph), 4.50 (d, J = 7.7 Hz, 1H, 
H1), 3.70 (q, J = 9.9 Hz, 1H, H5), 3.64 (t, J = 8.8 Hz, 1H, H3), 3.53 (t, J = 8.4 Hz, 0H, H2), 
3.34 (t, J = 9.2 Hz, 1H, H4), 2.45-2.33 (m, 1H, H6), 1.99 (dt, J = 10.3, 15.6 Hz, 1H, H6’). 
13C NMR (75 MHz, CDCl3)  ppm 138.7, 138.6, 138.2, 137.5, 128.9, 128.8, 128.8, 128.7, 
128.7, 128.5, 128.3, 128.2, 128.2, 128.0, 128.0, 102.6 (C1), 84.8 (C3), 82.7 (C2), 81.8 (d, 
3JPCCC = 14.7 Hz, C4), 76.0, 75.3, 75.1, 71.2, 70.7 (d, 2JPCC = 7.2 Hz, C5), 68.0, 67.9, 67.5, 
67.5, 67.4, 67.3, 29.10 (d, 1JPC = 142.7 Hz, C6, C6’). 
31P NMR (121 MHz, CDCl3 ppm 30.59. 
HRMS (ESI): calc. C48H50O8P [M+H]+: 785.3243; found: 785.3240. 
M.p. 76–79°C. 
Rf (30% EtOAc:Pet ether) = 0.2. 
 
Synthesis of 4.24 
 
 
 
To a solution of 4.22 (0.2060 g, 0.31 mmol) in DCM (10 mL) was added TMSBr (200 µL, 
1.52 mmol) and the mixture was stirred for 24 hours at room temperature. After removal of 
the solvent in vacuo, the remaining residue was treated with a solvent mixture of 
MeOH:DCM (5:1, 10 mL) and stirred vigorously for 12 hours. The solvent was then removed 
in vacuo to give 4.24 (0.1854g, 98%) as a pale white-yellow solid that was spectroscopically 
pure by 1H NMR. 
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1H NMR (500 MHz , CDCl3)  ppm 7.43-7.03 (m, 20H, Ph), 4.96-4.79 (m, 4H, CH2Ph), 
4.74-4.65 (m, 2H, CH2Ph), 4.59 (d, J = 12.1 Hz, 1H, CH2Ph), 4.51 (d, J = 11.0 Hz, 1H, 
CH2Ph), 4.46 (d, J = 7.7 Hz, 1H, H1), 3.65-3.51 (m, 2H, H3, H5), 3.51-3.44 (m, 1H, H2), 
3.23 (t, J = 9.0 Hz, 1H, H4), 2.34-2.19 (m, 1H, H6), 1.91-1.78 (m, 1H, H6’). 
13C NMR (126 MHz, CDCl3)  ppm 138.6, 138.5, 137.8, 137.4, 128.7, 128.6, 128.5, 128.5, 
128.5, 128.2, 128.2, 128.1, 128.0, 127.8, 127.8, 102.4 (C1), 84.5 (C3), 82.4 (C2), 81.34 (d, 
3JPCCC = 14.8 Hz, C4), 75.9, 75.2, 74.9, 71.3, 70.20-70.10 (m, C5), 28.42 (d, 1JPC = 151.3 Hz, 
C6, C6’). 
31P NMR (121 MHz, CDCl3 ppm 34.82. 
HRMS (ESI): calc. C34H38O8P [M+H]+: 605.2304; found: 605.2297. 
M.p. 179–181°C 
 
Synthesis of 4.14 
 
 
 
To 4.24 (81.4 mg, 0.13 mmol) in AcOH (3 mL) was added 10% Pd/C (20% wt of 4.25). After 
three vacuum/H2 cycles, to flush the flask with H2, the mixture was vigorously stirred at room 
temperature under hydrogen (balloon) for 48 hours. The Pd/C was filtered through a small 
pad of celite and the pad washed with MeOH (3x). The filtrate was concentrate in vacuo to 
give crude 4.14 as an oil. The oil was purified using a reverse phase C18 silica column 
eluting with 10% MeOH:H2O. The relevant fractions were collected and freeze dried to give 
4.14 as a sticky white-yellow semi-solid (29.8 mg, 100%) containing both α- and β-anomers 
(1:1.3 ratio, respectively). 
 
1H NMR (500 MHz, D2O)  ppm 5.07 (d, J = 3.3 Hz, 1H, H1α), 4.53 (d, J = 7.7 Hz, 1H, 
H1β), 3.96 (q, J = 9.8 Hz, 1H, H5α), 3.60-3.46 (m, 2H, H3α and H5β), 3.42 (dd, J = 3.3, 9.9 
Hz, 1H, H2α), 3.34 (ap.t, J = 9.5 Hz, 1H, H3β), 3.16-3.07 (m, 3H, H4α, H2β, H4β), 2.25-2.13 
(m, 2H, H6α, H6β), 1.87-1.76 (m, 3H, H6’α, H6’β). 
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13C NMR (126 MHz, D2O)  ppm 96.0 (C1β), 92.1 (C1α), 75.5, 74.3, 74.1, 74.0, 72.7, 71.7, 
67.1, 29.7 (d, 1JPC = 137.7 Hz, C6β, C6’β), 29.6 (d, 1JPC = 137.7 Hz, C6α, C6’α). 
31P NMR (121 MHz, CDCl3 ppm 26.07, 25.49. 
HRMS (ESI): calc. C6H12O8P [M−H]−: 243.0270; found: 243.0267. 
 
Synthesis of 4.26 
 
 
 
To a solution of butan-1,4-diol (5.0385 g, 56 mmol) in DCM (100 mL) was added Ag2O 
(19.3293 g, 83.4 mmol) and BnBr (7.30 mL, 61.4 mmol) at room temperature. The mixture 
was stirred for four hours before the residual Ag2O was filtered through celite. The resulting 
filtrate was concentrated in vacuo and purified by flash chromatography (10 to 30% 
EtOAc:Pet ether) to give 4.26 (7.5065 g, 75%) as a colourless oil with spectral data in 
accordance with the literature.169 
 
1H NMR (500 MHz, CDCl3)  ppm 7.38-7.26 (m, 5H, Ph), 4.53 (s, 2H, CH2Ph), 3.65 (t, J = 
5.9 Hz, 2H, H4), 3.53 (t, J = 5.7 Hz, 2H, H1), 2.35 (br. s, 1H, OH), 1.77-1.63 (m, 4H, H2, 
H3). 
13C NMR (126 MHz, CDCl3)  ppm 171.4, 138.4, 128.7, 127.9, 73.3, 70.6 (C1), 62.9 (C4), 
30.4 (C3), 26.9 (C2). 
Rf (30% EtOAc:Pet ether) = 0.15 
 
Synthesis of 4.27 
 
 
 
To a solution of 4.26 (1.5020 g, 8.33 mmol) in DCM (25 mL) was added Ph3P (3.2773 g, 
12.5 mmol) and the solution was cooled to 0°C. To this cooled solution was added NBS 
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(2.2252 g, 12.5 mmol) portionwise. The mixture was then stirred for five hours at room 
temperature, concentrated in vacuo and filtered through a pad of celite to remove 
triphenylphosphine oxide. The pad was washed with ether, the filtrate collected, concentrated 
in vacuo and purified by flash chromatography (5% EtOAc:Pet ether) to give 4.27 (1.7419 g, 
86 %) as a colourless oil with spectral data in accordance with literature.173 
 
1H NMR (500 MHz, CDCl3)  ppm 7.38-7.25 (m, 5H, Ph), 4.51 (s, 2H, CH2Ph), 3.51 (t, J = 
6.1 Hz, 2H, H1), 3.44 (t, J = 6.8 Hz, 2H, H4), 2.03-1.94 (m, 2H, H3), 1.82-1.72 (m, 2H, H2). 
13C NMR (126 MHz, CDCl3)  ppm 138.6, 128.6, 127.8, 73.2 (CH2Ph), 69.5 (C1), 34.0 (C4), 
29.9 (C3), 28.6 (C2). 
Rf (10% EtOAc:Pet ether) = 0.60. 
 
Synthesis of 4.28 
 
 
 
To a solution of diethyl phosphite (530 µL, 4.11 mmol) in DMF (20 mL) was added TBAI 
(4.5576 g, 12.3 mmol) and Cs2CO3 (4.0153 g, 12.3 mmol). The solution was stirred 
vigorously for one hour at room temperature before the addition of 4.27 (0.5021 g, 2.07 
mmol) in DMF (5 mL). The reaction was stirred at room temperature for three days before 
the solution was poured into H2O and extracted with EtOAc (3x). The combined organic 
layers were washed with sat. NaCl, dried over MgSO4 and concentrated in vacuo. Flash 
chromatography (2:1 EtOAc:Pet ether to 5% MeOH:EtOAc) gave 4.28 (0.5170 g, 83%). 
 
1H NMR (500 MHz, CDCl3)  ppm 7.37-7.26 (m, 5H, Ph), 4.50 (s, 2H, CH2Ph), 4.16-4.02 
(m, 4H, OCH2CH3), 3.51-3.45 (m, 2H, H1), 1.81-1.67 (m, 6H, H2, H3, H4), 1.32 (t, J = 7.2 
Hz, 6H, OCH2CH3). 
13C NMR (126 MHz, CDCl3)  ppm 138.7, 128.6, 127.8, 127.8, 73.2 (CH2Ph), 69.8 (C1), 
61.7 (d, 2JPOC = 6.5 Hz, OCH2CH3), 30.8 (d, 3JPCCC = 16.7 Hz, C2), 25.7 (d, 1JPC = 141.0 Hz, 
C4), 19.7 (d, 2JPCC = 5.1 Hz, C3), 16.7 (d, 3JPOCC = 6.0 Hz, OCH2CH3). 
31P NMR (121 MHz, CDCl3 ppm 32.18. 
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HRMS (ESI): calc. C15H25NaO4P [M+Na]+: 323.1383; found: 323.1382. 
Rf (5% MeOH:EtOAc) = 0.6. 
 
Synthesis of 4.34 
Method 1: 
 
 
To 4.27 (0.5010 g, 2.06 mmol) was added P(OEt)3 in excess (52.5 mmol). The mixture was 
heated to 140–150°C on an oil bath. After three days the mixture was quenched with H2O and 
extracted with ether. The organic layer was washed with sat. NaHCO3, sat. NaCl and dried 
over MgSO4. The organic layer was concentrated to give a mixture of 4.28 and side-product 
4.30 that was inseparable by column chromatography. To the inseparable mixture of 4.28 and 
4.30 was added MeOH and 10% Pd/C (2% wt of mixture). After three vacuum/H2 cycles, to 
flush the flask with H2, the mixture was vigorously stirred at room temperature under 
hydrogen (balloon) for four days. The Pd/C was filtered through a small pad of celite and the 
pad washed with MeOH (3x). The filtrate was concentrate in vacuo and purified by flash 
chromatography (5% MeOH:EtOAc) to give 4.34 (86.9 mg, 20% over 2 steps) as a colourless 
oil. 
 
Method 2: 
 
 
A mixture of 4.28 (0.5017 g, 1.63 mmol) in MeOH (20 mL) was added 10% Pd/C (10% wt of 
4.28). The mixture was hydrogenated at 30 atm and 45°C using a Parr hydrogenator 
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overnight. The Pd/C was filtered through a small pad of celite and the pad washed with 
MeOH (3x). The filtrate was concentrate in vacuo and purified by flash chromatography (5% 
MeOH:EtOAc) to give 4.34 (85.2 mg, 24%). 
 
Method 3: 
 
 
 
A solution of 4.33 (0.5450 g, 1.68 mmol) in THF (10 mL) was treated with TBAF (2.5 mL, 1 
M solution in THF, 2.5 mmol). After stirring at room temperature for two hours, the reaction 
mixture was quenched with H2O and the aqueous mixture extracted with DCM (3x). The 
combined organic extracts were washed with sat. NaCl, dried (MgSO4) and the solvent 
removed in vacuo. Flash chromatography (5% MeOH:EtOAc) gave 4.34 (0.1879 g, 52%). 
 
1H NMR (500 MHz, CDCl3)  ppm 4.18-4.02 (m, 4H, OCH2CH3), 3.67 (t, J = 6.1 Hz, 2H, 
H1), 1.84-1.63 (m, 6H, H2, H3, H4), 1.33 (t, J = 7.2 Hz, 6H, OCH2CH3). 
13C NMR (126 MHz, CDCl3)  ppm 62.3 (C1), 61.7 (d, 2JPOC = 6.5 Hz, OCH2CH3), 33.5 (, 
3JPCCC = 14.9 Hz, C2), 25.5 (d, 1JPC = 141.0 Hz, C4), 19.1 (d, 2JPCC = 5.1 Hz, C3), 16.7 (d, 
3JPOCC = 6.0 Hz, OCH2CH3). 
31P NMR (121 MHz, CDCl3 ppm 32.34. 
HRMS (ESI): calc. C8H20O4P [M+H]+: 211.1099; found: 211.1098. 
Rf (5% MeOH:EtOAc) = 0.2. 
 
Synthesis of 4.36 
 
 
 
Compound 4.34 (0.3029 g, 1.44 mmol) was dissolved in DCM (10 mL) and freshly prepared 
DMP (1.2258 g, 2.89 mmol) was added. The mixture was stirred overnight, after which Et2O, 
sat. NaHCO3 and sat. NaS2O3 were added and the mixture was stirred till the solution was 
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clear. The mixture was transferred to a separating funnel and the aqueous layer extracted with 
Et2O (3x). The combined organic extracts were washed with sat. NaCl, dried (MgSO4) and 
the solvent removed in vacuo. Flash chromatography (5% MeOH:EtOAc) gave the aldehyde 
4.36 (0.2192 g, 73%) as a yellowish clear oil. 
 
1H NMR (500 MHz, CDCl3)  ppm 9.79 (s, 1H, H1), 4.19-4.04 (m, 4H, OCH2CH3), 2.62 (t, 
J = 7.0 Hz, 2H, H2), 1.95 (dq, J = 7.3, 14.6 Hz, 2H, H3), 1.84-1.73 (m, 2H, H4), 1.33 (t, J = 
7.0 Hz, 6H, OCH2CH3). 
13C NMR (126 MHz, CDCl3)  ppm 201.5 (C1), 61.9 (d, 2JPOC = 6.5 Hz, OCH2CH3), 44.1 (d, 
3JPCCC = 14.0 Hz, C2), 25.0 (d, 1JPC =141.9 Hz, C4), 16.7 (d, 3JPOCC = 6.0 Hz, OCH2CH3), 
15.6 (d, 2JPCC = 5.1 Hz, C3). 
31P NMR (121 MHz, CDCl3 ppm 30.99. 
HRMS (ESI): calc. C8H18O4P [M+H]+: 209.0943; found: 209.0943. 
Rf (5% MeOH:EtOAc) = 0.2. 
 
Synthesis of 4.29 
 
 
 
To a solution of dibenzyl phosphite (0.8145 g, 3.11 mmol) in DMF (20 mL) was added TBAI 
(3.4179 g, 9.25 mmol) and Cs2CO3 (3.0164 g, 9.26 mmol). The solution was stirred 
vigorously for one hour at room temperature before the addition of 4.27 (0.5019 g, 2.06 
mmol) in DMF (1 mL). The reaction was stirred at room temperature for six days before the 
solution was poured into water and extracted with EtOAc (3x). The combined organic layers 
were washed with H2O, sat. NaCl, dried over MgSO4 and concentrated in vacuo. Flash 
chromatography (30 to 50% EtOAc:Pet ether) gave 4.29 (0.3517 g, 49%). 
 
1H NMR (500 MHz, CDCl3)  ppm 7.47-7.20 (m, 15H, Ph), 5.08-4.93 (m, 4H, CH2Ph), 4.46 
(s, 2H, CH2Ph), 3.42 (t, J = 5.9 Hz, 2H, H1), 1.84-1.60 (m, 6H, H2, H3, H4). 
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13C NMR (126 MHz, CDCl3)  ppm 138.7, 136.7 (d), 128.8, 128.6 (d), 128.1, 127.8, 127.8, 
73.1 (CH2Ph), 69.7 (C1), 67.3 (d, J = 6.5 Hz, CH2Ph), 30.7 (d, 3JPCCC = 16.7 Hz, C2), 26.0 (d, 
1JPC =140.0 Hz, C4), 19.5 (d, 2JPCC = 5.1 Hz, C3). 
31P NMR (121 MHz, CDCl3 ppm 33.32. 
HRMS (ESI): calc. C25H29NaO4P [M+Na]+: 447.1696; found: 447.1703. 
Rf (1:1 EtOAc:Pet ether) = 0.2. 
 
Synthesis of 4.35 
 
 
 
To a solution of 4.29 (0.3505 g, 0.83 mmol) was added MeOH (5 mL) and 10% Pd/C (37.5 
mg, 10% wt of 4.29). After three vacuum/H2 cycles, to flush the flask with H2, the mixture 
was vigorously stirred at room temperature under hydrogen (balloon) for four hours. The 
Pd/C was filtered through a small pad of celite and the pad washed with MeOH (3x 10 mL). 
The filtrate was concentrate in vacuo to give spectroscopically pure 4.35 (0.1413 g, 100%). 
 
1H NMR (500 MHz, MeOH-d4)  ppm 3.58 (t, J = 5.9 Hz, 2H, H1), 1.79-1.58 (m, 6H, H2, 
H3, H4). 
13C NMR (126 MHz, MeOH-d4)  ppm 61.1 (C1), 33.3 (d, 3JPCCC = 16.3 Hz, C2), 26.7 (d, 
1JPC = 138.6 Hz, C4), 19.3 (d, 2JPCC = 4.7 Hz, C3). 
31P NMR (121 MHz, CDCl3 ppm 26.60. 
HRMS (ESI): calc. C4H10O4P [M−H]−: 153.0317; found: 153.0311.  
 
Synthesis of 4.31 
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TBDMSCl (12.4210 g, 82 mmol) in dry DCM (40 mL) was added dropwise to a solution of 
butan-1,4-diol (22.0162 g, 240 mmol) and imidazole (12.1774 g, 180 mmol) in DCM (60 
mL) at 0°C over 15 minutes. The solution was stirred overnight at room temperature then 
quenched using sat. NH4Cl, extracted with DCM and dried over MgSO4. The crude product 
was purified by flash chromatography (10 to 30% EtOAc:Pet ether) to give 4.31 (11.77 g, 
70%) as a colourless oil with spectral data in accordance with the literature.170 
 
1H NMR (500 MHz, CDCl3) ppm 3.72-3.60 (m, 4H, H1, H4), 2.35 (br. s, 1H, OH), 1.73-
1.57 (m, 4H, H2, H3), 0.90 (s, 9H, tBu), 0.07 (s, 6H, SiMe2). 
13C NMR (126 MHz, CDCl3)  ppm 63.6 (C4), 63.0 (C1), 30.5 (C3), 30.1 (C2), 26.1 (tBu, 
3C), 18.5 (tBu, 1C), -5.2 (SiMe2). 
HRMS (ESI): calc. C10H24NaO2Si [M+Na]+:227.1438; found: 227.1438. 
Rf (30% EtOAc:Pet ether) = 0.3. 
 
Synthesis of 4.32 
 
 
 
To a solution of 4.31 (0.5025 g, 2.46 mmol) in DCM (10 mL) was added triphenylphosphine 
(0.9654 g, 3.68 mmol) at 0°C. To this cooled solution was added, portion wise and slowly, 
NBS (0.6524 g, 3.67 mmol) at a rate to maintain the exothermic reaction. The solution was 
stirred overnight then concentrated and filtered through a pad of celite to remove 
triphenylphosphine oxide. The celite was washed with ether (3x) and the combined organic 
extracts were concentrated in vacuo. Flash chromatography (100% Pet ether to 30% 
EtOAc:Pet ether) gave 4.32 (0.2057 g, 31%) with spectral data in accordance with the 
literature.172 
 
1H NMR (500 MHz, CDCl3)  ppm 3.65 (t, J = 6.2 Hz, 2H, H1), 3.45 (t, J = 6.8 Hz, 2H, H4), 
1.95 (quin, J = 7.2 Hz, 2H, H3), 1.71-1.61 (m, 2H, H2), 0.90 (s, 9H, tBu), 0.05 (s, 6H, 
SiMe2). 
13C NMR (126 MHz, CDCl3)  ppm 62.4 (C1), 34.2 (C4), 31.5 (C2), 29.7 (C3), 26.2 (tBu, 
3C), 18.5 (tBu, 1C), -5.1 (SiMe2). 
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HRMS (ESI): calc. C10H23BrNaOSi [M+Na]+: 289.0594; found: 289.0595. 
Rf (Pet ether) = 0.2. 
 
Synthesis of 4.33 
 
 
 
To a solution of diethyl phosphite (470 µL, 3.65 mmol) in DMF (20 mL) was added TBAI 
(3.9965 g, 10.8 mmol) and Cs2CO3 (3.5292 g, 10.8 mmol). The solution was stirred 
vigorously for one hour at room temperature before the addition of 4.32 (0.4823 g, 1.80 
mmol) in DMF (1.0 mL). The reaction was stirred at room temperature for three days before 
the solution was poured into H2O and extracted with EtOAc (3x). The combined organic 
layers were washed with sat. NaCl, dried over MgSO4 and concentrated in vacuo. Flash 
chromatography (2:1 EtOAc:Pet ether to 5% MeOH:EtOAc) gave 4.33 (0.2866 g, 49%). 
 
1H NMR (500 MHz, CDCl3)  ppm 4.26-3.95 (m, 4H, OCH2CH3), 3.62 (t, J = 6.1 Hz, 2H, 
H1), 1.86-1.53 (m, 6H, H2, H3, H4), 1.32 (t, J = 7.2 Hz, 6H, OCH2CH3), 0.89 (s, 9H, tBu), 
0.04 (s, 6H, SiMe2). 
13C NMR (126 MHz, CDCl3)  ppm 62.6 (C1), 61.6 (d, 2JPOC = 6.5 Hz, OCH2CH3), 33.7 (d, 
3JPCCC = 16.3 Hz, C2), 26.2 (tBu, 3C), 25.7 (d, 1JPC = 140.5 Hz, C4), 19.2 (d, 2JPCC = 5.1 Hz, 
C3), 18.5 (tBu, 1C), 16.7 (d, 3JPOCC = 6.0 Hz, OCH2CH3), -5.1 (SiMe2). 
31P NMR (121 MHz, CDCl3 ppm 32.35. 
HRMS (ESI): calc. C14H34O4SiP [M+H]+: 325.1964; found: 325.1969. 
Rf (5% MeOH:EtOAc) = 0.5. 
 
Synthesis of 4.37 
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To 4.36 (0.1120 g, 0.54 mmol) in MeOH (8 mL) was added trimethyl orthoformate (590 µL, 
5.39 mmol) and conc. H2SO4 (6 µL, 0.11 mmol). After stirring overnight, an addition aliquot 
of trimethyl orthoformate (560 µL, 5.11 mmol) and conc. H2SO4 (10 µL, 0.19 mmol) was 
added and stirred for a further 24 hours. The mixture was transferred to a separating funnel 
containing sat. NaHCO3 and EtOAc. The aqueous layer was extracted with EtOAc (3x). The 
combined organic extracts were washed with sat. NaCl, dried (NaSO3) and the solvent 
removed in vacuo to give spectroscopically pure 4.37 (99 mg, 72%). 
 
1H NMR (500 MHz, CDCl3)  ppm 4.33 (ap.t, J = 4.6 Hz, 2H, H1), 4.14-4.00 (m, 4H, 
OCH2CH3), 3.29 (s, 6H, OMe), 1.79-1.59 (m, 6H, H2, H3, H4), 1.30 (t, J = 7.2 Hz, 6H, 
OCH2CH3). 
13C NMR (126 MHz, CDCl3)  ppm 104.2 (C1), 61.7 (d, 2JPOC = 6.5 Hz, OCH2CH3), 53.0 
(OMe), 33.4 (d, 3JPCCC = 15.8 Hz, C2), 25.6 (d, 1JPC = 140.0 Hz, C1), 18.1 (d, 2JPCC = 5.1 Hz, 
C3), 16.7 (d, 3JPOCC = 6.0 Hz, OCH2CH3). 
31P NMR (121 MHz, CDCl3 ppm 31.85. 
HRMS (ESI): calc. C10H23NaO5P [M+Na]+: 277.1175; found: 277.1178. 
Rf (1:1 EtOAc:Pet ether) = 0.1. 
 
Synthesis of 2,3-dideoxyerythrose 4-phosphonate 4.38 
 
 
 
To a solution of 4.37 (0.040 g, 0.16 mmol) in DCM (2.0 mL) was added Et3N (130 µL, 0.93 
mmol) and TMSBr (90 µL, 0.68 mmol). The mixture was stirred at room temperature over 
night before additional Et3N (50 µL, 0.36 mmol) and TMSBr (50 µL, 0.38 mmol) was added 
and stirred for 24 hours. The mixture was then reduced to dryness in vacuo. H2O (2.0 mL) 
and freshly activated Dowex-H+ resin was then added. The solution was stirred overnight, 
reduced in vacuo and made up to 1.0 mL in H2O. This solution was used in enzyme assays 
without further purification. 
 
HRMS (ESI): calc. C4H9O4P [M+H]+: 153.0311; found: 153.0311. 
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